Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3034780	fs-ace	u/l (u/l)	14389	28448	0.06%
3034780	fs-ace	— (—)	1829	2797	100.00%	Distribution not available
3034780	s-ace	u/l (u/l)	1403	2204	0.18%
3034780	s-ace	— (—)	637	717	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD, hospital admissions

784

1809

4.85

318.59

1.8

38.45

38.31

u/l

0.06

713

1542

Other interstitial pulmonary diseases

787

1826

4.82

317.36

1.8

38.43

38.32

u/l

0.04

716

1554

Interstitial lung disease

787

1835

4.79

315.38

1.8

38.43

38.26

u/l

0.07

716

1562

Interstitial lung disease endpoints

787

1835

4.79

315.38

1.8

38.43

38.26

u/l

0.07

716

1562

ILD, hospital admissions 1, main diag only

727

1595

5.15

315.26

1.8

38.47

38.37

u/l

0.04

660

1363

Headache

2307

8247

2.42

309.76

2.1

1.9

38.97

39.38

u/l

0.43

2093

7365

Other systemic involvement of connective tissue

1245

3997

3.35

308.88

1.7

2.0

38.19

39.14

u/l

0.85

1117

3515

Asthma, unspecified (mode), excluding more controls

2070

4579

3.73

307.65

2.2

1.2

38.85

38.80

u/l

0.03

1851

4063

Other heart diseases, wide

3754

10185

2.38

307.65

2.4

1.9

38.45

40.31

u/l

5.46

3250

9373

Other respiratory diseases principally affecting the interstitium

876

2164

4.47

307.65

1.8

38.20

38.46

u/l

0.12

792

1846

Autoimmune diseases excluding thyroid diseases

4395

9999

2.54

307.65

1.9

2.0

38.90

39.43

u/l

0.83

3970

8884

Asthma (only as main-diagnosis), excluding more controls

2764

5091

3.38

307.65

2.1

1.2

38.75

38.97

u/l

0.20

2496

4548

Autoimmune diseases related-to ILD

3255

13091

2.27

307.65

1.8

2.1

37.93

39.87

u/l

6.54

2932

11657

ILD medications: immunosuppressive drugs

2977

8245

3.69

307.65

2.5

1.5

37.82

40.21

u/l

7.54

2725

7288

Polyarthropathies

2833

7432

2.65

307.65

1.9

2.0

37.89

39.50

u/l

3.50

2526

6649

Heart failure, not strict

2861

8420

2.45

307.65

2.2

1.9

36.71

39.96

u/l

10.87

2326

7534

Cardiomyopathy

877

2113

4.55

307.65

2.5

1.7

33.41

39.47

u/l

10.28

637

1896

Inflammatory bowel disease treatment related agents

5702

10564

3.24

307.65

2.8

1.5

38.41

39.99

u/l

5.77

5191

9364

ILD medications: prednisolone, methylprednisolone, prednisone

5629

9516

3.54

307.65

2.8

1.5

38.59

40.08

u/l

4.94

5140

8400

ILD medications

5782

9661

3.47

307.65

2.7

1.5

38.38

40.06

u/l

6.40

5288

8537

Diagnoses used for exclusion with ILD

3142

3267

12.76

307.65

5.3

1.2

44.74

37.82

u/l

37.31

2979

2791

Anterior Iridocyclitis

1231

3021

4.56

307.65

2.4

1.9

39.46

39.21

u/l

0.16

1147

2681

Excluding asthma or asthma-COPD overlap

3127

5591

2.91

307.65

2.4

1.2

39.59

38.58

u/l

1.70

2844

4907

Asthma (mode)

3141

5579

3.23

307.65

2.2

1.2

39.03

38.59

u/l

0.50

2837

4891

Iridocyclitis

1392

3351

4.65

307.65

2.4

1.9

39.60

38.82

u/l

0.71

1293

2958

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

751

635

9.93

307.65

1.9

2.1

38.38

39.73

u/l

0.66

685

567

Asthma, excluding more controls

3135

5091

3.43

307.65

2.2

1.2

39.10

38.97

u/l

0.12

2830

4548

Other systemic involvement of connective tissue (FG)

1223

3414

3.84

307.65

1.7

2.0

37.96

39.57

u/l

1.88

1097

3001

Disorders of sclera, cornea, iris and ciliary body

2330

9018

2.73

307.65

2.2

2.0

39.51

39.20

u/l

0.31

2149

8005

Other heart diseases

2250

4946

3.17

307.65

2.7

1.9

38.14

41.25

u/l

8.29

1953

4675

Renal failure

1776

5294

3.26

307.65

2.4

1.7

39.62

38.37

u/l

1.39

1537

4544

Sarcoidosis

2876

1677

34.49

307.65

5.7

1.2

45.23

38.61

u/l

24.32

2742

1461

Acute and subacute iridocyclitis

1147

2796

4.58

307.65

2.3

1.9

39.53

38.99

u/l

0.39

1073

2481

Chronic kidney disease

1273

3497

3.90

307.65

2.5

1.7

39.69

37.95

u/l

1.83

1105

2992

Polyneuropathies and other disorders of the peripheral nervous system

1088

2905

4.12

307.65

1.7

1.8

40.13

38.43

u/l

1.69

959

2522

Other and unspecified polyneuropathies, also in other diseases

1012

2471

4.56

307.65

1.8

40.23

38.33

u/l

1.88

890

2134

Autoimmune diseases

4211

10042

2.21

307.65

1.9

2.0

38.99

39.44

u/l

0.65

3828

8924

Other arthritis (FG)

1369

4463

3.27

307.65

1.9

2.0

37.20

39.69

u/l

4.68

1234

3956

Asthma, unspecified (mode)

2086

4959

3.50

307.65

2.2

1.2

38.86

38.42

u/l

0.39

1861

4318

Autoimmune diseases excluding thyroid diseases, strict definition

4249

9695

2.54

307.65

1.9

2.0

38.93

39.48

u/l

0.86

3841

8614

COPD differential diagnosis

3100

5582

2.88

307.65

2.4

1.2

39.60

38.58

u/l

1.70

2823

4894

Asthma

3198

5530

3.24

307.65

2.2

1.2

39.14

38.57

u/l

0.70

2884

4850

Asthma (only as main-diagnosis)

2792

5530

3.18

307.65

2.1

1.2

38.75

38.57

u/l

0.16

2518

4850

Used for control exclusion in common control thyroid runs

3948

9254

2.23

307.65

1.9

2.0

38.90

39.53

u/l

1.00

3603

8218

Oral corticosteroids

5539

10263

3.47

307.65

2.9

1.5

38.42

39.94

u/l

5.16

5040

9082

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5674

10561

4.16

307.65

3.5

1.2

42.25

37.91

u/l

33.82

5153

9329

L04AX Other immunosuppressants

2438

9228

2.79

307.65

2.6

1.9

37.61

39.85

u/l

6.07

2238

8203

Pain in joint

2420

6255

2.67

307.65

2.2

2.0

39.50

39.75

u/l

0.23

2176

5539

Other pulmonary diagnosis

2859

5591

2.64

307.65

2.0

1.2

39.06

38.58

u/l

0.56

2596

4907

Enlarged lymph nodes

1332

1881

8.40

307.65

3.5

1.8

43.00

38.88

u/l

7.14

1248

1663

Finngen Rheumatological endpoints

3650

9971

2.15

307.65

1.9

2.1

38.35

40.02

u/l

4.97

3292

8972

First line medication for Crohn's disease

5363

9553

3.22

307.65

2.7

1.5

38.43

40.05

u/l

5.69

4902

8463

ILD differential diagnosis

3100

5579

2.89

307.65

2.4

1.2

39.59

38.59

u/l

1.67

2823

4891

Cough

1629

5454

3.02

307.65

2.3

1.8

40.62

39.23

u/l

1.91

1475

4832

Myocarditis

444

517

10.60

307.65

7.1

1.8

36.34

42.11

u/l

5.30

411

483

Systemic connective tissue disorders

1721

5249

3.54

307.65

1.7

2.0

37.50

39.20

u/l

2.82

1552

4600

Abnormal findings on diagnostic imaging of lung

2857

6150

5.03

307.65

3.0

1.7

40.74

38.62

u/l

4.95

2607

5255

Certain disorders involving the immune mechanism

3149

2512

19.57

307.65

5.3

1.2

44.57

38.39

u/l

27.83

2992

2193

Dyspnoea

3470

11720

2.36

307.65

2.1

1.9

39.03

39.38

u/l

0.41

3034

10445

Other specific joint derangements/joint disorders

2815

8311

2.35

307.65

2.2

2.0

39.71

39.52

u/l

0.18

2540

7494

General symptoms and signs

4646

9302

2.60

307.65

2.2

1.8

39.48

39.37

u/l

0.12

4193

8294

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3605

8578

4.26

307.65

2.8

1.7

40.42

38.76

u/l

4.20

3279

7429

Second line medication for Crohn's disease

2489

9494

2.77

307.65

2.6

1.9

37.70

39.83

u/l

5.66

2285

8438

Abnormalities of breathing

3688

8900

2.56

307.65

2.2

1.9

39.42

39.39

u/l

0.03

3273

8039

Fever of other and unknown origin

2404

7022

3.35

307.65

2.0

1.8

38.86

38.92

u/l

0.04

2183

6193

Heart failure and antihypertensive medication

1222

2157

4.03

307.65

2.1

1.8

34.93

42.48

u/l

19.58

951

2030

Symptoms and signs involving the circulatory and respiratory systems

3861

8943

2.23

307.65

2.1

1.9

39.27

39.42

u/l

0.16

3480

8082

Asthma (diagnoses ohter than nonallergic)

3163

13240

2.11

306.67

2.1

1.9

38.78

39.49

u/l

1.16

2852

11791

Anaemias

1004

1708

4.13

305.85

2.0

39.37

41.18

u/l

1.52

912

1648

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1341

1963

3.54

303.97

2.0

1.7

39.15

38.93

u/l

0.13

1222

1774

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

538

949

6.65

300.69

1.8

36.11

38.58

u/l

1.66

468

822

Medical observation and evaluation for suspected diseases and conditions

2532

5562

2.41

296.85

2.1

1.9

39.40

39.04

u/l

0.34

2258

4935

Cardiac arrhythmias

2441

7077

2.37

293.96

2.5

2.0

38.89

40.72

u/l

3.81

2132

6598

Other specified/unspecified arthritis

1190

3839

3.31

291.83

1.9

36.92

39.39

u/l

4.05

1071

3398

Other soft tissue disorders, not elsewhere classified

3316

10124

2.08

291.38

1.9

2.0

39.27

u/l

0.00

2985

9064

GASTRO-related operations

2936

6829

2.22

285.77

2.0

1.9

39.87

39.28

u/l

0.76

2675

6130

Any gastric operation

2936

6829

2.22

285.77

2.0

1.9

39.87

39.28

u/l

0.76

2675

6130

Reimbursement for rheumatic diseases

2212

9820

2.35

282.88

1.7

2.0

37.86

39.69

u/l

4.20

2006

8712

Cardiovascular diseases (excluding rheumatic etc)

2448

6216

2.35

281.88

2.3

1.9

38.47

40.97

u/l

6.50

2190

5898

Heart failure,strict

1863

5385

2.61

280.47

2.0

1.8

35.22

39.39

u/l

10.36

1446

4747

Pain in throat and chest

2926

8545

2.15

279.54

2.1

1.9

38.86

39.52

u/l

0.87

2611

7697

Renal tubulo-interstitial diseases

3016

11538

2.07

271.68

2.3

1.9

39.31

39.20

u/l

0.10

2633

10266

Disorders of calcium metabolism

439

733

7.13

260.34

3.2

1.9

41.75

39.45

u/l

1.05

383

651

Disorders of mineral metabolism

509

984

5.96

257.01

3.0

1.8

41.96

39.20

u/l

1.62

443

873

Bacterial infection, other or unspecified

1847

7096

2.45

256.05

1.8

1.9

37.50

39.16

u/l

2.49

1589

6207

Cardiovascular diseases

2252

5394

2.34

254.66

2.1

1.9

38.66

40.79

u/l

4.78

2035

5143

Chronic lower respiratory diseases

4168

12590

1.83

246.81

2.1

2.0

39.02

39.60

u/l

0.96

3761

11242

Asthma, including avohilmo

4045

13088

1.84

246.02

2.0

38.93

39.54

u/l

1.06

3650

11672

Symptoms and signs involving the skin and subcutaneous tissue

2437

11872

2.12

243.60

2.0

39.51

39.25

u/l

0.25

2212

10532

Chronic iridocyclitis

393

633

7.53

242.50

2.9

2.0

38.34

39.31

u/l

0.38

364

559

Neurological diseases, wide definition

1112

1684

3.43

240.88

1.9

2.2

38.97

40.86

u/l

1.92

1020

1554

Neurological diseases

3049

7728

2.04

240.71

1.9

2.0

38.90

39.89

u/l

1.76

2743

6917

Infections, IBD-co-morbidities

634

1018

4.80

240.10

1.8

2.2

38.76

41.00

u/l

1.50

553

928

Malaise and fatigue

1601

5431

2.55

239.80

1.8

38.37

38.71

u/l

0.25

1381

4755

Asthma-related infections

2029

9194

2.25

236.83

2.1

1.9

37.87

39.51

u/l

3.07

1795

8154

Asthma, hospital admission 2, infections

2029

9194

2.25

236.83

2.1

1.9

37.87

39.51

u/l

3.07

1795

8154

Conduction disorders

1094

3091

3.10

233.37

3.0

1.7

37.51

39.67

u/l

2.39

923

2742

Heart failure, strict

1923

6119

2.35

233.05

1.9

1.8

35.27

39.27

u/l

10.04

1493

5341

Asthma, hospital admissions , main diagnosis only

2863

13413

1.97

231.59

2.1

1.9

38.70

39.52

u/l

1.37

2581

11963

Other bacterial diseases

3176

11728

1.92

229.56

1.9

2.0

38.43

39.71

u/l

2.48

2766

10460

Hypertensive diseases (excluding secondary)

1960

5030

2.34

224.48

2.2

1.9

38.89

41.26

u/l

4.72

1734

4751

Abnormal findings on examination of blood, without diagnosis

1650

6668

2.42

223.94

1.8

1.9

40.20

38.21

u/l

2.85

1441

5819

ILD medications: azathioprine

647

1691

4.11

219.86

3.8

1.4

37.41

39.76

u/l

2.01

595

1486

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3036

10081

1.94

219.59

2.1

1.9

38.62

39.97

u/l

2.85

2696

9019

3036

10081

1.94

219.59

2.1

1.9

38.62

39.97

u/l

2.85

2696

9019

All-cause Heart Failure

1861

6001

2.32

219.22

1.9

1.8

35.21

39.27

u/l

10.18

1447

5234

Condition for Implicit Sepsis (Organ dysfunction codes)

2830

10814

1.96

216.53

2.1

1.9

38.80

39.57

u/l

1.07

2476

9613

Examination and observation for other reasons

1991

5522

2.26

213.09

2.0

1.9

39.53

39.08

u/l

0.39

1789

4902

1571

6796

2.39

210.12

2.1

1.9

38.21

39.59

u/l

1.87

1403

6071

Cardiomyopathies, Primary/intrinsic

572

1433

4.35

207.17

2.1

1.6

32.14

39.41

u/l

9.02

381

1276

ILD, hospital admission 2, with pulmonary infections

465

995

5.19

206.93

1.8

37.73

38.59

u/l

0.34

419

843

Other arrhythmias

2129

7990

2.10

201.20

2.5

1.9

38.70

40.15

u/l

2.47

1858

7277

Pain in limb

2574

9717

1.97

201.04

1.9

2.0

39.28

39.26

u/l

0.02

2310

8683

Azathioprine

647

1801

3.86

200.83

3.8

1.5

37.41

39.85

u/l

2.14

595

1593

Implicit Sepsis

2390

9528

2.01

199.94

2.0

1.9

38.58

39.25

u/l

0.76

2086

8399

Diseases of the eye and adnexa

2837

7448

1.95

199.73

2.0

1.9

39.56

39.34

u/l

0.21

2621

6692

Chorioretinal inflammation

271

367

9.60

198.41

3.0

2.0

41.48

38.48

u/l

1.20

253

328

Cardiomyopathy (excluding other)

578

1524

4.12

194.94

2.1

1.7

32.08

39.32

u/l

9.08

386

1362

Symptoms and signs involving the nervous and musculoskeletal systems

1950

9550

2.11

194.81

1.8

2.0

38.96

39.25

u/l

0.26

1768

8418

AV-block

651

1654

3.80

194.53

3.4

1.6

37.40

38.54

u/l

0.62

566

1444

Disturbances of skin sensation

1115

4358

2.70

191.58

1.9

2.0

38.95

39.25

u/l

0.21

1027

3922

Influenza and pneumonia

3469

13193

1.77

190.90

2.1

2.0

38.67

39.75

u/l

2.25

3074

11854

Other disorders of lacrimal gland

1273

5302

2.53

190.75

2.7

1.9

40.30

39.18

u/l

1.11

1161

4676

Diseases of liver

1265

5283

2.52

188.38

2.0

44.74

38.80

u/l

13.69

1134

4668

Other special examinations and investigations of persons without complaint or reported diagnosis

2231

5562

2.08

186.91

2.0

1.9

39.17

39.04

u/l

0.10

2017

4935

Persons encountering health services for specific procedures and health care

3549

12863

1.75

185.05

2.2

1.9

39.04

39.59

u/l

0.79

3129

11565

Other diseases of pleura

1448

5666

2.36

184.22

1.7

1.8

36.79

38.77

u/l

2.91

1260

4885

Disorders of lacrimal system

1477

6660

2.31

183.59

2.6

1.9

40.21

39.41

u/l

0.76

1344

5851

Oedema, not elsewhere classified

1000

3766

2.76

181.37

2.0

1.8

40.85

38.75

u/l

2.20

869

3282

Pneumonias (Asthma/COPD co-morbidities)

3261

13079

1.77

180.88

2.1

2.0

38.49

39.80

u/l

2.97

2892

11716

All pneumoniae

3276

13125

1.76

179.83

2.1

2.0

38.53

39.77

u/l

2.68

2901

11767

Any reimbursement code in KELA

1992

4774

2.14

179.63

1.9

2.0

38.82

40.85

u/l

4.17

1824

4424

Tramadol

2644

9254

1.88

177.26

1.9

2.0

39.44

39.46

u/l

0.02

2337

8274

Arthropathies

3006

8523

1.83

176.35

1.9

2.0

39.11

39.53

u/l

0.50

2730

7682

Disorders of other endocrine glands

1493

6748

2.26

176.10

1.9

39.85

39.29

u/l

0.46

1304

6006

Dorsalgia

3286

10254

1.77

175.23

1.9

2.0

39.55

39.24

u/l

0.36

2958

9161

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3082

12030

1.78

175.10

2.4

1.9

38.93

39.63

u/l

0.99

2693

10815

Obesity related asthma

1218

5167

2.47

175.02

2.3

1.9

38.20

39.39

u/l

1.21

1095

4564

Pneumonia, organism unspecified

2915

11966

1.81

174.78

2.0

38.42

39.78

u/l

2.89

2576

10692

Sleep disorders (combined)

3251

12428

1.76

173.94

2.2

2.0

39.25

39.59

u/l

0.40

2906

11094

Episodal and paroxysmal disorders

3620

10973

1.72

173.44

2.1

1.9

38.92

39.62

u/l

1.18

3262

9787

Hypertension, essential

2651

8243

1.88

172.63

2.1

2.0

38.49

40.58

u/l

4.96

2320

7561

Pacemaker

1037

3989

2.64

171.59

2.7

1.6

37.01

38.39

u/l

1.14

851

3367

Visual disturbances and blindness

1675

8173

2.12

169.47

1.9

39.07

39.16

u/l

0.06

1485

7224

Diseases of oesophagus, stomach and duodenum

3439

12421

1.72

168.61

1.9

2.0

39.74

39.33

u/l

0.50

3064

11114

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3158

13007

1.75

168.10

2.1

2.0

38.47

39.80

u/l

2.98

2788

11652

Other joint disorders

2860

8518

1.83

167.76

2.0

39.57

39.53

u/l

0.03

2579

7677

Non-ischemic cardiomyopathy

1018

3260

2.69

167.48

2.0

1.8

34.84

39.47

u/l

7.22

784

2836

Other necrotizing vasculopathies (FG)

329

636

5.87

165.61

1.6

2.0

32.97

39.16

u/l

6.83

302

560

Certain infectious and parasitic diseases

3260

9493

1.75

165.03

2.0

39.48

39.44

u/l

0.03

2900

8557

Other and unspecified iridocyclitis

296

528

6.64

164.23

2.2

2.1

39.80

39.15

u/l

0.20

276

474

Metabolic disorders

3053

11008

1.76

164.22

2.1

2.0

38.34

39.87

u/l

3.41

2644

9904

Disorders of thyroid, IBD co-morbidities

594

1216

3.71

163.89

2.2

38.50

41.24

u/l

2.20

535

1114

COPD/asthma/ILD related infections

3412

10090

1.73

163.66

2.0

1.9

38.30

39.98

u/l

4.78

3048

9028

COPD/asthma related infections

3412

10090

1.73

163.66

2.0

1.9

38.30

39.98

u/l

4.78

3048

9028

Acute renal failure

728

2480

3.11

162.57

2.3

1.7

38.67

38.33

u/l

0.15

634

2131

Atrial fibrillation and flutter

1121

2946

2.58

162.29

2.3

1.9

39.06

41.65

u/l

3.04

949

2745

Hypothyroidism (congenital or acquired)

921

1883

2.90

161.37

2.1

2.0

39.37

40.76

u/l

1.25

848

1812

Other necrotizing vasculopathies

376

834

5.08

161.19

1.6

1.8

33.06

38.83

u/l

7.04

343

722

Disorders of eyelid, lacrimal system and orbit

2668

11927

1.80

160.39

2.3

1.9

39.54

39.26

u/l

0.28

2394

10572

Visual disturbances

1563

7620

2.13

158.69

1.9

39.02

39.16

u/l

0.10

1395

6744

Undetermined asthma, excluding more controls

441

1105

4.23

157.92

1.9

1.2

37.76

39.00

u/l

0.54

384

965

Codeine

3126

10066

1.74

157.83

2.0

39.21

39.45

u/l

0.26

2787

9044

Hypothyroidism, levothyroxine purchases

909

1873

2.88

157.47

2.1

2.0

39.34

40.72

u/l

1.24

837

1803

Hypothyroidism and >3 levothyroxin purchases

909

1873

2.88

157.47

2.1

2.0

39.34

40.72

u/l

1.24

837

1803

Sleep apnoea

2963

11785

1.75

156.87

2.2

2.0

39.19

39.56

u/l

0.41

2637

10489

Abnormalities of heart beat

1103

4646

2.44

156.19

2.2

1.8

39.67

39.06

u/l

0.42

993

4104

Nerve, nerve root and plexus disorders

3366

12833

1.68

153.96

2.0

39.97

39.21

u/l

1.26

3010

11415

Adjustment and management of implanted device

658

2188

3.19

153.30

3.8

1.7

38.02

38.33

u/l

0.12

524

1862

Cardiomyopathy, other and unspecified

382

900

4.68

150.82

3.3

1.7

33.80

39.51

u/l

4.73

291

800

Diseases of the respiratory system

2049

5316

1.97

149.39

2.0

1.9

38.96

39.92

u/l

1.23

1856

4705

Non-allergic asthma (mode), excluding more controls

577

1778

3.35

148.59

2.1

1.2

39.93

39.05

u/l

0.44

514

1544

Opioids

3232

10189

1.70

147.54

1.9

2.0

38.93

39.44

u/l

0.72

2883

9161

Aplastic and other anaemias

1352

6058

2.19

147.29

1.7

1.8

39.32

38.56

u/l

0.52

1157

5242

Hypertensive diseases

2623

8465

1.80

146.99

2.1

2.0

38.54

40.54

u/l

4.66

2310

7777

Low back pain

2309

9953

1.83

146.83

1.9

2.0

39.59

39.23

u/l

0.36

2074

8885

Hypertension

2618

8459

1.79

146.00

2.1

2.0

38.54

40.54

u/l

4.69

2305

7771

Sleep apnoea, including avohilmo

3081

12057

1.70

145.66

2.2

2.0

39.53

39.57

u/l

0.03

2742

10760

Asthma/COPD (KELA code 203)

2969

12540

1.70

145.53

2.0

38.23

39.58

u/l

3.14

2674

11196

Other and unspecified dermatitis

1645

8421

2.02

145.38

2.1

2.0

39.97

39.25

u/l

0.71

1487

7465

Undetermined asthma

441

1179

3.96

144.29

1.9

1.2

37.76

38.55

u/l

0.30

384

1010

Soft tissue disorders

3269

10278

1.68

144.28

1.9

2.0

39.36

39.32

u/l

0.03

2930

9210

Paroxysmal tachycardia

785

2455

2.82

143.84

2.8

1.8

37.45

41.21

u/l

5.14

687

2286

ILD, hospital admissions 3, with pneumonia sepsis

368

875

4.63

143.54

1.7

37.22

39.01

u/l

0.82

331

744

Atrial fibrillation and flutter with reimbursement

905

2234

2.71

142.74

2.3

1.8

37.86

41.57

u/l

4.88

757

2069

Antihypertensive medication - note that there are other indications

2003

5777

1.94

142.17

2.1

1.9

38.40

41.18

u/l

7.27

1796

5514

Endocrine, nutritional and metabolic diseases

2670

7803

1.78

141.64

2.0

39.25

39.90

u/l

0.82

2393

7169

Dermatitis

1908

10343

1.90

141.39

2.1

2.0

39.73

39.29

u/l

0.41

1724

9162

Allergic asthma (mode), excluding more controls

706

2482

2.89

141.39

1.9

1.2

38.60

39.01

u/l

0.22

655

2243

Other anaemias

1251

5639

2.22

140.86

1.7

1.8

39.25

38.66

u/l

0.35

1065

4864

Other symptoms and signs involving the nervous and musculoskeletal systems

1397

6833

2.12

140.60

1.9

2.0

38.87

39.25

u/l

0.31

1289

6065

Other and unspecified anaemias

1239

5590

2.22

140.20

1.7

1.8

39.40

38.67

u/l

0.46

1054

4824

Erythema nodosum

231

387

7.25

137.45

2.9

2.0

40.56

39.58

u/l

0.27

212

348

Dermatitis and eczema

3374

13869

1.63

136.57

2.0

39.70

39.34

u/l

0.45

3058

12357

Diseases of the musculoskeletal system and connective tissue

1696

4251

2.04

136.38

1.9

2.0

39.23

39.57

u/l

0.26

1540

3841

Other dorsopathies, not elsewhere classified

3188

10289

1.67

135.69

1.9

2.0

39.47

39.23

u/l

0.25

2868

9195

Pain, not elsewhere classified

851

3436

2.57

135.42

1.9

1.8

38.50

39.08

u/l

0.35

779

3063

Non-allergic asthma (mode)

577

1885

3.16

134.78

2.1

1.2

39.93

38.84

u/l

0.58

514

1613

Parasetamol

2581

7611

1.76

134.22

1.9

2.0

39.13

39.89

u/l

1.03

2346

6892

Asthma-related pneumonia

1095

4951

2.29

134.18

2.1

1.8

37.88

39.09

u/l

1.15

959

4300

Bacterial Sepsis

1330

5735

2.13

133.93

1.9

1.8

37.88

38.88

u/l

0.87

1137

4986

Asthma, hospital admissions 3, pneumonia

1095

4960

2.28

133.56

2.1

1.8

37.88

39.08

u/l

1.13

959

4309

Asthma-related pneumonia or sepsis

1095

4960

2.28

133.56

2.1

1.8

37.88

39.08

u/l

1.13

959

4309

Implicit bacterial Sepsis

1175

4997

2.23

133.49

1.9

1.8

37.98

38.75

u/l

0.55

1000

4322

Codeine or tramadol medication

3606

12707

1.60

132.58

2.0

39.17

39.40

u/l

0.26

3202

11374

Presence of cardiac and vascular implants and grafts

1338

4887

2.14

131.99

2.8

1.7

37.12

38.65

u/l

1.64

1089

4208

General examination and investigation of persons without complaint and reported diagnosis

1952

5561

1.91

131.31

2.0

1.9

40.36

39.05

u/l

1.74

1786

4934

Gout

814

2960

2.61

130.50

1.9

1.8

37.17

38.69

u/l

1.10

693

2527

Allergic asthma (mode)

706

2593

2.76

130.13

1.9

1.2

38.60

38.74

u/l

0.06

655

2304

3494

11709

1.60

128.31

2.0

1.9

38.89

39.72

u/l

1.53

3130

10434

Disorders of parathyroid gland

715

2699

2.76

128.08

1.8

1.9

39.18

39.10

u/l

0.03

596

2343

Pleural effusion

544

1803

3.21

127.76

1.6

1.7

36.12

38.47

u/l

1.65

464

1536

Diseases of the skin and subcutaneous tissue

3215

10015

1.64

127.24

2.0

1.9

39.60

39.14

u/l

0.58

2885

8952

Syncope and collapse

1222

5191

2.14

125.94

2.1

1.8

39.03

38.61

u/l

0.29

1064

4529

Migraine

1561

6951

1.96

125.23

2.1

2.0

38.28

39.67

u/l

2.15

1463

6310

Gastro-oesophageal reflux disease

2078

10563

1.79

124.75

1.9

2.0

39.48

39.21

u/l

0.23

1843

9385

Heart failure and bmi 25plus

1098

3441

2.29

123.90

2.0

1.9

35.16

38.66

u/l

4.98

846

2988

Nonischemic cardiomyopathy

308

725

4.79

122.79

1.8

2.0

31.14

38.87

u/l

6.27

197

642

Persons encountering health services in other circumstances, wide

3707

12519

1.56

121.58

2.0

39.25

39.43

u/l

0.19

3330

11153

Lower back pain or/and sciatica

3141

13850

1.60

121.43

1.9

2.0

39.53

39.34

u/l

0.19

2825

12351

Non-invasive ventilation

720

2658

2.65

119.89

1.9

37.62

40.65

u/l

3.61

646

2439

Pain (limb, back, neck, head abdominally)

2252

6468

1.78

119.66

1.9

2.0

39.05

39.64

u/l

0.64

2014

5712

Polymyalgia rheumatica

465

1471

3.38

118.42

1.4

1.8

34.01

38.37

u/l

5.00

409

1244

Spondylopathies

2404

8710

1.71

116.64

1.9

2.0

39.32

39.25

u/l

0.05

2133

7698

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3382

12471

1.57

116.53

2.0

39.10

39.45

u/l

0.43

3045

11115

Persons encountering health services for examination and investigation

1992

5562

1.83

116.48

1.9

39.39

39.04

u/l

0.29

1784

4935

Dorsopathies

3191

10331

1.60

116.41

1.9

2.0

39.40

39.25

u/l

0.16

2871

9235

Primary_lymphoid and hematopoietic malignant neoplasms

772

3207

2.52

116.21

1.7

1.9

40.74

38.60

u/l

1.72

697

2756

Hypothyroidism, strict autoimmune

2069

7878

1.77

116.20

2.0

39.70

39.28

u/l

0.40

1871

6966

Idiopathic pulmonary fibrosis

317

791

4.39

116.00

1.5

1.8

37.01

38.44

u/l

0.54

283

668

Urticaria and erythema

1204

5988

2.08

115.93

2.2

2.0

41.37

39.32

u/l

3.02

1092

5394

L04AA Selective immunosuppressants

807

3438

2.47

115.54

2.0

1.9

38.26

39.77

u/l

1.28

731

3069

Other diseases of liver

674

2647

2.70

115.26

2.0

43.15

39.32

u/l

4.50

598

2355

Eosinophilic disease (BM)

120

113

13.20

114.69

1.6

1.2

43.17

40.90

u/l

0.35

111

Demyelinating diseases of the central nervous system

419

1280

3.57

114.04

1.5

2.1

36.21

39.58

u/l

3.11

394

1174

Glomerular diseases

654

2542

2.72

113.99

1.7

1.9

38.34

38.75

u/l

0.17

564

2238

Unspecified kidney failure

365

1017

3.86

113.55

2.8

1.8

40.41

38.09

u/l

1.09

335

853

Haemorrhage from respiratory passages

951

4024

2.26

112.63

1.8

39.06

38.48

u/l

0.34

814

3483

Hyperparathyroidism

615

2299

2.78

112.58

1.8

38.82

39.19

u/l

0.16

514

1985

Depression medications

943

2025

2.40

111.09

1.9

2.0

39.72

41.06

u/l

1.10

863

1953

Chronic sinusitis

1369

7223

1.95

110.52

2.1

2.0

38.97

39.64

u/l

0.62

1245

6457

Primary_lymphoid and hematopoietic malignant neoplasms

772

3291

2.45

109.90

1.7

1.8

40.74

38.56

u/l

1.78

697

2829

Other diseases of intestines

3243

12268

1.56

109.14

1.9

2.0

39.23

39.51

u/l

0.32

2914

11012

Symptoms and signs involving cognition, perception, emotional state and behaviour

2880

12923

1.59

108.24

1.9

2.0

38.81

39.45

u/l

0.91

2543

11545

Scleritis and episcleritis

304

784

4.30

106.91

1.6

2.0

36.95

38.84

u/l

0.95

285

710

Myalgia

770

3326

2.41

106.12

1.9

2.0

39.48

39.14

u/l

0.18

695

2995

Gout, FINNGEN

814

3599

2.35

105.96

1.9

1.7

37.17

38.50

u/l

0.95

693

3060

Other intervertebral disc disorders

2502

9492

1.64

104.90

2.0

40.05

39.26

u/l

1.08

2247

8451

Rheumatoid arthritis

990

4288

2.17

104.87

1.6

1.9

37.77

39.45

u/l

1.77

878

3776

Sicca syndrome [Sjögren]

375

1139

3.58

102.92

2.0

40.02

40.05

u/l

0.01

342

1012

Other disorders of skin and subcutaneous tissue

1958

10721

1.71

102.08

2.1

1.9

40.04

39.13

u/l

1.14

1719

9452

Gastrointestinal diseases

1883

5396

1.78

101.02

1.9

2.1

39.13

39.45

u/l

0.27

1704

4886

Viral Sepsis

618

2476

2.61

100.71

2.4

1.9

38.56

38.90

u/l

0.13

552

2184

Symptoms and signs involving the digestive system and abdomen

3076

10027

1.56

100.26

1.9

2.0

39.11

39.68

u/l

0.76

2765

8929

Implicit viral Sepsis

616

2471

2.61

100.13

2.4

1.9

38.62

38.90

u/l

0.11

550

2180

Sulfasalazine

837

3833

2.26

99.75

1.6

1.5

37.12

39.61

u/l

3.41

741

3368

Hypothyroidism, drug reimbursement

483

1175

3.05

98.34

1.9

37.87

41.14

u/l

2.78

446

1131

Cerebrovascular diseases (FINNGEN)

944

3177

2.19

98.18

1.8

1.9

37.92

41.50

u/l

5.45

797

2967

Bronchitis

3138

13682

1.53

98.05

2.0

38.92

39.51

u/l

0.86

2816

12213

Acute upper respiratory infections

3071

12716

1.54

97.79

2.0

39.00

39.56

u/l

0.80

2781

11296

Disorders of choroid and retina

2264

10258

1.64

96.85

2.0

1.9

40.06

39.03

u/l

1.40

1969

9007

Subjective visual disturbances

802

3683

2.27

95.81

2.0

1.9

39.51

38.88

u/l

0.40

716

3259

Dialysis, with operation codes

460

1643

2.98

94.86

1.8

39.28

38.74

u/l

0.19

412

1431

Other headache syndromes

1274

6910

1.89

94.47

1.9

2.0

39.64

39.89

u/l

0.17

1167

6180

Continuous positive airway pressure

615

2151

2.57

94.40

2.5

1.9

37.64

40.63

u/l

2.92

516

1953

Disorders of optic nerve and visual pathways

395

1304

3.26

94.21

2.2

1.9

38.62

39.12

u/l

0.20

370

1181

Valvular heart disease excluding rheumatic fever

1263

4944

1.91

91.81

1.9

1.8

38.59

39.88

u/l

1.21

1064

4412

Abdominal and pelvic pain

3018

10027

1.54

91.68

2.0

39.02

39.68

u/l

0.95

2711

8929

Other diseases of blood and blood-forming organs, wide

729

3289

2.32

91.15

1.9

41.53

38.99

u/l

1.97

643

2892

Non-rheumatic valve diseases

1256

4922

1.91

90.71

1.9

1.8

38.55

39.88

u/l

1.26

1058

4391

Fibromyalgia

362

1160

3.35

90.64

1.8

2.1

40.56

39.72

u/l

0.36

319

1073

Other diseases of pericardium

209

459

5.06

90.55

1.8

1.6

34.56

39.73

u/l

2.54

178

407

Disorders of lipoprotein metabolism and other lipidaemias

2330

9279

1.61

89.96

1.9

2.0

37.72

39.90

u/l

5.01

1992

8257

Other specified/unspecified systemic involvement of connective tissue

276

751

4.05

89.91

1.7

2.0

40.35

39.38

u/l

0.32

251

664

Other diseases of upper respiratory tract

3227

11350

1.50

89.75

2.0

1.9

39.08

39.49

u/l

0.54

2876

10090

Early onset COPD, excluding more controls

514

1984

2.68

89.60

2.0

1.2

38.56

37.95

u/l

0.26

438

1672

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1336

4613

1.88

89.47

2.2

1.9

39.91

41.12

u/l

1.27

1205

4348

Acute sinusitis

1588

8675

1.75

89.42

2.2

2.0

39.03

39.76

u/l

0.73

1424

7823

Other or ill-defined heart diseases

235

570

4.48

89.13

3.5

1.7

35.43

40.42

u/l

2.99

208

514

Mixed connective tissue disease

302

880

3.77

88.87

1.7

2.0

40.00

39.14

u/l

0.30

274

790

Asthma and allergy, excluding more controls

378

1230

3.15

88.53

2.0

1.2

37.99

39.49

u/l

0.84

352

1126

Factors influencing health status and contact with health services

949

2258

2.15

87.61

2.0

1.8

38.62

39.05

u/l

0.25

836

2022

Other nutritional deficiencies

1890

11436

1.65

86.77

2.0

38.63

39.45

u/l

0.99

1675

10296

Complications of surgical and medical care, not elsewhere classified

2797

13421

1.52

86.37

2.0

39.33

39.36

u/l

0.03

2482

11963

Nonalcoholic fatty liver disease

386

1328

3.13

85.87

2.2

1.9

44.04

39.19

u/l

4.15

347

1191

MS-disease / Multiple Sclerosis

337

1074

3.40

85.66

1.4

2.1

36.08

39.77

u/l

3.01

316

982

Care involving dialysis

318

982

3.50

84.91

1.7

1.8

39.20

39.15

u/l

0.01

291

861

Abnormal findings on diagnostic imaging of central nervous system

215

509

4.69

84.82

1.8

38.31

40.08

u/l

0.62

198

452

Glomerular disorders in diseases classified elsewhere

422

1530

2.93

84.76

1.8

1.9

39.21

38.79

u/l

0.13

363

1338

Septicaemia

1077

5508

1.93

84.33

2.0

1.8

38.11

39.05

u/l

0.67

936

4791

Symptoms and signs concerning food and fluid intake

328

1029

3.36

84.21

1.6

1.7

38.08

39.33

u/l

0.38

289

904

Dizziness and giddiness

2108

10873

1.60

84.18

1.9

38.91

39.28

u/l

0.37

1858

9650

Any operation in hilmo

134

10.98

83.68

2.3

1.2

37.88

36.92

u/l

0.14

122

Secondary hypertension

278

789

3.70

82.48

1.9

1.8

38.82

41.92

u/l

1.66

250

734

Arthropathies in other diseases classified elsewhere

195

439

5.01

82.41

3.5

2.0

43.25

38.02

u/l

2.49

171

388

Disorders of the thyroid gland

2738

11997

1.52

82.35

2.0

1.9

39.39

39.09

u/l

0.32

2469

10654

Osteopathies and chondropathies

1548

8757

1.72

82.00

2.3

1.9

39.86

39.37

u/l

0.40

1356

7732

COPD (mode)

684

2432

2.29

81.79

1.7

1.2

37.58

37.62

u/l

0.01

574

2039

Type 2 diabetes, wide definition

2266

9525

1.58

81.70

2.1

2.0

38.22

39.98

u/l

3.22

1928

8477

Explicit Sepsis

1133

5935

1.88

81.47

2.0

1.8

37.91

38.83

u/l

0.70

989

5201

Asthma and allergy

378

1290

3.00

81.45

2.0

1.2

37.99

39.19

u/l

0.62

352

1168

Small fibre neuropathy

166

333

5.86

81.29

2.1

39.26

38.32

u/l

0.19

150

289

Diseases of arteries, arterioles and capillaries (FINNGEN)

693

2178

2.29

80.18

1.9

1.8

38.47

41.56

u/l

2.96

590

2027

Other acute lower respiratory infections

1474

8347

1.72

79.46

2.0

1.9

38.45

39.23

u/l

0.77

1291

7411

Other antidepressants

3047

10868

1.48

79.42

1.8

2.0

39.40

39.35

u/l

0.05

2709

9703

Left bundle-branch block

265

760

3.74

79.15

2.2

1.6

34.44

39.71

u/l

3.39

203

670

Gout, idiopatic and unspecified

682

3180

2.23

78.34

1.9

1.7

37.06

38.32

u/l

0.78

573

2725

Abnormal results of function studies

313

1004

3.33

78.19

2.0

1.7

41.75

38.92

u/l

1.51

278

895

Care involving use of rehabilitation procedures

1776

10540

1.63

77.94

2.0

1.9

39.25

39.55

u/l

0.24

1582

9406

Sciatica+with lumbago

1437

8087

1.72

77.83

1.9

2.0

39.55

39.34

u/l

0.14

1308

7210

Acute bronchitis

1138

6198

1.84

77.69

2.1

1.9

38.95

39.06

u/l

0.06

987

5465

Intracranial trauma

1502

6666

1.71

77.04

1.9

2.0

40.82

39.97

u/l

0.76

1320

6012

Vocal cord dysfunction

417

1447

2.78

76.78

1.9

2.0

38.30

41.34

u/l

2.39

369

1333

Chronic rhinitis, nasopharyngitis and pharyngitis

954

5051

1.95

76.65

2.1

2.0

39.13

39.53

u/l

0.25

858

4514

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

298

942

3.40

76.49

1.9

1.8

37.83

37.91

u/l

0.02

260

781

Eosinophilia

120

188

7.82

76.49

1.6

2.1

43.17

39.13

u/l

0.87

111

169

Diseases of pulp and periapical tissues

1046

5706

1.88

76.44

1.8

2.0

39.46

39.12

u/l

0.21

928

5064

Other/unspecified dorsalgia

1067

5843

1.86

75.47

2.0

39.56

39.14

u/l

0.27

958

5199

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

435

1709

2.68

74.35

1.8

42.51

38.26

u/l

3.26

390

1454

Other septicaemia

941

4909

1.93

74.13

2.0

1.8

38.10

39.08

u/l

0.64

818

4269

Acute upper respiratory infections of multiple and unspecified sites

2107

10293

1.56

74.04

2.0

39.20

39.69

u/l

0.52

1925

9235

Obesity and other hyperalimentation

1774

11132

1.61

74.00

2.1

2.0

38.60

39.47

u/l

1.02

1570

10016

Shoulder lesions

2166

8648

1.56

73.38

1.9

2.0

40.08

39.29

u/l

0.94

1919

7672

Complications of medical and surgical care

2007

12430

1.56

73.21

2.0

1.9

39.17

39.30

u/l

0.10

1768

11046

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

201

506

4.37

73.06

2.1

1.9

39.12

38.82

u/l

0.06

168

424

Other demyelinating diseases of the central nervous system

207

536

4.34

72.96

1.4

2.2

34.49

40.80

u/l

5.60

197

491

Concussion

1285

6473

1.75

72.91

1.9

2.0

40.88

39.93

u/l

0.81

1139

5830

Rheumatoid arthritis, including avohilmo

1105

6225

1.82

72.77

1.6

2.0

38.18

39.40

u/l

1.20

977

5455

Nephropathy related operations

422

1654

2.70

72.71

1.7

1.9

38.80

39.13

u/l

0.11

381

1441

Migraine with aura

721

3528

2.11

72.67

2.0

38.22

39.85

u/l

1.52

669

3240

Obesity

1760

11089

1.60

72.39

2.1

2.0

38.61

39.42

u/l

0.92

1558

9975

Iridocyclitis in diseases classified elsewhere

122

205

7.08

72.23

4.6

2.3

42.72

40.59

u/l

0.40

112

185

Hypothyroidism, other/unspecified

2512

11227

1.50

72.21

2.0

1.9

39.43

39.14

u/l

0.30

2274

9985

Nutritional anaemias

1276

7282

1.74

72.17

1.9

38.36

38.94

u/l

0.42

1088

6381

Presence of other functional implants

1454

6193

1.70

70.91

1.8

38.42

39.18

u/l

0.66

1266

5369

Provisional assignment of new diseases of uncertain etiology

1263

7456

1.73

70.20

1.9

37.41

39.46

u/l

3.38

1135

6696

Codes for special purposes

1264

7464

1.73

70.18

1.9

37.42

39.45

u/l

3.34

1136

6703

Obesity due to excess calories

1338

8032

1.71

70.01

2.1

2.0

38.56

39.42

u/l

0.81

1189

7234

Iron deficiency anaemia

1099

6186

1.80

69.85

1.9

38.76

39.14

u/l

0.22

944

5428

Giant cell arteritis

181

439

4.58

69.35

1.5

1.9

33.21

39.04

u/l

3.82

162

380

Gout, strict definition

501

2170

2.41

69.04

1.9

1.7

36.93

38.30

u/l

0.68

414

1842

Covid-19 confirmed case

814

4238

1.98

68.92

1.9

36.29

39.06

u/l

3.82

723

3763

Polyarthrosis

564

2456

2.28

68.55

1.7

1.9

39.82

39.27

u/l

0.24

479

2123

Diseases of salivary glands

607

2854

2.21

68.34

2.0

39.06

39.24

u/l

0.08

551

2517

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1454

8771

1.66

68.21

1.9

2.0

39.17

39.58

u/l

0.34

1313

7807

Erysipelas

1423

7932

1.67

68.21

2.0

1.9

38.54

39.25

u/l

0.58

1213

6952

Immunodeficiencies

223

636

3.86

67.98

2.9

2.0

40.82

39.21

u/l

0.53

211

566

Neoplasms

2287

8173

1.52

67.83

1.9

2.0

38.81

39.61

u/l

1.08

2088

7417

Gout, unspecified

558

2548

2.28

67.70

2.0

1.7

37.41

38.28

u/l

0.41

466

2165

Exclusions for E4_PCOS_BROAD

547

2478

2.30

67.69

2.0

1.9

39.03

39.47

u/l

0.19

501

2236

Pure hypercholesterolaemia

1927

8407

1.56

67.40

1.9

37.37

39.87

u/l

5.15

1638

7438

Depression

2742

13194

1.45

67.40

1.9

2.0

39.83

39.55

u/l

0.30

2471

11838

Other and unspecified iron deficiency

872

4685

1.91

66.89

2.0

1.9

38.78

39.22

u/l

0.22

754

4122

Anxiety disorders, excluding more controls

2417

10938

1.49

66.87

2.0

2.1

39.83

39.59

u/l

0.23

2188

9837

Diplopia

428

1759

2.56

66.60

1.8

1.9

37.92

38.78

u/l

0.41

393

1557

Mood [affective] disorders

2920

13589

1.43

66.49

1.9

2.0

39.83

39.48

u/l

0.41

2623

12174

Disorders of conjunctiva

2274

12954

1.49

66.47

2.1

2.0

39.29

39.58

u/l

0.30

2058

11624

Hypothyreosis and Thyroxine purchase for inclusion criteria

2571

11746

1.47

66.04

2.0

1.9

39.44

39.19

u/l

0.25

2327

10447

Mood disorders

2922

13605

1.43

65.82

1.9

2.0

39.82

39.48

u/l

0.40

2627

12189

Depression or dysthymia

2086

7708

1.54

65.54

1.9

2.0

40.49

39.32

u/l

1.63

1857

6879

Benign neoplasms

2821

11052

1.44

65.08

1.9

2.0

38.79

39.40

u/l

0.84

2533

9962

Fibrosis and cirrhosis of liver

275

916

3.23

64.80

2.2

1.8

48.20

38.51

u/l

6.24

247

800

Dentinal caries

675

3352

2.07

64.54

1.9

2.0

38.32

39.23

u/l

0.53

586

2981

Arthrosis

1955

7014

1.56

64.47

2.0

39.13

39.45

u/l

0.27

1749

6250

Lumbar disc prolapse

1757

9049

1.57

64.31

2.1

2.0

39.81

39.36

u/l

0.41

1573

8058

Mood disorders, excluding more controls

2736

11688

1.44

64.18

1.9

2.0

39.89

39.37

u/l

0.63

2452

10462

Temporomandibular joint disorders

478

2089

2.37

64.12

1.9

39.85

39.70

u/l

0.06

438

1880

Diabetes, varying definitions

2902

12297

1.43

64.11

2.1

2.0

39.06

39.84

u/l

1.06

2500

11127

Complications of procedures, not elsewhere classified

2192

12899

1.49

64.10

2.0

39.35

39.31

u/l

0.04

1942

11481

Papilloedema, unspecified

130

259

5.77

63.86

2.9

2.2

38.61

38.80

u/l

0.04

117

235

Other neurological diseases

1889

10022

1.54

63.83

1.9

38.53

39.02

u/l

0.51

1652

8783

Disorders of lens

1848

7589

1.56

63.70

2.1

1.9

38.93

39.41

u/l

0.41

1637

6639

Dental caries

744

3819

1.99

63.69

1.9

2.0

38.45

39.33

u/l

0.54

645

3401

Other general symptoms and signs

187

484

4.09

63.67

1.8

1.9

38.20

39.72

u/l

0.42

176

440

Other disorders of optic [2nd] nerve and visual pathways

249

791

3.40

63.65

2.4

2.0

38.80

39.16

u/l

0.10

228

707

Bleeding

2180

10746

1.50

63.62

1.8

1.9

39.34

39.26

u/l

0.06

1890

9469

Immunodeficiency with predominantly antibody defects

138

290

5.39

63.52

2.7

1.2

41.53

38.54

u/l

0.88

127

257

Nausea and vomiting

703

3514

2.02

63.41

1.9

1.8

39.02

39.16

u/l

0.06

617

3079

Diabetes mellitus

2910

12345

1.43

63.40

2.1

2.0

39.07

39.82

u/l

1.00

2508

11171

ILD-related respiratory insufficiency

147

327

5.04

63.06

1.6

2.0

39.27

37.38

u/l

0.42

132

284

Other pleural conditions

311

1122

2.92

62.85

1.6

1.7

35.15

38.33

u/l

1.84

265

950

Coxibs

804

2183

2.00

62.70

1.8

1.9

38.33

38.12

u/l

0.10

720

1907

Other disorders of white blood cells

232

715

3.53

62.54

2.0

1.9

42.02

38.79

u/l

1.11

209

634

Other disorders involving the immune mechanism, not elsewhere classified

152

352

4.83

61.99

2.2

1.2

36.20

37.40

u/l

0.28

139

310

Migraine without aura

595

2880

2.13

61.90

2.2

2.0

39.39

40.14

u/l

0.43

555

2685

Spondylosis

1408

7535

1.63

61.51

1.7

2.0

39.62

39.15

u/l

0.38

1252

6600

Acute tubulo-interstitial nephritis

1552

8806

1.59

61.14

1.9

1.8

39.25

38.94

u/l

0.21

1346

7794

Pericarditis

155

367

4.62

61.01

2.0

1.7

34.77

40.35

u/l

2.27

140

333

Transplanted organ and tissue status

330

1250

2.79

60.96

1.8

40.12

39.34

u/l

0.24

298

1114

Follow-up examination after treatment for conditions other than malignant neoplasms

1151

4413

1.74

60.93

2.1

1.9

40.53

39.07

u/l

1.48

1030

3905

Rheumatism, unspecified

458

2017

2.37

60.86

2.0

38.97

39.65

u/l

0.32

405

1797

Pulmonary heart disease, diseases of pulmonary circulation

825

4497

1.88

60.54

1.8

37.82

38.97

u/l

0.78

724

3882

Irritable bowel syndrome

811

4404

1.89

60.37

1.9

2.0

40.28

39.19

u/l

0.88

731

3939

Neurotic, stress-related and somatoform disorders

2520

12598

1.44

60.31

2.0

39.73

39.74

u/l

0.01

2288

11353

Anxiety disorders

2537

12700

1.44

59.23

2.0

39.79

39.71

u/l

0.07

2301

11443

Intestinal infectious diseases

2548

14056

1.43

59.08

2.0

39.25

39.40

u/l

0.13

2230

12604

Osteoporosis

661

3217

2.02

58.99

2.5

1.8

40.24

39.17

u/l

0.59

553

2751

Postprocedural disorders of nervous system

287

1031

2.97

58.92

2.2

2.0

39.41

39.95

u/l

0.19

272

951

Type 2 diabetes

2769

11744

1.42

58.74

2.1

2.0

38.84

39.80

u/l

1.41

2379

10603

Other cataract

1141

5272

1.71

58.56

2.2

1.9

39.85

39.00

u/l

0.65

992

4568

Abnormal findings on diagnostic imaging of other body structures

373

1526

2.56

58.52

2.6

1.7

38.71

39.55

u/l

0.32

338

1335

Reactive arthropathies, FINNGEN

258

877

3.12

58.39

1.9

2.0

37.30

39.40

u/l

0.95

239

793

Recurrent or chronic depression

1224

5364

1.68

58.18

2.0

2.2

40.20

39.79

u/l

0.28

1106

4893

Chronic periapical parodontitis

614

3087

2.06

57.79

1.9

2.0

39.44

39.32

u/l

0.05

543

2718

Other retinal disorders

1570

8173

1.57

57.70

1.9

40.43

38.73

u/l

2.30

1351

7122

Diarrhoea and gastroenteritis of presumed infectious origin

1900

11689

1.50

57.63

2.1

2.0

39.21

39.39

u/l

0.14

1661

10514

Other arthrosis

1351

6022

1.63

57.51

2.0

39.76

39.45

u/l

0.21

1206

5322

Diverticular disease of intestine

1890

8413

1.52

57.45

2.0

38.06

39.35

u/l

1.92

1624

7362

Seropositive rheumatoid arthritis

669

3459

1.98

57.33

1.6

2.0

37.30

39.77

u/l

2.34

585

3021

Gonarthrosis [arthrosis of knee](FG)

1932

7618

1.51

57.29

1.9

2.1

38.71

40.06

u/l

1.98

1695

6744

Genitourinary diseases

1738

5666

1.56

57.08

1.9

2.0

39.00

39.65

u/l

0.59

1573

5107

Episcleritis

217

680

3.45

56.88

1.5

2.1

37.09

39.16

u/l

0.87

201

620

Benign neoplasms

2230

8698

1.47

56.86

1.9

2.0

38.82

39.51

u/l

0.86

2017

7903

Disorders of synovium and tendon

1418

8147

1.60

56.83

1.9

2.0

40.20

39.48

u/l

0.68

1287

7273

Other disorders of eye and adnexa

444

1993

2.33

56.47

2.3

1.9

37.70

39.35

u/l

1.08

412

1793

Hypertensive heart and/or renal disease

635

2492

2.03

55.52

1.6

1.7

37.45

39.92

u/l

1.98

517

2182

Symptoms and signs involving the urinary system

1985

10536

1.48

54.81

1.7

2.0

38.28

39.23

u/l

1.17

1732

9276

Dysphagia

642

3335

1.98

54.79

1.8

1.9

39.20

39.12

u/l

0.04

555

2881

SLE (Finngen)

149

373

4.36

54.55

1.7

2.1

39.82

40.25

u/l

0.09

132

334

Keratitis

941

5500

1.75

54.50

2.1

1.9

40.15

39.22

u/l

0.68

854

4861

Secondary right heart disease

166

453

3.99

53.90

1.6

1.9

36.32

38.44

u/l

0.56

144

394

Extracorporeal dialysis

229

769

3.21

53.42

1.5

1.8

38.13

38.18

u/l

0.01

210

676

Spondylopathies (FG)

427

1927

2.30

53.40

1.9

2.0

38.42

39.46

u/l

0.55

389

1745

Chronic gastritis

718

3902

1.89

53.29

1.7

1.8

38.82

38.91

u/l

0.04

606

3342

Urticaria

847

4847

1.79

53.03

2.1

2.0

41.59

39.25

u/l

2.74

763

4374

Other pulmonary heart/vessel disease

173

491

3.81

52.88

1.7

2.0

36.43

38.50

u/l

0.57

151

428

Coagulation defects, purpura and other haemorrhagic conditions

554

2778

2.06

52.66

2.1

1.9

41.90

38.86

u/l

2.08

501

2468

Spondyloarthritis

522

2560

2.10

52.53

1.9

38.35

39.38

u/l

0.58

464

2277

Conjunctivitis

2008

12205

1.45

51.99

2.1

2.0

39.30

39.76

u/l

0.49

1822

10987

Spinal stenosis

1257

6209

1.62

51.98

1.9

39.78

38.86

u/l

0.76

1099

5351

Functional dyspepsia

739

4088

1.86

51.93

2.0

41.43

39.09

u/l

2.37

664

3629

STROKE

1551

7084

1.55

51.88

1.8

2.0

37.82

40.22

u/l

4.31

1305

6374

Benign neoplasm of colon, rectum, anus and anal canal

1440

6672

1.57

51.87

1.9

2.0

39.24

39.08

u/l

0.10

1245

5861

Other disorders of fluid, electrolyte and acid-base balance

737

3924

1.86

51.62

1.8

38.59

39.57

u/l

0.58

631

3428

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1580

10543

1.52

51.46

2.0

1.9

39.13

39.21

u/l

0.06

1388

9327

Benign neoplasm of colon, rectum, anus and anal canal

1528

9153

1.53

51.34

1.9

39.28

38.99

u/l

0.22

1318

7941

Other CVD (FINNGEN)

298

892

2.73

51.26

2.0

1.7

38.50

41.26

u/l

1.34

250

815

Other diseases of the respiratory system

526

2613

2.08

51.15

1.8

1.7

36.29

38.32

u/l

1.46

461

2234

Other respiratory disorders and diseases

526

2613

2.08

51.15

1.8

1.7

36.29

38.32

u/l

1.46

461

2234

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

133

323

4.57

51.00

1.9

1.2

35.81

36.82

u/l

0.21

121

288

Respiratory insufficiency

193

594

3.38

50.98

1.5

1.2

36.22

38.53

u/l

0.80

161

483

Temporal arteritis

149

393

4.17

50.96

1.5

1.9

33.43

38.65

u/l

2.77

133

339

Later onset COPD, excluding more controls

396

1350

2.34

50.22

1.4

1.2

36.56

37.54

u/l

0.36

334

1085

Reactive arthropathies

297

1176

2.65

50.12

1.8

2.0

37.24

39.04

u/l

0.84

273

1056

Infections of the skin and subcutaneous tissue

1510

10051

1.52

49.65

2.0

39.22

39.30

u/l

0.05

1331

9040

Hypopituitarism

249

910

2.91

49.52

2.1

2.0

40.25

39.49

u/l

0.22

231

822

Chronic laryngitis and laryngotracheitis

418

1940

2.24

48.95

1.9

41.24

39.10

u/l

1.28

375

1693

Benign neoplasm: Colon

1244

6083

1.60

48.81

1.9

2.0

39.41

38.94

u/l

0.33

1067

5322

Hyperlipidaemia, other/unspecified

938

5332

1.70

48.66

1.8

37.33

39.13

u/l

1.76

771

4647

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2603

11612

1.39

48.65

2.1

2.0

38.84

39.90

u/l

1.57

2249

10477

Bronchiectasis

248

912

2.87

48.63

2.0

1.8

38.67

39.01

u/l

0.09

220

777

Other disorders of skin and subcutaneous tissue, not elsewhere classified

413

1913

2.24

48.58

2.1

1.8

40.09

38.61

u/l

0.72

356

1677

Migraine with aura and triptan purchases

458

2209

2.15

48.45

2.0

38.40

39.25

u/l

0.45

433

2054

Hernia of abdominal wall, postoperative

437

2067

2.18

48.32

2.2

1.8

38.97

38.90

u/l

0.02

375

1805

Diseases of the ear and mastoid process

3294

12564

1.34

48.31

2.0

39.18

39.51

u/l

0.40

2959

11267

Type 2 diabetes, definitions combined

2570

11191

1.39

48.18

2.1

2.0

38.28

39.84

u/l

2.94

2195

10072

Diseases of oral cavity, salivary glands and jaws

2503

9282

1.40

48.08

1.9

2.0

39.31

39.21

u/l

0.08

2228

8250

Senile cataract

1593

6627

1.51

47.75

2.1

1.9

38.88

39.26

u/l

0.28

1409

5756

Optic neuritis

187

598

3.39

47.61

1.9

2.1

38.25

39.89

u/l

0.57

182

550

Glomerulonephritis

324

1372

2.48

47.43

1.6

1.9

37.79

39.12

u/l

0.48

281

1214

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

412

1928

2.23

47.35

1.8

48.46

38.41

u/l

9.60

369

1685

All influenza

641

3490

1.88

47.33

2.2

1.9

39.20

39.51

u/l

0.14

563

3087

Hypothyroidism, strict autoimmune, 3 medication purchases required

2241

10981

1.41

47.26

2.0

1.9

39.70

39.29

u/l

0.42

2022

9768

Type 2 diabetes, strict (exclude DM1)

2576

11264

1.38

47.20

2.1

2.0

38.27

39.82

u/l

2.91

2198

10138

Noninfective enteritis and colitis

1228

7943

1.57

46.98

1.8

2.0

39.02

39.46

u/l

0.30

1072

7109

Persons encountering health services in other circumstances

991

6104

1.65

46.78

1.8

1.9

40.09

39.19

u/l

0.66

897

5433

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

903

5456

1.70

46.42

2.0

38.67

39.45

u/l

0.54

813

4860

Giant cell arteritis with polymyalgia rheumatica

149

420

3.89

46.37

1.5

1.9

33.43

38.28

u/l

2.45

133

364

Non-follicular lymphoma, hilmo, excluding all cancers

285

1152

2.60

46.17

1.9

1.8

43.07

38.13

u/l

2.84

254

975

Other disorders of urethra and urinary system

1809

9442

1.46

46.16

1.9

39.98

39.31

u/l

0.71

1600

8394

Pulmonary embolism

724

4123

1.80

46.08

1.8

1.9

38.18

39.01

u/l

0.46

639

3562

Wegener granulomatosis

185

5.83

46.00

1.6

2.2

30.88

39.75

u/l

4.40

167

Insulin medication

1525

8835

1.50

45.92

2.2

1.9

40.30

39.43

u/l

0.74

1304

7845

Cervicalgia

563

2975

1.95

45.81

1.8

1.9

41.16

39.04

u/l

1.65

490

2640

Other gastritis (incl. Duodenitis)

598

3229

1.90

45.50

2.0

1.9

41.10

38.99

u/l

1.38

534

2803

Disorders of gallbladder, biliary tract and pancreas

2607

12427

1.37

45.49

1.9

2.0

39.13

39.34

u/l

0.20

2313

11050

Abnormalities of gait and mobility

334

1458

2.39

45.49

1.6

1.8

38.57

38.63

u/l

0.02

285

1240

Other inflammation of eyelid

384

1777

2.25

45.41

2.0

1.9

39.13

39.55

u/l

0.15

341

1575

Ocular pain

273

1094

2.63

45.18

2.5

2.0

36.81

39.70

u/l

1.72

256

993

Pulmonary heart disease

724

4158

1.78

44.77

1.8

1.9

38.18

38.93

u/l

0.41

639

3591

Type 2 diabetes, definitions combined, including avohilmo

2576

11264

1.37

44.70

2.1

2.0

38.29

39.86

u/l

3.02

2207

10150

Rotator cuff syndrome

1567

7951

1.49

44.30

1.9

2.0

39.69

39.28

u/l

0.32

1390

7011

Vasomotor and allergic rhinitis

1008

6230

1.62

44.22

2.1

2.0

39.01

39.78

u/l

0.65

906

5641

Benign neoplasm: Colon

1259

8138

1.54

44.11

1.9

1.8

39.39

38.85

u/l

0.41

1081

7048

Other disorders of adrenal gland

173

552

3.38

44.10

2.4

1.9

37.61

39.38

u/l

0.47

156

492

Purpura and other haemorrhagic conditions

389

1832

2.21

43.99

2.1

1.9

42.47

38.70

u/l

2.06

355

1613

Localized swelling, mass and lump of skin and subcutaneous tissue

813

4847

1.72

43.95

2.1

1.9

40.36

38.96

u/l

1.10

730

4277

Gonarthrosis

1630

6389

1.48

43.79

2.0

38.79

39.48

u/l

0.63

1440

5658

Hypertensive Heart Disease

536

2285

1.96

43.67

1.6

1.7

37.22

39.81

u/l

1.87

428

1990

Cervical disc disorders

950

5899

1.64

43.66

1.9

2.0

39.55

39.13

u/l

0.27

847

5180

Insulin, combination of fast acting with intermediate-acting or long-acting

1526

9657

1.48

43.48

2.1

1.9

40.30

38.92

u/l

1.48

1304

8508

Other degenerative diseases of the nervous system

635

2644

1.86

43.35

1.5

1.8

36.75

39.04

u/l

2.17

563

2306

Cirrhosis of liver, NAS

185

622

3.21

43.22

2.2

1.9

48.88

37.84

u/l

4.91

164

541

Disorders of ocular muscles, binocular movement, accommodation and refraction

1222

7989

1.54

43.08

2.0

38.84

39.44

u/l

0.49

1110

7193

L04AD Calcineurin inhibitors

337

1517

2.33

42.86

2.2

1.9

40.09

39.08

u/l

0.33

307

1354

Other diseases of hard tissues of teeth

1698

8840

1.45

42.81

2.0

39.51

39.32

u/l

0.15

1544

7895

Diabetes medication

2779

12713

1.34

42.77

2.1

2.0

39.00

39.72

u/l

0.94

2409

11452

Abnormal weight loss

271

1112

2.56

42.62

1.6

1.8

38.71

38.92

u/l

0.04

237

968

Ischaemic heart disease, wide definition

1980

8863

1.42

42.44

1.9

2.0

37.71

39.87

u/l

4.18

1651

7837

Adrenocortical insufficiency

149

446

3.64

42.31

2.5

2.0

37.58

39.58

u/l

0.48

136

403

Seronegative rheumatoid arthritis

324

1438

2.34

42.30

1.5

2.0

36.94

39.92

u/l

1.98

290

1263

Other diseases of urinary system

2723

11491

1.35

42.29

1.9

2.0

38.84

39.28

u/l

0.51

2423

10234

Ischemic heart diseases

2006

9014

1.41

42.20

1.9

2.0

37.66

39.91

u/l

4.58

1678

7974

Other (seronegative) rheumatoid arthritis, wide

530

2830

1.93

42.00

1.6

2.0

38.17

39.38

u/l

0.73

473

2484

Viral infections characterized by skin and mucous membrane lesions

1064

6843

1.58

41.99

2.3

2.0

39.10

39.44

u/l

0.21

950

6091

Cystitis

2228

9946

1.39

41.82

1.9

38.78

39.22

u/l

0.48

2005

8853

Acetic acid derivatives and related substances

735

2166

1.80

41.78

1.8

1.9

38.25

38.13

u/l

0.05

643

1890

Non-follicular lymphoma

285

1208

2.48

41.71

1.9

1.8

43.07

38.19

u/l

2.81

254

1033

Somatoform disorder

479

2482

1.99

41.58

2.1

2.0

39.74

39.52

u/l

0.09

426

2245

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1445

9929

1.48

41.45

2.0

1.9

39.06

39.25

u/l

0.13

1268

8760

Lung cancer and mesothelioma

363

1434

2.21

41.27

1.7

1.2

36.93

37.87

u/l

0.37

309

1175

Other and unspecified visual disturbances

290

1248

2.44

41.00

1.8

39.24

38.77

u/l

0.14

251

1111

5-aminosalicylic acid

517

2753

1.92

40.95

1.8

1.5

38.60

39.64

u/l

0.58

447

2450

Disorders of skin appendages

1243

8316

1.52

40.84

1.9

2.0

40.49

39.41

u/l

1.09

1129

7485

DVT of lower extremities and pulmonary embolism

997

6341

1.60

40.83

1.9

38.28

38.82

u/l

0.32

875

5481

Glucagon-like peptide-1 (GLP-1) analogues

1350

7521

1.50

40.75

2.1

1.9

36.99

39.68

u/l

4.56

1129

6561

Diabetes, insulin treatment (Kela reimbursement)

2678

12365

1.34

40.50

2.1

2.0

38.91

39.77

u/l

1.18

2313

11085

Other anxiety disorders

1210

7136

1.53

40.27

1.8

2.0

39.40

39.61

u/l

0.13

1098

6542

Mycoses

691

4042

1.75

40.24

2.2

1.9

40.39

38.90

u/l

1.05

619

3562

Systemic lupus erythematosus

149

463

3.49

39.83

1.7

2.0

39.82

39.57

u/l

0.05

132

414

Budesonide

341

1583

2.22

39.78

2.1

1.5

40.03

39.77

u/l

0.09

302

1401

Exposure to unspecified factor

2519

14750

1.34

39.65

1.9

2.0

39.98

39.31

u/l

0.86

2213

13235

Other bacterial intestinal infections

471

2465

1.97

39.60

1.7

1.9

39.01

39.04

u/l

0.01

393

2173

Bacterial pneumoniae

969

5456

1.60

39.47

2.1

1.9

36.98

39.08

u/l

2.60

835

4775

Dentofacial anomalies [including malocclusion]

736

4348

1.71

39.43

1.9

2.1

40.45

39.54

u/l

0.62

676

3925

Use of hypnotics and sedatives

2874

12704

1.32

39.36

2.0

39.04

39.40

u/l

0.42

2538

11377

Insulin, intermediate and long-acting

1336

8958

1.49

39.34

2.1

1.9

40.93

38.88

u/l

2.53

1137

7884

Weight loss

281

1217

2.42

39.13

1.6

1.8

38.68

38.99

u/l

0.07

246

1067

Other functional intestinal disorders

1067

6634

1.56

39.07

1.8

1.9

39.30

39.15

u/l

0.08

952

5834

Polyarthritis, unspecified

142

433

3.53

38.98

1.9

2.1

38.09

38.69

u/l

0.14

125

384

Other/unspecified reactive arthropathies

235

947

2.63

38.63

1.9

2.0

37.14

39.33

u/l

1.00

221

849

Other symptoms and signs involving the circulatory and respiratory systems

190

685

2.91

38.60

1.9

1.8

38.15

39.44

u/l

0.39

171

604

Internal derangement of knee

924

5857

1.60

38.43

2.0

39.70

39.32

u/l

0.22

824

5216

Secondary and unspecified malignant neoplasm of lymph nodes

256

1074

2.50

38.41

1.9

43.57

38.78

u/l

2.58

232

929

All anxiety disorders

1649

9432

1.43

38.27

1.9

2.1

39.77

39.66

u/l

0.07

1502

8588

Venous thromboembolism

1295

8598

1.49

38.04

2.0

1.9

38.16

39.11

u/l

0.82

1145

7470

COPD

1005

5352

1.57

37.94

1.7

1.8

37.68

38.53

u/l

0.60

857

4580

Bacterial pneumonia (organism specified)

1050

6255

1.55

37.93

2.0

1.8

37.37

38.94

u/l

1.66

912

5467

Anxiety (asthma-related co-morbidities)

1626

9104

1.43

37.77

1.9

2.1

39.76

39.68

u/l

0.06

1482

8305

Abnormal serum enzyme levels

708

4183

1.71

37.72

1.8

42.77

37.65

u/l

6.47

622

3624

Bacterial intestinal infections, IBD co-morbidities

468

2487

1.94

37.59

1.7

1.9

38.99

39.11

u/l

0.04

389

2194

Biological medication for rheuma

462

2449

1.95

37.58

1.6

2.0

37.41

39.55

u/l

1.62

434

2227

Preparatory care for dialysis

163

554

3.18

37.51

1.9

41.78

39.00

u/l

0.85

147

487

Diseases of the digestive system

1071

7060

1.54

37.43

1.8

1.9

40.57

38.81

u/l

1.81

941

6170

Carpal tunnel syndrome

1531

9770

1.44

37.27

2.0

40.25

39.48

u/l

0.77

1361

8676

Diaphragmatic hernia

898

5722

1.60

37.21

1.9

39.74

39.14

u/l

0.34

769

4996

Constipation

2183

11668

1.36

36.72

1.8

2.0

39.01

39.37

u/l

0.34

1921

10320

Conjunctivitis (acute, non atopic)

716

4319

1.69

36.62

2.0

1.9

39.21

39.67

u/l

0.26

656

3878

Other skin changes

432

2260

1.97

36.50

2.3

1.8

39.22

38.76

u/l

0.17

384

1970

Viral pneumonia

333

1587

2.17

36.48

2.2

1.9

35.96

39.12

u/l

2.02

297

1399

Other reaction to severe stress, and adjustment disorders

982

6410

1.56

36.46

2.0

2.1

38.95

39.68

u/l

0.52

887

5853

Bacterial pneumonia, not elsewhere classified

909

5138

1.59

36.42

2.0

1.9

37.02

39.03

u/l

2.36

784

4494

Gingivitis and periodontal diseases

2388

9261

1.34

36.18

1.9

2.0

39.20

39.23

u/l

0.02

2112

8236

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2493

12361

1.33

35.92

2.1

2.0

39.37

39.35

u/l

0.02

2193

11025

Diseases of arteries, arterioles and capillaries

1556

8247

1.43

35.83

1.8

1.9

37.89

38.99

u/l

1.20

1316

7163

Symptoms and signs involving speech and voice

824

5200

1.62

35.65

1.9

38.71

39.08

u/l

0.19

720

4589

Other viral diseases

759

4682

1.65

35.58

1.9

2.0

39.56

39.44

u/l

0.05

705

4263

Encephalitis

126

380

3.62

35.48

1.9

2.0

33.21

38.78

u/l

2.70

115

342

Insulin, fast-acting

899

5790

1.58

35.38

2.3

1.9

42.21

39.05

u/l

3.70

781

5149

Oxycodone

821

5010

1.61

35.18

1.7

1.9

38.13

38.78

u/l

0.37

714

4366

Temporomandibular joint disorders, including avohilmo

1088

7304

1.51

35.13

1.9

2.0

39.22

39.37

u/l

0.10

1009

6653

Selective serotonin reuptake inhibitors

2691

10883

1.31

34.92

1.9

2.0

39.32

39.36

u/l

0.04

2406

9717

Cerebral cysts

186

702

2.80

34.89

1.8

2.0

39.58

39.39

u/l

0.05

167

639

Diseases of the myoneural junction and muscle

323

1552

2.16

34.78

1.6

1.8

39.57

38.86

u/l

0.23

287

1359

Meniscus derangement

1359

6465

1.46

34.69

1.9

2.0

39.70

39.53

u/l

0.11

1218

5730

Chronic diseases of tonsils and adenoids

2068

9749

1.36

34.56

2.1

2.0

39.12

39.82

u/l

0.85

1878

8777

SLE, strict definition

145

484

3.25

34.53

1.6

2.0

40.08

40.00

u/l

0.01

128

431

SLE, ICD10

145

484

3.25

34.53

1.6

2.0

40.08

40.00

u/l

0.01

128

431

Thyroiditis, ILD-related definition

325

1571

2.14

34.42

2.1

2.0

39.64

39.89

u/l

0.08

303

1421

Oxicams

597

1931

1.79

34.26

1.8

1.9

39.74

37.97

u/l

1.19

522

1670

Disorders of muscles

288

1333

2.24

34.13

2.0

38.69

38.86

u/l

0.05

262

1194

Osteoporosis with pathological fracture (FG)

172

630

2.86

33.99

2.7

2.0

41.36

40.30

u/l

0.23

136

541

Migraine, single triptan purchase ok & required. ICD-code if available is included

2077

10550

1.35

33.52

2.1

2.0

39.56

39.73

u/l

0.14

1929

9535

Triptan medication for migraine, single purchase ok

2077

10550

1.35

33.52

2.1

2.0

39.56

39.73

u/l

0.14

1929

9535

Excessive, frequent and irregular menstruation

1052

3864

1.54

33.49

2.0

40.12

39.71

u/l

0.29

948

3503

Special screening examination for infectious and parasitic diseases

622

2737

1.73

33.47

2.1

2.0

40.91

39.31

u/l

1.26

565

2513

Benign neoplasm: Colon, unspecified

559

3230

1.76

33.46

1.8

1.9

39.33

38.42

u/l

0.47

478

2764

Psychiatric diseases

2984

11691

1.29

33.42

1.9

2.0

39.51

39.38

u/l

0.12

2652

10474

Other noninfective gastroenteritis and colitis

609

3621

1.72

33.30

1.9

39.93

39.09

u/l

0.40

525

3216

Ulcer of lower limb, not elsewhere classified

342

1707

2.07

33.15

2.1

1.8

41.46

37.99

u/l

2.02

278

1464

Fall on same level

3076

13543

1.28

33.15

1.9

2.0

39.94

39.30

u/l

0.90

2704

12219

Suggestive for eosinophilic asthma

266

1209

2.29

33.11

2.1

1.8

36.49

38.86

u/l

1.18

245

1050

Enthesopathies of lower limb, excluding foot

574

3373

1.74

32.94

2.1

2.0

39.67

39.19

u/l

0.23

524

3011

Other (not insulin) diabetes medications

2508

11654

1.31

32.71

2.1

2.0

38.12

39.73

u/l

3.18

2160

10443

Deforming dorsopathies

686

4234

1.65

32.50

2.0

1.9

39.09

39.28

u/l

0.09

620

3761

Asthma mixed form (mode), excluding more controls

135

442

3.17

32.48

2.0

1.2

39.12

38.13

u/l

0.21

125

387

Hard cardiovascular diseases

1958

9384

1.36

32.40

1.8

2.0

37.32

39.89

u/l

5.77

1617

8308

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

378

1972

1.98

32.30

1.8

1.9

41.66

38.49

u/l

1.86

338

1685

Hypermobility syndrome

180

695

2.73

32.30

2.1

39.48

39.75

u/l

0.06

168

647

Enterocolitis due to Clostridium difficile

273

1266

2.23

32.17

1.7

1.8

38.10

38.45

u/l

0.10

224

1097

Other and unspecified immunodeficiencies with predominantly antibody defects

133

5.66

32.12

2.9

1.2

41.71

37.60

u/l

0.75

119

Other encephalitis

116

354

3.57

32.10

2.0

33.43

38.38

u/l

2.14

107

320

Migraine without aura and triptan purchases

440

2415

1.87

32.03

2.4

2.0

38.95

39.28

u/l

0.15

411

2249

Hypokalaemia

293

1401

2.16

31.92

2.0

1.8

39.31

39.80

u/l

0.15

252

1229

Paracetamol of NSAID medication

447

1181

1.93

31.90

1.9

38.82

38.44

u/l

0.14

398

1050

Inflammatory diseases of the central nervous system

258

1179

2.29

31.78

1.9

2.0

35.64

39.36

u/l

2.53

233

1053

Any mental disorder

3011

11893

1.28

31.59

1.9

2.0

39.53

39.33

u/l

0.20

2674

10637

Cholelithiasis, broad definition with cholecystitis

2177

11372

1.33

31.52

2.0

38.83

39.31

u/l

0.51

1920

10081

Soft tissue disorders related to use, overuse and pressure

648

3978

1.66

31.43

2.0

39.47

39.17

u/l

0.13

573

3512

Tumor necrosis factor alpha inhibitors

406

2191

1.91

31.35

1.6

2.0

37.33

39.48

u/l

1.54

382

2005

Drug-induced adrenocortical insufficiency

224

4.37

31.23

3.0

2.3

34.80

39.37

u/l

1.32

200

Convulsions, not elsewhere classified

496

2797

1.78

31.21

1.7

1.8

40.75

38.97

u/l

0.98

452

2496

Amiodarone users

270

1265

2.22

31.21

3.1

1.7

36.34

38.71

u/l

1.04

219

1074

367

1920

1.97

31.10

2.2

2.0

37.99

39.29

u/l

0.59

327

1743

Pruritus

292

1411

2.14

31.00

1.9

40.08

39.51

u/l

0.20

273

1268

Retinal detachments and breaks

810

5259

1.57

30.97

1.9

1.8

39.59

38.66

u/l

0.62

699

4568

Diabetic nephropathy, excluding more controls

380

1666

1.97

30.93

1.9

2.0

41.05

37.11

u/l

2.36

317

1423

Insulin, fast-acting or short human

899

5965

1.53

30.92

2.3

1.9

42.21

38.96

u/l

3.89

781

5290

Other disorders of teeth and supporting structures

528

3087

1.75

30.90

2.1

2.0

38.28

39.13

u/l

0.40

461

2710

Other enthesopathies

754

4824

1.59

30.76

2.1

39.46

39.36

u/l

0.05

671

4298

Vasculitis limited to skin, not elsewhere classified

102

296

3.75

30.49

1.7

2.1

38.53

38.46

u/l

0.01

263

Asthma mixed form (mode)

135

459

3.05

30.46

2.0

1.2

39.12

38.02

u/l

0.24

125

399

Benign intracranial hypertension

106

6.21

30.38

1.7

1.9

39.17

40.41

u/l

0.16

Polycystic ovarian syndrome, consortium definition

1805

8102

1.36

30.28

1.9

2.0

40.35

39.71

u/l

0.70

1609

7361

Radiculopathy

411

2248

1.88

30.24

1.8

1.9

39.45

38.54

u/l

0.41

381

1954

Benzodiazepine use

2558

14267

1.29

30.13

1.8

2.0

39.44

39.36

u/l

0.07

2239

12777

Other disorders of kidney and ureter

334

1714

2.02

30.08

2.1

1.8

40.10

38.50

u/l

0.62

291

1493

Degeneration of macula and posterior pole

975

5426

1.50

30.07

1.9

1.8

40.02

38.32

u/l

1.62

835

4603

Coxarthrosis [arthrosis of hip](FG)

1164

5853

1.46

30.05

1.9

2.0

38.94

39.79

u/l

0.72

1021

5105

Obesity, other/unspecified

856

5664

1.54

30.02

2.1

2.0

38.42

39.43

u/l

0.78

755

5139

Other symptoms and signs involving cognitive functions and awareness

994

6345

1.49

29.95

1.8

1.9

38.29

38.73

u/l

0.27

858

5520

Disorders resulting from impaired renal tubular function

129

437

3.18

29.91

1.6

2.0

40.75

39.16

u/l

0.35

114

391

Secondary uncertain malignant neoplasm

318

1609

2.04

29.75

1.7

1.8

41.87

38.53

u/l

1.78

281

1388

Hypertrophic cardiomyopathy

143

515

2.97

29.64

2.9

1.9

38.38

39.00

u/l

0.11

115

455

Diabetic retinopathy, excluding more controls

659

2270

1.68

29.55

2.1

2.0

40.48

37.93

u/l

1.82

561

1956

Other abnormal immunological findings in serum

223

4.19

29.50

1.8

2.2

38.20

39.12

u/l

0.17

203

Artrosis, including avohilmo

2243

9461

1.31

29.39

2.0

2.1

39.41

39.39

u/l

0.02

2000

8480

Pain in thoracic spine

394

2148

1.88

29.35

1.8

2.0

40.61

39.05

u/l

0.87

358

1933

Dental caries 3 and operation codes

2362

9366

1.31

29.32

2.0

1.9

39.38

39.16

u/l

0.21

2088

8317

Emphysema

181

734

2.57

29.18

1.6

1.8

38.82

38.05

u/l

0.15

158

612

Cholelithiasis

2083

11194

1.32

29.18

2.0

38.82

39.27

u/l

0.47

1841

9923

Other metabolic disorders

351

1852

1.95

29.05

1.9

2.0

39.19

39.99

u/l

0.31

313

1686

Abnormal involuntary movements

342

1790

1.97

29.02

1.6

1.9

38.85

38.96

u/l

0.03

311

1574

Seropositive rheumatoid arthritis, wide

668

4219

1.62

28.96

1.6

2.0

37.31

39.31

u/l

1.73

584

3696

Other and unspecified urticaria

506

2980

1.74

28.94

2.1

2.0

42.11

39.27

u/l

2.46

453

2699

Bell's palsy

317

1622

2.02

28.77

2.5

1.9

40.20

39.36

u/l

0.30

294

1439

Cardiodefibrillation

801

5267

1.55

28.72

2.0

1.8

36.97

38.45

u/l

1.11

655

4527

Other chronic obstructive pulmonary disease

921

5158

1.51

28.71

1.7

37.47

38.45

u/l

0.70

782

4397

Other and unspecified vasculitis limited to skin

265

3.83

28.61

1.7

2.1

39.01

39.09

u/l

0.01

235

ILD medications: pirfenidone

6.90

28.57

1.3

1.7

38.51

42.55

u/l

0.45

Childhood asthma (age<16), excluding more controls

269

1011

2.15

28.36

2.0

1.2

41.88

38.98

u/l

1.46

247

948

Fenamates

389

1406

1.91

28.27

2.0

39.27

38.17

u/l

0.46

348

1228

Myositis

101

306

3.57

28.21

1.6

2.0

37.52

37.92

u/l

0.06

268

Allergic rhinitis

787

5132

1.55

28.19

2.0

38.96

39.89

u/l

0.71

708

4701

Voice disturbances

657

4170

1.61

27.94

2.0

39.13

39.19

u/l

0.02

582

3687

Other disorders of ear

2278

11827

1.30

27.89

2.0

39.28

39.40

u/l

0.10

2013

10477

Dental caries 1 and operation codes

2241

8888

1.31

27.78

2.0

1.9

39.19

39.06

u/l

0.10

1982

7880

Other disorders of conjunctiva

352

1889

1.92

27.70

2.3

1.9

38.61

38.87

u/l

0.09

316

1645

Pain and other conditions associated with female genital organs and menstrual cycle

520

2987

1.70

27.66

2.0

2.1

39.70

39.63

u/l

0.03

476

2733

Non-selective monoamine reuptake inhibitors

953

6354

1.48

27.52

1.9

2.0

38.95

39.76

u/l

0.63

844

5595

Other symptoms and signs involving the digestive system and abdomen

407

2286

1.82

27.49

2.0

1.9

39.55

39.94

u/l

0.16

353

2029

Benign neoplasm: Colon, unspecified

559

3426

1.67

27.47

1.8

39.33

38.69

u/l

0.30

478

2936

Ulcerative colitis, NAS

379

2089

1.87

27.37

1.8

2.0

38.76

39.34

u/l

0.23

319

1897

Statin medication

1906

8123

1.33

27.34

2.0

2.1

38.12

40.69

u/l

5.92

1678

7470

Other and unspecified disorders of skin and subcutaneous tissue

193

833

2.43

27.33

2.3

1.9

42.20

38.59

u/l

1.65

169

732

Granulomatous disorders of skin and subcutaneous tissue

105

333

3.41

27.30

2.0

40.65

38.88

u/l

0.32

294

Exclusions for E4_PCOS_CONSORTIUM

1850

8805

1.33

27.26

1.9

2.0

39.73

39.82

u/l

0.06

1645

7999

Diseases of pulp and periapical tissues, including avohilmo

2841

11782

1.26

27.22

1.9

2.0

39.72

39.27

u/l

0.53

2523

10547

Drug-induced cataract

101

315

3.51

27.14

3.7

2.1

38.25

39.41

u/l

0.21

280

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1351

9727

1.38

27.12

2.0

39.13

39.89

u/l

0.75

1218

8785

Asthma and opportunity respiratory infection

142

533

2.82

27.10

2.1

1.9

36.61

39.29

u/l

0.91

123

459

Glaucoma

1248

7904

1.40

27.08

2.1

1.8

40.00

38.83

u/l

1.20

1108

6817

Dental pulpitis 1

2844

11805

1.26

27.07

1.9

2.0

39.64

39.26

u/l

0.42

2525

10568

Dental pulpitis 4

2843

11801

1.26

27.01

1.9

2.0

39.69

39.25

u/l

0.51

2524

10564

Visual impairment including blindness (binocular or monocular)

180

756

2.48

26.98

1.7

1.8

40.56

38.37

u/l

0.66

151

657

Cervicobrachial syndrome

557

3425

1.66

26.97

2.1

2.0

39.41

39.40

u/l

0.01

511

3055

Microscopic polyangiitis

7.77

26.52

1.1

2.3

31.77

37.44

u/l

0.89

Hypertensive Renal Disease

102

321

3.35

26.52

1.4

1.8

37.58

39.70

u/l

0.47

272

Atypical facial pain

158

633

2.63

26.40

2.0

39.67

39.39

u/l

0.06

144

566

Other peripheral vascular diseases

227

1063

2.22

26.35

1.6

1.8

38.76

39.29

u/l

0.15

198

947

Fungal Sepsis

122

430

3.02

26.29

2.0

41.81

39.18

u/l

0.51

113

384

Childhood asthma (age<16)

269

1044

2.08

26.16

2.0

1.2

41.88

38.72

u/l

1.67

247

972

Other and unspecified nerve root and plexus disorders, also in other diseases

476

2838

1.72

26.10

2.0

40.61

39.50

u/l

0.62

423

2538

Inflammatory bowel disease

799

5370

1.51

26.07

1.7

2.0

38.17

39.50

u/l

1.18

702

4843

Coronary atherosclerosis

1591

7682

1.35

26.03

1.7

2.0

37.81

39.52

u/l

2.17

1310

6750

Biguanides

2403

11706

1.28

25.93

2.1

2.0

37.82

39.86

u/l

4.72

2062

10474

Zoster [herpes zoster]

412

2368

1.78

25.79

2.2

1.8

37.93

38.64

u/l

0.28

354

2062

Irregular menses

1188

6953

1.40

25.58

2.0

2.1

39.74

39.62

u/l

0.08

1087

6377

Other/unspecified seropositive rheumatoid arthritis

647

4178

1.58

25.54

1.5

2.0

37.14

39.31

u/l

1.93

566

3660

Coxarthrosis

1086

5203

1.43

25.54

1.9

38.98

39.25

u/l

0.16

957

4540

Propionic acid derivatives

705

2263

1.58

25.43

1.8

1.9

39.57

38.23

u/l

0.95

630

1984

Menorrhagia

913

3434

1.49

25.41

2.1

40.19

39.93

u/l

0.15

812

3107

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

639

4121

1.58

25.39

1.5

2.0

37.18

39.34

u/l

1.89

561

3608

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

243

1186

2.13

25.31

1.9

38.88

38.85

u/l

0.01

211

1061

Postprocedural endocrine and metabolic disorders, not elsewhere classified

318

1702

1.92

25.28

1.9

2.0

38.40

40.37

u/l

0.99

285

1557

Primary biliary cholangitis (PBC)

225

3.84

25.05

2.4

2.1

47.60

40.21

u/l

1.79

204

Allergic conjunctivitis

1409

10356

1.36

25.00

2.0

39.23

39.83

u/l

0.56

1272

9361

Implicit fungal Sepsis

113

394

3.06

24.88

2.0

42.16

38.49

u/l

0.76

104

351

Other CVD

397

2279

1.78

24.87

1.9

1.7

37.32

38.26

u/l

0.39

334

1935

Idiopathic gout

223

1061

2.18

24.84

1.9

1.7

36.40

38.43

u/l

0.71

187

902

Chronic periodontitis

372

2101

1.82

24.82

1.7

1.9

38.66

39.35

u/l

0.25

324

1836

Other diseases of lip and oral mucosa

394

2270

1.78

24.50

2.0

42.60

39.06

u/l

2.88

354

1980

Other external causes of accidental injury

2271

8952

1.28

24.45

1.9

2.0

39.33

39.04

u/l

0.27

2031

8069

Adalimumab

262

1332

2.04

24.43

1.6

2.1

36.90

39.63

u/l

1.52

245

1217

Dialysis

128

482

2.81

24.34

1.6

2.0

41.10

39.65

u/l

0.31

122

428

Disorders of vestibular function (Vertigo)

1068

7619

1.41

24.34

1.7

1.9

37.88

39.27

u/l

1.55

933

6673

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

122

448

2.88

24.30

1.6

1.8

41.81

39.10

u/l

0.62

101

383

Other specified/unspecified necrotizing vasculopathies

163

4.44

24.17

2.3

2.1

37.74

38.74

u/l

0.13

145

Diseases of spleen

213

3.94

24.15

2.3

2.1

45.24

39.05

u/l

0.89

194

Injuries to the knee and lower leg

3015

14084

1.23

24.14

2.0

39.82

39.31

u/l

0.66

2678

12614

Neovascular glaucoma

126

473

2.81

24.06

3.0

2.0

41.94

38.61

u/l

0.84

113

420

Glaucoma secondary to other eye disorders

126

473

2.81

24.05

3.0

1.9

41.94

38.91

u/l

0.73

113

420

Pleural plaque

213

1007

2.18

24.02

1.5

1.7

35.64

37.35

u/l

0.56

186

833

Endometriosis

892

3644

1.48

24.01

1.9

2.0

39.38

39.86

u/l

0.26

797

3302

Other viral diseases, not elsewhere classified

450

2695

1.70

23.99

1.9

40.61

39.14

u/l

0.73

419

2445

Dental caries 3

2108

8428

1.29

23.97

1.9

38.98

39.14

u/l

0.13

1864

7485

External causes of morbidity and mortality

1854

7142

1.31

23.93

2.1

2.0

39.17

39.09

u/l

0.05

1662

6438

Benign neoplasm of other and ill-defined parts of digestive system

413

2431

1.74

23.82

1.8

1.9

39.33

39.15

u/l

0.06

353

2099

Gastric ulcer

387

2237

1.77

23.69

1.8

40.78

38.60

u/l

0.85

338

1907

Adverse effects, not elsewhere classified

488

3004

1.66

23.67

1.9

39.00

39.23

u/l

0.10

453

2717

Hyperkalaemia

134

522

2.68

23.61

1.7

1.8

37.43

39.84

u/l

0.63

113

443

Anaemia in chronic diseases classified elsewhere

264

3.52

23.60

1.4

2.0

40.12

38.91

u/l

0.18

237

Other and unspecified effects of external causes

667

4412

1.54

23.58

2.0

39.98

39.46

u/l

0.28

615

3998

Inflammatory diseases of female pelvic organs

1482

8434

1.34

23.54

1.9

2.0

40.07

39.77

u/l

0.23

1336

7639

Hodgkin lymphoma

102

347

3.14

23.51

1.9

2.0

45.17

39.45

u/l

1.34

308

Diabetic nephropathy

381

2175

1.78

23.50

1.9

2.1

41.09

37.86

u/l

1.77

318

1851

Systemic lupus erythematosus, unspecified

115

419

2.95

23.50

1.6

2.0

40.70

39.95

u/l

0.15

101

376

Cholecystectomy

1671

11382

1.31

23.43

2.0

39.12

39.36

u/l

0.19

1486

10069

Chronic ulcer of skin, not elsewhere classified

178

794

2.33

23.34

1.9

1.8

38.63

38.34

u/l

0.06

150

684

Injuries to the head

2737

14492

1.24

23.26

1.9

2.0

40.23

39.25

u/l

1.57

2412

12996

Ankylosing spondylitis

245

1237

2.04

23.22

1.9

2.0

38.80

38.75

u/l

0.01

223

1118

Strabismus

635

4164

1.55

23.19

2.0

38.21

39.37

u/l

0.76

575

3738

Rosacea

302

1638

1.90

23.15

2.1

1.9

40.14

39.54

u/l

0.20

271

1473

Ethmoidectomy

349

1978

1.82

23.14

2.4

1.9

39.85

39.32

u/l

0.19

325

1779

Disorders of vitreous body and globe

1134

8092

1.39

23.07

2.2

1.9

39.77

39.34

u/l

0.29

1001

7044

Gastroduodenal ulcer

540

3413

1.60

23.06

1.8

40.30

38.67

u/l

0.77

473

2918

Rash and other nonspecific skin eruption

253

1296

2.02

23.03

2.1

1.8

40.19

38.83

u/l

0.47

233

1146

Protozoal diseases

336

3.17

23.01

2.3

2.2

42.39

39.77

u/l

0.45

300

conjunctival haemorrhage

197

922

2.22

23.00

2.1

1.8

37.88

39.10

u/l

0.39

177

801

Hypotension

336

1882

1.83

22.97

1.9

1.7

37.93

38.27

u/l

0.10

279

1592

Falls/tendency to fall

2939

12013

1.23

22.95

2.0

39.70

39.32

u/l

0.44

2621

10837

Accidents

2255

8952

1.27

22.95

2.0

39.35

39.04

u/l

0.29

2019

8069

Diseases of inner ear

1236

8986

1.36

22.84

1.7

1.9

37.92

39.28

u/l

1.65

1083

7881

Other and unspecified rosacea

240

1213

2.05

22.83

2.0

1.9

39.95

39.56

u/l

0.11

215

1091

Brachial plexus disorders

261

1356

1.99

22.83

1.8

2.1

40.07

39.19

u/l

0.32

245

1235

FESS (DNB20)

337

1900

1.83

22.76

2.5

1.9

40.03

39.27

u/l

0.29

313

1711

Endocarditis

336

3.10

22.74

1.9

1.6

37.19

40.40

u/l

0.74

301

Tuberculosis, IBD comorbidity

179

808

2.29

22.71

1.8

39.76

38.41

u/l

0.40

157

693

Streptococcal septicaemia

203

965

2.17

22.65

1.8

1.9

37.65

39.34

u/l

0.53

179

845

Disorders of orbit

139

565

2.59

22.63

2.0

40.03

40.11

u/l

0.02

127

504

Malignant immunoproliferative diseases

100

5.47

22.58

1.6

2.6

39.88

40.15

u/l

0.02

Polyarteritis nodosa and related conditions

158

4.33

22.50

1.3

2.2

35.55

39.15

u/l

0.72

137

Unspecified haematuria

906

5474

1.44

22.48

1.7

1.9

37.72

38.55

u/l

0.60

776

4761

Exposure to other specified factors

1793

13158

1.29

22.44

1.9

2.0

40.16

39.39

u/l

0.87

1600

11808

Other and unspecified drugs and medicaments

225

1118

2.09

22.42

1.9

38.80

39.23

u/l

0.11

195

997

Ulcerative colitis

611

4012

1.55

22.41

1.8

2.0

38.20

39.41

u/l

0.84

532

3610

Pollen allergy

454

2751

1.67

22.40

1.8

2.0

39.16

39.50

u/l

0.14

408

2548

Other disorders of eyelid

940

6472

1.42

22.35

1.8

39.04

39.07

u/l

0.02

816

5575

Corneal ulcer

437

2656

1.68

22.32

2.2

1.9

41.51

39.22

u/l

1.37

398

2379

Methotrexate

320

1782

1.84

22.31

1.6

1.5

39.69

39.80

u/l

0.03

279

1558

Heart failure and coronary heart disease

649

3188

1.54

22.30

1.7

35.48

38.27

u/l

2.40

515

2678

Dental caries 1

1973

7897

1.29

22.28

1.9

39.02

39.03

u/l

0.01

1743

7000

Ovarian cyst

924

3745

1.45

22.26

2.0

38.74

39.77

u/l

0.86

837

3395

Other and unspecified tonsillitis

809

4747

1.46

22.25

2.1

38.64

39.70

u/l

0.82

752

4366

Dental operations

1639

6430

1.32

22.24

1.8

1.9

38.84

39.03

u/l

0.14

1450

5631

Thrombocytopenia, unspecified

192

902

2.22

22.23

2.0

1.8

44.74

38.29

u/l

2.25

179

787

Volume depletion

195

918

2.18

22.20

2.0

1.7

37.72

39.39

u/l

0.41

165

777

Diffuse large B-cell lymphoma, helper endpoint

127

499

2.68

22.20

1.8

1.9

43.26

39.11

u/l

1.02

112

421

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

127

499

2.68

22.20

1.8

1.9

43.26

39.11

u/l

1.02

112

421

Anti-inflammatory and antirheumatic products, non-steroids

687

2263

1.54

22.20

1.9

39.22

38.23

u/l

0.60

612

1984

Dental caries, including avohilmo

1970

7889

1.29

22.19

1.9

39.03

u/l

0.00

1741

6993

Other overlap syndromes

225

3.68

22.19

1.8

2.2

40.56

40.68

u/l

0.02

202

Other extrapyramidal and movement disorders in other diseases

514

3261

1.61

22.04

1.8

1.9

38.96

39.17

u/l

0.10

459

2840

Psoriatic and enteropathic arthropathies

290

1576

1.89

22.01

1.6

2.0

39.66

39.69

u/l

0.01

268

1412

Deposits [accretions] on teeth

186

834

2.23

21.95

1.7

2.0

39.21

39.33

u/l

0.03

167

742

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

603

3972

1.55

21.90

2.4

2.0

37.33

40.15

u/l

2.58

522

3548

Degenerative macular diseases

273

1459

1.92

21.85

1.9

1.7

39.16

38.20

u/l

0.31

233

1240

Hypo-osmolality and hyponatraemia

355

2045

1.77

21.82

1.5

1.8

38.96

39.56

u/l

0.19

299

1770

Oter anti-inflammatory and antirheumatic agents, non-steroids

508

1739

1.64

21.77

1.9

2.0

39.38

37.85

u/l

0.85

449

1486

Paralytic strabismus

189

890

2.21

21.75

1.8

35.61

38.93

u/l

1.39

166

778

Disorders of refraction and accommodation

622

4109

1.53

21.75

2.1

2.0

39.57

39.68

u/l

0.05

562

3721

Spirochaetal infections, other/unspecified

229

1159

2.05

21.74

1.7

1.9

40.58

38.90

u/l

0.69

196

1035

Cerebrovascular diseases

1672

9296

1.30

21.61

1.6

1.9

37.44

39.35

u/l

3.18

1400

8134

Disorders of vitreous body

1097

7902

1.38

21.58

2.2

1.9

39.90

39.41

u/l

0.33

969

6879

Tuberculosis, wide

182

848

2.22

21.38

1.7

1.8

39.88

38.05

u/l

0.62

159

724

Hypoparathyroidism

112

424

2.80

21.17

1.9

2.0

39.80

39.86

u/l

0.01

370

Intracranial injury

1300

9498

1.34

21.15

1.8

1.9

40.87

38.85

u/l

2.65

1136

8438

Other and unspecified types of non-Hodgkin lymphoma, hilmo

122

482

2.67

21.11

1.6

1.9

41.81

38.91

u/l

0.69

101

421

Pneumocystosis

175

4.03

21.10

2.1

44.88

38.70

u/l

0.92

158

Deviated nasal septum

762

5292

1.46

21.02

1.9

2.0

39.39

39.42

u/l

0.01

686

4666

Conductive and sensorineural hearing loss

1841

10051

1.28

20.86

1.9

38.81

39.21

u/l

0.37

1629

8799

Lichen simplex chronicus and prurigo

176

820

2.23

20.85

1.9

39.25

39.14

u/l

0.02

152

730

Right bundle-branch block

353

2.94

20.83

3.5

1.6

35.82

40.42

u/l

1.19

312

Other inflammatory liver diseases

184

873

2.19

20.81

2.0

1.9

44.24

38.84

u/l

2.48

167

779

Hodgkin lymphoma, hilmo

102

372

2.93

20.79

1.9

2.0

45.17

38.66

u/l

1.64

329

Candidiasis

333

1921

1.78

20.78

2.2

1.9

42.33

39.13

u/l

1.88

299

1727

Fitting and adjustment of other devices

706

4498

1.48

20.77

1.9

1.7

39.05

38.58

u/l

0.22

618

3864

Chronic nephritic syndrome

129

529

2.57

20.70

1.6

1.9

39.80

38.99

u/l

0.14

117

465

Collagenous colitis

231

1194

2.00

20.60

2.0

1.8

40.29

38.99

u/l

0.43

194

1073

Dental caries 3, only avohilmo

2121

8657

1.26

20.52

1.9

38.96

39.14

u/l

0.14

1875

7691

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2271

10841

1.25

20.37

2.0

2.1

40.11

39.46

u/l

0.74

2041

9721

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2271

10845

1.25

20.29

2.0

2.1

40.13

39.46

u/l

0.76

2040

9725

Malignant neoplasm, wide definition for exclusion

2271

10847

1.25

20.26

2.0

2.1

40.13

39.46

u/l

0.76

2040

9726

Cardiac arrest

142

518

2.43

20.26

2.5

1.7

37.72

41.20

u/l

0.88

110

477

Agranulocytosis

278

1534

1.87

20.23

1.8

40.74

38.67

u/l

0.72

249

1363

Trochanteric bursitis

319

1832

1.78

20.18

1.8

2.0

39.74

39.27

u/l

0.15

279

1617

Unknown and unspecified causes of morbidity

171

796

2.21

20.11

2.0

1.7

37.68

39.36

u/l

0.56

162

715

Other complications of surgical and medical care, not elsewhere classified

245

1301

1.94

20.11

1.9

38.88

39.31

u/l

0.13

225

1170

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

248

3.32

20.09

1.4

2.0

32.04

40.75

u/l

3.03

203

Other disorders of patella

423

2619

1.65

20.08

2.1

2.0

38.77

39.49

u/l

0.33

384

2370

Nasal polyp

449

2825

1.62

19.98

2.1

1.9

38.60

39.22

u/l

0.29

407

2474

Benign neoplasm of other and ill-defined parts of digestive system

413

2549

1.66

19.98

1.8

1.9

39.33

39.14

u/l

0.07

353

2214

Other disorders of bone

494

3179

1.59

19.97

2.0

1.9

39.48

39.24

u/l

0.10

446

2877

Noninfectious colitis NAS

326

1890

1.77

19.96

1.9

39.19

38.93

u/l

0.07

285

1700

Explicit bacterial Sepsis

233

1218

1.96

19.95

1.8

1.9

37.06

39.06

u/l

0.77

208

1076

Diffuse large B-cell lymphoma

127

526

2.54

19.94

1.8

1.9

43.26

39.24

u/l

0.98

112

457

Hernia

2298

12666

1.24

19.88

2.0

39.92

39.54

u/l

0.38

2007

11331

Sensorineural hearing loss

1720

9476

1.28

19.82

1.9

38.64

39.17

u/l

0.51

1520

8263

Other abnormal uterine and vaginal bleeding

545

2530

1.56

19.80

1.9

2.0

41.73

39.75

u/l

1.55

466

2244

Dental caries 1, only avohilmo

1998

8136

1.27

19.75

1.9

39.11

39.04

u/l

0.05

1762

7217

IgA nephropathy (IgA glomerulonephritis)

322

3.04

19.72

1.6

2.1

36.07

38.14

u/l

0.41

290

Excessive attrition of teeth

974

3815

1.40

19.72

1.9

2.1

39.32

39.67

u/l

0.21

886

3481

Chronic tubulo-interstitial nephritis

116

463

2.63

19.62

2.7

2.0

39.23

40.11

u/l

0.17

110

414

Presence of other devices

450

2841

1.61

19.58

1.8

1.7

39.80

38.34

u/l

0.73

394

2410

Trigeminal neuralgia

161

743

2.25

19.55

1.9

38.37

39.73

u/l

0.43

143

657

Dental pulpitis 2

1754

7052

1.28

19.48

1.9

38.77

39.03

u/l

0.20

1559

6237

Other diseases of anus and rectum

639

4355

1.49

19.46

1.9

39.18

38.55

u/l

0.31

568

3789

Malignant immunoproliferative diseases

114

4.78

19.33

1.6

2.4

39.88

38.72

u/l

0.11

101

Neuralgia and neuritis, unspecified

144

638

2.35

19.32

2.0

38.68

38.82

u/l

0.03

126

573

Dental pulpitis 2, only avohilmo

1792

7232

1.28

19.23

1.9

38.97

39.02

u/l

0.04

1591

6399

Papulosquamous disorders

917

6689

1.39

19.23

2.0

39.12

39.31

u/l

0.10

813

5931

Nonorganic sleeping disorders, excluding more controls

421

2633

1.63

19.20

2.0

39.38

39.44

u/l

0.02

391

2405

Pneumonia due to other infectious organisms, not elsewhere classified

371

2.82

19.10

1.9

2.0

41.10

38.85

u/l

0.38

327

Multiple myeloma, excluding all cancers (controls excluding all cancers)

120

493

2.55

19.10

1.4

1.8

35.33

38.23

u/l

0.68

111

411

Gonarthrosis,primary

2108

10714

1.25

19.04

1.9

2.0

38.64

39.49

u/l

1.09

1836

9419

Abnormal findings on examination of urine, without diagnosis

127

537

2.48

19.03

1.7

1.9

42.01

38.70

u/l

0.86

105

479

Triptan medication for migraine, min. 3 purchases

1382

8419

1.31

18.98

2.1

2.0

39.24

39.72

u/l

0.45

1294

7689

Heart failure and hypertrophic cardiomyopathy

198

3.63

18.94

3.2

2.1

36.90

39.09

u/l

0.23

175

Other diseases of intestine

279

1572

1.82

18.90

2.1

1.8

37.97

37.82

u/l

0.04

246

1360

Polyuria

486

3155

1.57

18.89

1.6

1.8

36.83

38.58

u/l

1.14

422

2753

Dermatographic urticaria

187

927

2.09

18.86

1.7

2.0

42.79

39.05

u/l

1.65

177

846

Behavioural syndromes associated with physiological disturbances and physical factors

736

5187

1.44

18.81

2.0

1.9

39.65

39.25

u/l

0.23

672

4735

Lesion of ulnar nerve

339

2022

1.72

18.77

2.2

1.9

39.54

39.40

u/l

0.04

313

1799

Herpesviral [herpes simplex] infections

289

1651

1.80

18.73

2.1

1.9

40.65

39.28

u/l

0.54

259

1493

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

138

4.21

18.71

1.3

2.2

43.29

38.52

u/l

0.66

120

Hyperhidrosis

318

2.94

18.71

1.9

39.84

40.87

u/l

0.23

292

Dental pulpitis 4, only avohilmo

2814

12205

1.21

18.69

1.9

2.0

39.59

39.28

u/l

0.32

2511

10927

Cutaneous abscess, furuncle and carbuncle

592

4017

1.50

18.63

2.1

1.9

39.37

39.14

u/l

0.09

520

3601

Elevated blood glucose level

207

1069

2.00

18.54

2.0

1.9

38.34

38.84

u/l

0.11

174

953

All influenza (not pneumonia)

346

2079

1.70

18.53

2.1

1.9

39.15

39.51

u/l

0.12

309

1856

Multiple myeloma and malignant plasma cell neoplasms

118

488

2.53

18.53

1.4

1.8

35.13

38.16

u/l

0.71

109

405

Unspecified acute lower respiratory infection

356

2160

1.68

18.43

2.1

1.9

37.51

39.02

u/l

0.76

322

1924

Direct fill therapy

325

1928

1.73

18.36

2.0

1.9

40.07

39.07

u/l

0.37

280

1733

Chronic hepatitis, not elsewhere classified

111

450

2.61

18.34

2.0

2.1

48.03

38.97

u/l

2.85

102

399

Calculus of kidney and ureter

667

4649

1.46

18.25

2.2

1.9

38.02

38.88

u/l

0.51

597

4070

Other specified/unspecified inflammatory spondylopathies

144

654

2.29

18.24

1.9

2.2

39.84

38.91

u/l

0.25

130

596

Benign neoplasm of other and unspecified endocrine glands

305

1785

1.75

18.17

1.9

38.84

38.97

u/l

0.04

270

1556

Dermatitis due to substances taken internally

147

674

2.26

18.15

2.2

2.0

39.35

38.94

u/l

0.08

132

600

Sacroiliitis, not elsewhere classified

140

630

2.31

18.11

1.9

2.2

36.96

38.34

u/l

0.40

130

586

Other sleep disorders

261

1463

1.83

18.02

2.5

1.8

41.33

39.28

u/l

0.88

238

1289

Other dialysis

385

2.73

17.87

1.8

2.0

42.04

38.27

u/l

0.94

341

Early onset COPD

514

3421

1.53

17.87

2.0

1.9

38.56

39.13

u/l

0.25

438

2992

Monoarthritis, not elsewhere classified

121

515

2.45

17.83

1.7

2.0

39.00

38.21

u/l

0.17

113

460

Other specified and unspecified retinal disorders

107

432

2.62

17.83

2.0

2.1

40.32

38.91

u/l

0.29

384

Other keratitis

268

1520

1.81

17.81

1.8

2.0

38.67

39.34

u/l

0.22

241

1359

GI-bleeding

643

4476

1.46

17.64

1.8

39.61

38.60

u/l

0.54

550

3858

Disorder of lipoprotein metabolism, unspecified

283

1634

1.77

17.61

2.0

1.7

37.49

39.03

u/l

0.56

220

1414

Drug-induced osteoporosis with pathological fracture

188

3.62

17.59

2.9

2.2

38.43

39.74

u/l

0.17

164

Other/unspecified synovitis and tenosynovitis

282

1629

1.77

17.57

2.1

2.0

38.52

39.21

u/l

0.22

255

1463

Alzheimer disease, including avohilmo

241

3071

0.56

17.48

1.5

1.6

38.01

38.21

u/l

0.04

184

2519

Injury, poisoning and certain other consequences of external causes

1472

5750

1.29

17.33

2.0

38.47

39.18

u/l

0.70

1314

5170

Other enthesopathy of foot (+metatarsalgia)

248

1387

1.84

17.30

2.3

2.1

38.82

39.23

u/l

0.12

219

1258

Dental pulpitis 1, only avohilmo

2805

12256

1.20

17.29

1.9

2.0

39.63

39.29

u/l

0.36

2502

10976

Glaucoma suspect

760

5475

1.41

17.26

2.3

1.8

40.34

39.02

u/l

0.98

680

4717

Other specified/unspecified soft tissue disorders

127

560

2.35

17.23

2.0

1.9

39.24

38.19

u/l

0.25

121

495

Diabetic retinopathy

755

3395

1.43

17.21

2.0

40.48

37.78

u/l

2.28

628

2907

Angina pectoris

1315

6883

1.30

17.16

1.9

38.31

39.44

u/l

1.03

1116

6014

Iron deficiency anaemia secondary to blood loss (chronic)

343

2100

1.67

17.15

1.7

1.8

38.32

39.07

u/l

0.24

299

1842

Extrapyramidal and movement disorders

775

5607

1.40

17.14

1.7

1.9

38.65

38.96

u/l

0.17

687

4860

Other diseases of jaws

183

932

2.03

17.11

1.9

2.1

41.05

39.34

u/l

0.59

162

831

Other shoulder lesions

228

1248

1.88

17.07

1.8

2.0

40.42

38.92

u/l

0.50

203

1137

Metatarsalgia

234

1292

1.86

17.05

2.3

2.0

38.55

39.31

u/l

0.23

207

1174

Viral hepatitis, IBD co-morbidity

108

444

2.49

16.97

1.8

2.5

48.24

40.29

u/l

1.84

418

Retinal vascular occlusion

248

1395

1.82

16.94

1.9

1.8

37.92

37.85

u/l

0.02

203

1186

Dental operations, only avohilmo

1722

7034

1.26

16.93

1.9

39.24

39.02

u/l

0.17

1533

6180

Nephrotic syndrome

395

2.65

16.93

1.4

2.0

41.06

39.14

u/l

0.34

351

Cellulitis

486

3237

1.53

16.84

2.2

1.9

38.75

39.18

u/l

0.18

420

2879

COPD, hospital admissions

924

5813

1.36

16.80

1.7

1.8

37.36

38.41

u/l

0.77

783

4992

Type 1 diabetes, wide definition, subgroup 1

485

3227

1.53

16.76

2.1

1.9

44.12

39.55

u/l

3.98

431

2948

Isolated proteinuria

368

2.71

16.74

1.8

2.1

43.70

38.21

u/l

1.33

330

Diseases of external ear

733

5277

1.41

16.73

1.7

1.9

39.42

39.04

u/l

0.21

626

4670

Atopic dermatitis

1295

8612

1.29

16.71

1.9

2.0

39.77

39.47

u/l

0.23

1183

7836

Otalgia

195

1024

1.96

16.68

2.2

1.9

41.25

39.52

u/l

0.67

173

928

Acute generalized exanthematous pustulosis

128

576

2.32

16.67

2.3

2.0

37.99

38.87

u/l

0.19

114

510

Sleep disorders

496

3325

1.52

16.66

2.1

2.0

39.55

39.31

u/l

0.10

457

3019

779

5323

1.39

16.66

2.0

1.7

39.60

38.25

u/l

0.98

667

4498

Retinal vascular disorders

251

1424

1.80

16.65

1.8

1.7

38.03

37.75

u/l

0.08

205

1209

Urolithiasis

698

4989

1.42

16.62

2.1

1.9

37.92

38.77

u/l

0.51

622

4355

Generalized anxiety disorder

349

2168

1.64

16.46

1.9

2.0

37.70

39.22

u/l

0.95

325

2008

Coeliac disease

293

1744

1.72

16.43

2.0

1.9

41.81

39.17

u/l

1.35

270

1573

Sequelae of external causes of morbidity and mortality

542

3710

1.48

16.41

1.9

38.20

39.06

u/l

0.44

486

3250

COPD, early/later onset

928

5850

1.35

16.38

1.7

1.8

37.42

38.43

u/l

0.73

787

5020

Amyloidosis

216

3.26

16.38

1.3

1.9

38.32

39.21

u/l

0.10

190

Idiopathic thrombocytopenic purpura

366

2.68

16.37

2.8

2.0

46.06

38.78

u/l

1.43

328

Mature T/NK-cell lymphomas, hilmo

152

3.81

16.35

1.3

2.2

43.29

39.28

u/l

0.53

133

Kidney transplant status

146

699

2.18

16.30

1.5

2.0

37.49

38.88

u/l

0.35

141

625

Allergic contact dermatitis

329

2023

1.66

16.25

1.9

2.0

39.42

39.54

u/l

0.04

297

1834

Cerebral palsy and other paralytic syndromes

266

1547

1.76

16.23

1.7

1.9

37.93

39.09

u/l

0.41

236

1379

Flat foot [pes planus] (acquired)

219

1204

1.87

16.19

2.0

1.9

42.77

39.34

u/l

1.62

195

1069

Multiple myeloma and malignant plasma cell neoplasms

118

520

2.37

16.14

1.4

1.9

35.13

37.97

u/l

0.66

109

449

Other diseases of the digestive system

634

4483

1.43

16.03

1.8

39.52

38.68

u/l

0.43

542

3868

Panic disorder

340

2114

1.64

15.99

1.9

2.0

39.71

39.31

u/l

0.14

311

1956

Benign neoplasm of other and unspecified endocrine glands

305

1850

1.69

15.97

1.9

38.84

39.51

u/l

0.22

270

1640

Cluster headache, wide

112

485

2.41

15.95

1.6

2.0

37.35

40.02

u/l

0.81

102

443

Injuries to the thorax

956

7222

1.34

15.94

2.1

1.9

40.70

38.90

u/l

1.76

845

6345

Retention of urine

670

4036

1.42

15.85

1.5

1.8

37.84

38.13

u/l

0.12

573

3496

Cardiomyopathy, Hypertrophic obstructive

184

3.41

15.83

3.1

1.8

39.77

41.27

u/l

0.16

168

Other infectious diseases

186

980

1.95

15.76

2.3

1.8

37.74

38.92

u/l

0.31

167

851

Actinic keratosis

701

4800

1.40

15.71

2.0

1.7

39.36

38.17

u/l

0.77

595

4039

Fissure and fistula of anal and rectal regions

550

3807

1.47

15.70

1.9

38.91

38.92

u/l

0.01

496

3363

Valvular operations

274

1620

1.72

15.66

2.0

1.6

37.96

39.24

u/l

0.44

229

1436

Injuries to the ankle and foot

1640

12080

1.25

15.64

2.0

40.06

39.46

u/l

0.58

1481

10922

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

345

2.66

15.51

1.5

1.9

31.61

39.55

u/l

3.14

284

Psoriasis

655

4692

1.42

15.48

1.8

1.9

38.79

39.28

u/l

0.26

586

4161

Non-Hodgkin lymphoma, all

405

2.52

15.48

1.6

1.9

41.63

37.67

u/l

0.88

350

Ankylosing spondylitis, ICD10

239

1371

1.79

15.44

2.0

38.85

39.29

u/l

0.14

217

1235

IBD patients in KELA-register

545

3782

1.46

15.39

1.7

2.0

37.95

39.35

u/l

1.00

479

3427

Heartburn

233

1326

1.80

15.35

1.8

38.81

39.14

u/l

0.09

204

1167

Cervicocranial syndrome

250

1452

1.76

15.35

2.0

42.53

38.87

u/l

2.03

228

1303

Other and unspecified myopathies

196

1062

1.90

15.26

1.6

1.9

40.04

38.41

u/l

0.45

175

925

Dislocation, sprain and strain of joints and ligaments at neck level

360

2300

1.60

15.19

1.7

1.9

38.82

39.14

u/l

0.11

323

2100

Pain associated with micturition

265

1570

1.73

15.16

1.7

1.9

36.73

39.36

u/l

1.32

229

1388

Cluster headache, strict

106

459

2.41

15.14

1.6

2.0

37.30

40.28

u/l

0.90

422

Third [oculomotor] nerve palsy

211

3.21

15.12

1.6

2.2

33.76

39.01

u/l

1.40

187

Injuries to the abdomen, lower back, lumbar spine and pelvis

814

6014

1.36

15.11

1.8

1.9

40.42

39.02

u/l

1.12

707

5292

Superficial injury of lower leg

542

3775

1.46

14.99

1.9

40.57

39.23

u/l

0.77

479

3373

Spondylolisthesis/Spondylolysis

406

2671

1.55

14.99

2.0

39.65

39.14

u/l

0.20

367

2358

Bipolar affective disorders

439

2935

1.52

14.99

1.7

2.0

39.13

39.35

u/l

0.09

390

2702

Mouth breathing

922

6993

1.33

14.97

2.1

2.0

39.22

u/l

0.00

826

6214

Skin changes due to chronic exposure to nonionizing radiation

719

4967

1.39

14.96

1.9

1.7

39.24

38.26

u/l

0.60

612

4186

Psoriatic arthropathies

238

1374

1.77

14.95

1.6

1.9

40.24

39.35

u/l

0.28

223

1222

Alcoholic liver disease

228

1302

1.80

14.93

1.5

1.9

48.37

38.32

u/l

6.05

209

1129

Other medical care

805

5846

1.36

14.93

1.4

1.8

37.64

38.78

u/l

0.74

708

5116

Sixth [abducent] nerve palsy

395

2.53

14.91

1.9

2.0

35.21

39.94

u/l

1.36

351

Other diseases of stomach and duodenum

156

790

2.04

14.90

2.1

1.8

39.00

39.47

u/l

0.11

140

687

Other chronic obstructive pulmonary disease, including avohilmo

1107

7148

1.30

14.80

1.7

1.9

37.73

38.60

u/l

0.69

945

6159

Seborrhoeic dermatitis

224

1276

1.80

14.79

1.6

1.9

39.34

38.61

u/l

0.21

206

1125

Other/unspecified enthesopathies of lower limb, excluding foot

178

945

1.94

14.77

1.9

2.0

40.36

38.91

u/l

0.45

164

862

Diabetic neuropathy

259

1532

1.73

14.69

1.9

2.0

41.93

37.67

u/l

2.07

219

1297

Guillain-Barre syndrome

199

3.25

14.68

1.9

2.1

32.38

39.17

u/l

1.66

178

Transient ischemic attack

1081

6943

1.30

14.66

1.7

1.9

38.39

38.97

u/l

0.43

926

6006

Thyrotoxicosis, other and/or unspecified

442

2975

1.51

14.64

2.2

2.0

38.99

39.25

u/l

0.09

391

2651

Restless leg syndrome

279

1693

1.69

14.64

1.8

1.9

38.83

39.55

u/l

0.30

246

1508

Benign neoplasm: Transverse colon

216

1222

1.82

14.62

2.3

1.7

38.32

38.49

u/l

0.04

185

1026

Recurring oral aphthae, including avohilmo

310

1931

1.64

14.61

2.0

1.9

39.73

39.23

u/l

0.18

283

1727

Lung diseases due to external agents

274

1652

1.69

14.61

2.0

1.8

40.77

37.72

u/l

1.16

248

1419

Allergic urticaria

204

1135

1.85

14.60

2.2

2.0

39.44

39.08

u/l

0.09

182

1036

Endometriosis of pelvic peritoneum

387

2501

1.55

14.58

1.9

2.2

38.24

39.70

u/l

0.75

342

2294

Mucosal proctocolitis

307

1912

1.64

14.47

1.7

2.0

38.34

39.18

u/l

0.33

266

1737

Type 1 diabetes

563

3969

1.44

14.44

2.1

1.9

43.55

39.51

u/l

3.83

501

3610

Stomatitis and related lesions

198

1095

1.86

14.43

1.9

2.0

40.78

39.22

u/l

0.56

175

985

Covid-19 suspected case

480

3294

1.48

14.41

1.9

2.0

38.85

39.34

u/l

0.23

444

2997

Calcific aortic valvular stenosis, operated

523

3568

1.45

14.33

1.7

1.6

37.95

37.84

u/l

0.04

432

2996

Calcific aortic valvular stenosis

523

3568

1.45

14.33

1.7

1.6

37.95

37.84

u/l

0.04

432

2996

Crohn disease

310

1940

1.63

14.33

1.6

2.0

37.80

39.22

u/l

0.66

277

1763

Thyrotoxicosis

561

3968

1.44

14.32

2.1

2.0

38.96

39.49

u/l

0.24

498

3524

Missing teeth due to accident, extraction or parodontitis

263

1580

1.70

14.32

2.1

1.9

38.85

39.32

u/l

0.12

233

1377

Other abnormalities of plasma proteins

171

3.42

14.29

1.9

2.2

41.16

38.97

u/l

0.26

153

Amyloidosis, other/unspecified

181

3.32

14.27

1.4

1.9

39.72

38.63

u/l

0.13

159

Operations 2 for CAVS

522

3563

1.45

14.26

1.7

1.6

37.95

37.83

u/l

0.04

431

2993

Calcific aortic valvular stenosis, diagnosis (helper)

522

3563

1.45

14.26

1.7

1.6

37.95

37.83

u/l

0.04

431

2993

Use of pramipexole

470

3221

1.48

14.26

2.0

1.9

39.55

39.34

u/l

0.08

411

2810

Astigmatism

147

740

2.05

14.24

1.7

2.0

39.40

39.58

u/l

0.04

135

665

Type 1 diabetes, wide definition

496

3429

1.47

14.21

2.1

1.9

43.81

39.38

u/l

3.88

440

3130

6-mercaptopurine

307

2.68

14.20

1.6

1.7

42.54

41.75

u/l

0.12

277

Thyroiditis

184

1002

1.89

14.19

2.2

1.9

37.11

39.54

u/l

0.97

170

908

Spontaneous rupture of synovium and tendon

185

1008

1.88

14.16

1.5

1.8

41.03

38.90

u/l

0.65

160

887

Inflammatory bowel disease, strict (require KELA)

545

3845

1.44

14.11

1.7

2.0

37.95

39.41

u/l

1.07

479

3488

Sequelae with surgical and medical care as external cause

427

2879

1.51

14.08

1.8

1.9

37.91

39.05

u/l

0.55

389

2515

Persons with potential health hazards related to communicable diseases

864

6504

1.33

14.02

2.0

37.47

39.80

u/l

3.14

795

5987

Injuries to the neck

510

3563

1.45

13.95

1.9

39.81

39.11

u/l

0.32

458

3215

Calcific aortic valvular stenosis, including rheumatic fever

522

3577

1.44

13.91

1.7

37.95

37.86

u/l

0.03

431

3005

Other/unspecified rheumatoid arthritis

275

1684

1.67

13.90

1.7

1.9

38.50

39.26

u/l

0.26

244

1465

Other and unspecified disorders of white blood cells

114

529

2.25

13.88

2.6

2.0

40.65

38.84

u/l

0.30

100

467

Unspecific neurodegenerative disorder

352

3699

0.65

13.87

1.5

1.6

36.54

38.33

u/l

0.92

280

3075

Allergic purpura

391

2.47

13.79

1.8

2.3

37.83

39.24

u/l

0.26

349

Insomnia

365

2393

1.55

13.77

1.9

2.0

39.14

38.91

u/l

0.09

335

2183

Benign paroxysmal vertigo

607

4385

1.40

13.72

1.6

1.9

36.96

39.23

u/l

2.23

522

3828

Neuromuscular dysfunction of bladder

209

1195

1.79

13.67

1.6

1.9

37.52

39.10

u/l

0.53

184

1039

Familial hypercholesterolemia

304

1915

1.62

13.63

1.6

1.7

36.74

38.88

u/l

1.01

249

1643

Complications of internal orthopaedic prosthetic devices, implants and grafts

442

3019

1.49

13.62

1.9

1.8

39.79

38.90

u/l

0.37

381

2596

Injuries to the wrist and hand

2360

14477

1.19

13.62

2.0

40.18

39.31

u/l

1.25

2133

12952

Phlebitis and thrombophlebitis (not including DVT)

492

3434

1.45

13.56

2.0

1.9

39.09

39.15

u/l

0.02

433

3030

Suppurative and necrotic conditions of lower respiratory tract

132

653

2.09

13.53

2.0

1.9

36.76

38.12

u/l

0.38

117

572

COPD, hospital admission 2, with asthma infections

615

3793

1.40

13.48

1.7

1.8

37.09

38.41

u/l

0.83

519

3229

Hallux valgus (acquired)

705

3758

1.37

13.43

2.0

40.12

39.81

u/l

0.16

625

3322

COPD related to multimorbidity

750

4714

1.35

13.39

1.6

1.8

36.50

38.43

u/l

1.67

623

4018

Other disorders of veins

862

6585

1.32

13.37

1.9

40.00

39.53

u/l

0.27

737

5844

Psoriasis vulgaris

423

2880

1.49

13.32

1.9

38.75

39.34

u/l

0.25

379

2563

Chronic periodontitis, complicated

222

1303

1.75

13.29

1.7

1.9

39.76

38.85

u/l

0.24

189

1142

Ascites

155

815

1.95

13.28

1.5

1.8

42.78

38.44

u/l

1.15

133

709

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

379

2527

1.53

13.23

1.8

2.0

38.55

39.38

u/l

0.37

332

2294

Granuloma annulare

169

3.30

13.17

1.8

1.9

37.38

38.69

u/l

0.16

150

Other strabismus

478

3327

1.45

13.15

2.0

39.09

39.50

u/l

0.17

435

3017

Osteomyelitis

149

777

1.98

13.14

2.6

1.8

41.03

38.07

u/l

0.82

132

684

Nontoxic multinodular goitre

418

2849

1.49

13.07

1.8

1.9

41.52

39.33

u/l

1.23

367

2472

Alzheimer disease

203

2603

0.58

13.01

1.4

1.6

37.14

38.23

u/l

0.29

146

2149

Atopic dermatitis, strict definition with reimbursement

668

4787

1.37

12.99

1.9

2.0

39.88

39.43

u/l

0.26

613

4407

COPD-related respiratory insufficiency

234

1400

1.71

12.96

1.8

1.7

34.83

38.00

u/l

1.42

195

1178

Other disorders of nervous system

159

853

1.92

12.90

2.3

1.9

40.29

38.79

u/l

0.45

138

753

Exophthalmic conditions

126

3.71

12.90

1.9

2.3

40.92

39.12

u/l

0.18

116

Malignant neoplasm

2186

10938

1.19

12.81

1.9

2.1

40.10

39.39

u/l

0.81

1964

9774

Seropositive rheumatoid arthritis, strict definition

346

2281

1.55

12.80

1.4

2.0

36.99

39.62

u/l

1.55

302

2013

Oesophageal varices

109

514

2.21

12.78

1.9

52.60

38.30

u/l

5.83

452

Artificial joint operation, meniscal resection

2106

11803

1.19

12.77

2.0

39.44

39.45

u/l

0.01

1841

10425

Other spirochaetal diseases

565

4088

1.40

12.73

1.8

2.0

42.44

39.16

u/l

3.38

485

3612

Macular cyst

290

2.66

12.72

2.2

2.0

39.29

39.59

u/l

0.04

254

Other disorders of cornea

210

1228

1.75

12.72

1.8

1.9

40.66

39.02

u/l

0.55

189

1089

Glaucoma-related operations

126

628

2.08

12.68

1.9

1.8

36.90

38.80

u/l

0.48

110

544

Nonorganic sleeping disorders

421

2895

1.48

12.60

2.0

39.38

39.02

u/l

0.15

391

2634

Abnormal blood-pressure reading, without diagnosis

103

476

2.23

12.59

1.6

1.9

40.41

40.17

u/l

0.04

426

Cardiac murmurs and other cardiac sounds

176

967

1.83

12.55

2.3

1.8

37.72

40.01

u/l

0.86

156

877

TMD related pain

101

466

2.26

12.52

1.5

2.0

37.41

40.27

u/l

0.97

423

Other noninfective disorders of lymphatic vessels and lymph nodes

447

2.29

12.49

1.8

2.0

38.94

38.65

u/l

0.05

397

Monoplegia

186

3.12

12.42

1.9

2.1

40.84

39.20

u/l

0.24

163

Viral pneumonia (unknown virus, not influenza)

162

885

1.88

12.41

2.5

1.9

35.32

38.83

u/l

1.37

146

798

Acute pharyngitis

314

2023

1.57

12.41

1.7

2.1

37.11

40.16

u/l

2.14

291

1840

Post-traumatic stress disorder

182

1028

1.81

12.40

2.0

2.1

38.74

39.10

u/l

0.10

164

965

Diseases of male genital organs

1192

4783

1.27

12.40

1.9

2.1

39.19

39.24

u/l

0.03

1058

4255

Tuberculosis of other organs

224

2.87

12.37

1.7

2.0

39.48

37.89

u/l

0.23

197

Generalized skin eruption due to drugs and medicaments

108

514

2.19

12.37

2.4

2.0

38.51

39.05

u/l

0.09

454

Other juvenile arthritis

447

2.26

12.37

2.1

40.64

39.10

u/l

0.30

426

Fibroblastic disorders

477

3367

1.44

12.35

1.8

1.9

40.60

38.60

u/l

1.35

416

2928

Vitreous haemorrhage

222

1329

1.71

12.35

1.9

1.8

43.13

39.16

u/l

1.68

201

1154

Other diseases of arteries and capillaries

197

1141

1.77

12.35

2.2

1.8

38.06

39.03

u/l

0.27

177

997

Visual field defects

188

1075

1.79

12.35

1.7

1.8

36.28

38.53

u/l

0.89

168

934

Ulcerative colitis (strict definition, require KELA)

386

2624

1.50

12.29

1.8

2.0

38.48

39.46

u/l

0.46

339

2380

Persistent mood disorders

430

2985

1.46

12.24

1.9

2.0

38.81

39.10

u/l

0.11

379

2669

Lyme disease

557

4052

1.39

12.17

1.8

2.0

42.43

39.21

u/l

3.23

477

3580

Speech disturbances, not elsewhere classified

184

1050

1.80

12.16

1.8

36.87

38.85

u/l

0.50

153

915

Injuries to the shoulder and upper arm

1883

13265

1.20

12.14

1.9

2.0

40.20

39.36

u/l

0.98

1678

11765

Benign neoplasm: Ascending colon

258

1612

1.63

12.11

1.9

1.8

37.86

38.38

u/l

0.15

217

1360

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

440

2.27

12.09

2.6

2.1

38.50

39.13

u/l

0.11

381

Haemorrhoids and perianal venous thrombosis

586

4295

1.38

12.07

1.7

1.9

39.85

38.73

u/l

0.64

509

3713

Trigger finger

312

2038

1.56

12.04

1.8

2.0

40.80

39.32

u/l

0.69

282

1823

Moderate visual impairment, binocular

273

2.63

12.01

1.7

1.9

42.23

38.13

u/l

0.72

241

Achilles tendinitis

236

1447

1.67

11.96

1.9

2.0

38.73

39.43

u/l

0.20

213

1301

Dissociative [conversion] disorders

454

2.23

11.96

1.6

2.2

40.47

38.84

u/l

0.36

424

Other meningitis

201

2.97

11.94

1.8

2.1

37.68

40.71

u/l

0.59

182

Juvenile arthritis (FINNGEN)

109

527

2.13

11.88

2.0

2.2

40.62

39.79

u/l

0.16

100

496

Viral infections of the central nervous system

181

1038

1.79

11.83

2.0

38.26

39.39

u/l

0.34

165

937

Infections with a predominantly sexual mode of transmission

694

5237

1.34

11.81

2.2

2.0

41.54

39.49

u/l

1.84

631

4827

Pyogenic arthritis

144

769

1.92

11.81

2.1

1.9

35.93

38.39

u/l

0.77

121

679

Personality disorders, excluding more controls

569

4171

1.38

11.79

1.9

2.1

40.96

39.56

u/l

0.82

505

3846

Tuberculosis

133

692

1.97

11.79

1.7

1.8

40.15

38.35

u/l

0.51

117

590

Degenerative diseases of the nervous system

268

3135

0.64

11.76

1.5

1.6

37.38

38.26

u/l

0.28

203

2613

Lichen simplex chronicus

446

2.25

11.73

2.3

2.1

40.50

39.27

u/l

0.20

405

Special screening examination for other diseases and disorders

172

973

1.80

11.64

1.9

40.86

38.35

u/l

0.91

158

863

Ganglion

458

3247

1.43

11.62

2.1

2.0

42.81

39.24

u/l

3.52

419

2927

Benign neoplasm: Transverse colon

216

1307

1.69

11.59

2.3

1.8

38.32

38.67

u/l

0.09

185

1121

Tuberculosis of other organs, strict

249

2.69

11.59

1.6

2.1

39.85

38.36

u/l

0.22

218

Other coagulation defects

171

971

1.81

11.56

2.1

2.0

38.79

38.96

u/l

0.03

149

880

Acute lymphadenitis

153

842

1.87

11.50

1.8

2.0

39.95

39.01

u/l

0.20

136

776

Early lumbar disc prolapse, operated

238

1478

1.64

11.47

2.2

2.1

40.97

38.91

u/l

0.96

226

1383

Other and unspecified disorders of vitreous body

845

6552

1.30

11.42

2.2

1.9

39.59

39.34

u/l

0.13

740

5700

Appendicitis, broad definition

1751

13459

1.20

11.40

2.0

39.67

39.44

u/l

0.18

1575

12071

Gout due to impairment of renal function

117

3.64

11.34

2.9

2.1

41.47

39.23

u/l

0.31

103

Diseases of appendix

1763

13519

1.20

11.34

2.0

39.65

39.45

u/l

0.15

1587

12129

Unspecified/other endometriosis

215

1306

1.68

11.32

2.0

39.02

39.61

u/l

0.13

196

1227

Chronic lymphocytic leukaemia, helper endpoint

276

2.57

11.30

1.8

2.0

42.23

39.65

u/l

0.36

234

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

276

2.57

11.30

1.8

2.0

42.23

39.65

u/l

0.36

234

Other disorders of the musculoskeletal system and connective tissue

314

2087

1.53

11.25

1.6

1.9

39.74

39.09

u/l

0.22

278

1837

Other and unspecified coagulation defects

126

657

1.98

11.24

2.0

2.1

37.98

39.38

u/l

0.30

110

592

Other hammer toe(s) (acquired)

332

2087

1.51

11.22

2.0

1.9

41.61

39.15

u/l

1.27

280

1801

Melanocytic naevi

607

4532

1.36

11.22

1.9

2.0

38.28

39.12

u/l

0.55

539

4056

Excessive vomiting in pregnancy

196

1167

1.72

11.18

1.8

2.0

38.49

39.41

u/l

0.28

185

1082

Postmenopausal bleeding

605

2448

1.37

11.16

2.0

2.1

40.05

40.68

u/l

0.31

523

2160

Macular pucker

288

1883

1.56

11.14

2.0

1.7

41.83

38.24

u/l

2.25

253

1587

Gluteal tendinitis

455

2.19

11.14

2.6

2.1

37.63

38.78

u/l

0.24

409

Cluster headache, wide,, including avohilmo

139

751

1.91

11.14

1.6

2.1

37.25

39.76

u/l

0.90

128

681

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

406

2842

1.45

11.13

1.8

1.9

38.25

39.42

u/l

0.62

357

2568

Chondropathies

349

2375

1.49

11.12

2.0

1.9

39.52

39.17

u/l

0.12

314

2144

Autonomic disorders

268

2.59

11.04

1.7

2.1

34.33

38.58

u/l

0.92

241

Need for other prophylactic measures

138

746

1.91

11.03

2.8

2.0

35.39

39.54

u/l

2.21

125

665

Cluster headache, strict, including avohilmo

133

711

1.94

11.03

1.6

2.1

37.20

39.70

u/l

0.84

122

645

Myocardial infarction, without ST-elevation

726

5136

1.32

10.97

1.8

1.7

36.59

38.33

u/l

1.27

598

4356

Benign neoplasm: Stomach

204

1234

1.69

10.97

1.9

39.22

38.84

u/l

0.09

167

1058

Vitamin deficiency

115

586

2.03

10.94

1.5

2.0

39.35

38.81

u/l

0.11

106

520

Vitamin deficiency, wide

115

586

2.03

10.94

1.5

2.0

39.35

38.81

u/l

0.11

106

520

Hyperplasia of prostate

753

3281

1.32

10.88

1.8

1.9

36.82

38.06

u/l

0.81

652

2842

Stenosis and insufficiency of lacrimal passages

197

1183

1.70

10.88

2.3

1.9

40.58

39.42

u/l

0.34

172

1040

Faecal incontinence

185

1094

1.73

10.82

2.0

1.8

38.03

39.51

u/l

0.45

163

953

Use of memantine

156

2342

0.57

10.76

1.3

1.6

35.47

38.15

u/l

0.88

117

1930

Use of other anti-dementia drugs

156

2342

0.57

10.76

1.3

1.6

35.47

38.15

u/l

0.88

117

1930

Misadventures to patients during surgical and medical care

295

1954

1.54

10.75

2.0

1.9

40.37

39.59

u/l

0.26

266

1732

Other diseases of oesophagus

197

1186

1.69

10.75

1.9

1.8

39.42

39.15

u/l

0.06

175

1023

Any dementia

337

3462

0.68

10.74

1.4

1.6

36.46

38.35

u/l

0.84

265

2875

484

3103

1.40

10.71

1.8

1.6

39.40

38.09

u/l

0.62

406

2575

Disorders of myoneural junction and muscle in diseases classified elsewhere

102

3.79

10.71

1.8

2.2

43.97

40.33

u/l

0.39

Epilepsy

602

4506

1.34

10.69

1.9

40.11

39.48

u/l

0.29

541

4005

Dementia

415

4022

0.71

10.66

1.5

1.7

35.95

38.35

u/l

1.53

335

3378

Recurring oral aphthae

115

593

2.01

10.62

2.2

1.9

41.43

38.32

u/l

0.98

102

530

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

597

4433

1.35

10.61

1.9

2.0

38.44

39.30

u/l

0.49

537

4102

Gonarthrosis, primary, with knee surgery

1129

7480

1.24

10.57

1.8

1.9

38.26

39.26

u/l

0.87

963

6475

Respiratory tuberculosis, bacteriologically and histologically confirmed

197

2.82

10.53

1.6

2.0

43.95

38.17

u/l

1.09

171

Other specified and unspecified disorders of eye and adnexa

101

499

2.10

10.53

2.3

2.1

39.80

39.75

u/l

0.01

438

Other follicular disorders

173

1014

1.75

10.52

2.0

38.60

39.53

u/l

0.26

162

926

Diseases of middle ear and mastoid

1291

8703

1.22

10.47

2.0

39.49

39.27

u/l

0.14

1166

7878

Hepatic failure, not elsewhere classified

427

2.19

10.45

2.2

2.0

48.52

39.57

u/l

1.74

377

Unspecified chronic bronchitis

367

2.27

10.45

1.8

2.0

35.91

37.77

u/l

0.39

313

Acute appendicitis

1637

13017

1.19

10.45

2.0

39.69

39.43

u/l

0.20

1477

11706

Impingement syndrome of shoulder

525

3881

1.37

10.42

2.1

2.0

41.67

39.04

u/l

2.22

460

3432

TMD related operations

379

2656

1.45

10.40

1.9

2.0

40.39

39.26

u/l

0.54

340

2409

Acute appendicitis, no complications

1297

10687

1.22

10.39

2.1

39.98

39.49

u/l

0.38

1177

9668

Other local infections of skin and subcutaneous tissue

219

1368

1.63

10.38

1.8

1.9

38.55

38.97

u/l

0.11

193

1223

Retinal breaks without detachment

335

2295

1.49

10.38

2.1

1.9

40.16

39.03

u/l

0.45

298

2001

Acute pancreatitis

402

2846

1.43

10.37

1.7

1.9

38.84

38.99

u/l

0.05

355

2485

Nontoxic goitre/thyroid nodule

617

4677

1.33

10.34

1.8

1.9

40.84

39.51

u/l

0.85

546

4084

Paralytic ileus and intestinal obstruction

491

3595

1.38

10.30

1.7

1.8

39.02

38.84

u/l

0.07

427

3097

Chronic conjunctivitis

391

2.24

10.27

2.3

2.1

40.63

39.56

u/l

0.22

344

Dermatophytosis

274

1806

1.55

10.26

2.1

1.9

39.12

38.70

u/l

0.11

242

1585

Alzheimer’s disease, wide definition

152

2180

0.58

10.26

1.4

1.6

38.13

38.08

u/l

0.01

111

1804

Appendectomy

1512

12217

1.20

10.22

2.1

2.0

39.67

39.56

u/l

0.07

1366

11006

Charcot foot

201

2.79

10.22

3.2

2.0

42.60

39.97

u/l

0.28

181

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

181

1081

1.71

10.22

1.7

2.0

40.59

39.06

u/l

0.56

165

996

Dystonia

134

736

1.88

10.21

1.6

2.0

40.39

38.91

u/l

0.34

118

663

Other symptoms and signs involving the urinary system

217

1358

1.63

10.21

1.9

1.8

37.07

38.68

u/l

0.48

200

1177

Respiratory tuberculosis, confirmed and not-confirmed

116

607

1.96

10.19

1.8

1.9

39.83

38.47

u/l

0.31

103

524

Respiratory tuberculosis

116

607

1.96

10.19

1.8

1.9

39.83

38.47

u/l

0.31

103

524

Adhesive capsulitis of shoulder

354

2458

1.46

10.18

1.8

1.9

40.91

39.19

u/l

1.00

322

2168

Other bursopathies

271

1784

1.55

10.18

2.4

1.9

38.99

38.82

u/l

0.05

249

1568

Scoliosis

177

1052

1.72

10.16

2.1

1.9

39.27

38.52

u/l

0.19

160

953

Pyothorax

101

506

2.07

10.15

2.1

1.8

36.46

38.03

u/l

0.38

442

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

358

2494

1.46

10.12

2.1

2.0

39.72

39.14

u/l

0.23

328

2289

Postmenopausal osteoporosis with pathological fracture

122

652

1.93

10.11

2.7

1.9

44.01

39.43

u/l

1.17

560

Respiratory tuberculosis, confirmed

190

2.81

10.11

1.7

2.0

43.95

37.56

u/l

1.26

164

Maternal care for other conditions predominantly related to pregnancy

469

3377

1.39

10.11

1.9

2.1

39.78

39.52

u/l

0.11

434

3169

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

815

6414

1.28

10.09

1.9

2.0

40.45

39.74

u/l

0.47

745

5877

Endometriosis of ovary

377

2648

1.44

10.04

2.0

2.1

40.17

39.92

u/l

0.08

334

2406

N06DA Anticholinesterases

257

3145

0.65

10.04

1.5

1.6

36.15

38.29

u/l

0.94

200

2578

Use of anticholinesterases

257

3145

0.65

10.04

1.5

1.6

36.15

38.29

u/l

0.94

200

2578

Other disorders of bladder

240

1544

1.58

10.03

1.8

36.25

38.41

u/l

1.01

216

1327

Other/unspecified enthesopathies, not elsewhere classified

188

1141

1.68

10.00

2.1

2.0

39.16

38.71

u/l

0.10

166

1012

Atrophic disorders of skin

305

2067

1.50

9.99

2.4

2.0

40.38

39.77

u/l

0.20

274

1836

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

826

5725

1.28

9.99

1.7

1.9

39.73

38.96

u/l

0.46

729

4988

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

5.10

9.97

1.2

3.3

30.93

42.08

u/l

1.67

Other and unspecified glaucoma

139

777

1.83

9.95

2.1

1.8

38.55

39.05

u/l

0.10

124

660

Otitis externa

465

3402

1.38

9.90

1.7

1.9

39.50

39.20

u/l

0.12

403

3043

Transport accidents

1036

7444

1.24

9.89

2.0

40.77

39.04

u/l

1.89

948

6709

Hydronephrosis

215

1353

1.62

9.86

2.0

1.8

37.55

39.04

u/l

0.53

196

1185

Benign neoplasm: Sigmoid colon

343

2384

1.46

9.84

2.0

1.8

38.47

38.74

u/l

0.09

297

2042

Other and unspecified vascular occlusions

176

1055

1.70

9.82

1.8

36.76

38.35

u/l

0.47

143

892

Major coronary heart disease event excluding revascularizations

1353

7759

1.21

9.78

1.8

1.9

36.61

39.15

u/l

4.21

1118

6752

Systemic atrophies primarily affecting the central nervous system

493

2.06

9.75

1.7

1.9

38.43

38.89

u/l

0.09

431

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

204

1274

1.64

9.73

1.9

1.8

39.50

39.02

u/l

0.12

180

1126

Adult-onset Still disease

4.94

9.72

1.8

2.4

40.09

42.87

u/l

0.22

Primary gonarthrosis, bilateral

1019

7229

1.24

9.71

1.8

1.9

38.76

39.40

u/l

0.45

878

6261

Special screening examination for neoplasms

452

2.09

9.69

1.5

1.7

36.65

38.06

u/l

0.24

392

Benign neoplasm: Adrenal gland

159

933

1.75

9.68

2.0

1.9

38.20

38.86

u/l

0.16

139

808

Myopia

273

1821

1.52

9.67

2.1

2.0

38.23

39.24

u/l

0.42

249

1678

Nonsuppurative otitis media

470

2978

1.38

9.64

1.9

1.8

39.50

39.05

u/l

0.19

425

2734

Atherosclerosis, excluding cerebral and coronary sclerosis

744

4646

1.29

9.62

1.7

38.13

38.41

u/l

0.12

610

3938

Ptosis of eyelid

214

1355

1.61

9.62

2.2

1.8

38.96

39.08

u/l

0.03

190

1176

Myocardial infarction

1014

5888

1.25

9.62

1.8

1.9

36.72

39.14

u/l

2.90

831

5122

Other and unspecified erythematous conditions

409

2.17

9.59

1.6

2.1

37.16

39.04

u/l

0.42

365

Phobic anxiety disorders

276

1847

1.52

9.57

1.8

2.0

39.05

39.50

u/l

0.14

261

1715

Other diseases of blood and blood-forming organs

151

877

1.77

9.54

1.8

1.9

40.14

38.35

u/l

0.49

126

771

Background retinopathy and retinal vascular changes

245

2.53

9.45

2.7

2.1

41.58

38.81

u/l

0.42

217

Lesion of lateral popliteal nerve

117

632

1.91

9.43

2.5

2.0

39.38

38.74

u/l

0.13

105

557

Heterophoria

177

1076

1.68

9.41

2.2

2.0

38.70

39.17

u/l

0.12

164

979

Nonalcoholic steatohepatitis

106

3.53

9.41

2.4

2.6

64.59

41.45

u/l

2.99

Peripheral artery disease

806

5135

1.27

9.41

1.8

1.7

37.71

38.74

u/l

0.64

665

4387

Haemorrhage, not elsewhere classified

332

2.27

9.39

1.2

1.8

35.39

40.00

u/l

1.33

284

Problems related to lifestyle

228

1473

1.58

9.38

1.6

1.9

43.79

38.81

u/l

2.41

207

1333

Use of antiglaucoma preparations and miotics

154

902

1.74

9.38

1.7

38.98

38.68

u/l

0.06

137

767

Other and unspecified local infections of skin and subcutaneous tissue

203

1278

1.62

9.37

1.8

1.9

38.17

38.93

u/l

0.21

179

1141

Striking against or struck by other objects

679

5284

1.30

9.35

2.0

39.81

39.40

u/l

0.20

587

4782

Other facial nerve disorders

360

2.23

9.35

1.6

2.1

38.55

40.16

u/l

0.30

316

Noninflammatory disorders of female genital tract

973

3929

1.26

9.33

1.9

2.0

39.92

39.66

u/l

0.17

893

3565

Nail disorders

188

1164

1.65

9.32

2.4

2.0

40.88

39.47

u/l

0.37

174

1046

Amenorrhoea

148

860

1.76

9.27

1.6

1.8

39.78

38.45

u/l

0.41

134

811

Benign neoplasm: Ascending colon

258

1718

1.53

9.27

1.9

1.8

37.86

38.50

u/l

0.20

217

1478

Ischaemic Stroke, excluding all haemorrhages

1111

6892

1.23

9.26

1.6

1.8

36.54

38.90

u/l

3.40

914

5959

Hernia of abdominal wall

936

7577

1.25

9.26

2.1

1.9

38.94

38.88

u/l

0.03

821

6660

Any event in cancer register

2234

11505

1.16

9.25

1.9

2.0

39.96

39.38

u/l

0.64

2000

10314

Other peripheral vertigo

195

1221

1.63

9.23

1.9

1.8

39.12

39.17

u/l

0.01

167

1080

Other benign neoplasms of skin

733

5661

1.28

9.22

2.1

1.9

39.18

38.96

u/l

0.10

643

4971

Parodontitis

2063

13165

1.16

9.20

1.9

2.0

39.79

39.41

u/l

0.35

1804

11738

Pneumothorax

144

834

1.77

9.17

2.2

1.9

41.93

39.08

u/l

0.75

125

722

Polyarteritis nodosa

4.03

9.16

1.3

2.2

36.41

38.84

u/l

0.27

Nummular dermatitis

171

1038

1.68

9.16

1.8

40.27

38.63

u/l

0.51

155

909

Other female pelvic inflammatory diseases

360

2561

1.43

9.15

2.0

2.1

39.91

39.52

u/l

0.15

325

2294

Parodontitis or operation codes

2064

13168

1.16

9.14

1.9

2.0

39.81

39.40

u/l

0.37

1805

11740

Other specified/unspecified bacterial intestinal infections

144

836

1.77

9.13

1.9

41.99

38.55

u/l

1.04

118

737

Etanercept

151

890

1.74

9.09

1.4

2.1

38.29

39.73

u/l

0.45

138

810

KRA_PSY_EATING, excluding more controls

158

936

1.71

9.08

1.6

2.1

39.68

38.96

u/l

0.17

141

889

Procreative management

720

4771

1.28

9.06

2.0

2.1

41.08

40.04

u/l

0.73

670

4389

Colonic or urogenital fistula

580

4447

1.32

9.04

1.9

38.68

39.00

u/l

0.15

525

3942

Benign neoplasm: Stomach

204

1299

1.60

9.01

1.9

1.8

39.22

39.07

u/l

0.03

167

1144

Stroke, excluding SAH

1195

7358

1.22

9.01

1.6

1.9

36.98

39.04

u/l

2.66

986

6378

Other blood glucose lowering drugs, excl. Insulins

324

2267

1.45

9.01

2.1

1.7

37.21

39.56

u/l

1.08

286

1961

Car occupant injured in other and unspecified transport accidents

401

2912

1.39

8.99

2.1

1.9

41.30

38.93

u/l

1.64

367

2641

Fracture of rib(s), sternum and thoracic spine

574

4400

1.32

8.94

1.9

39.55

39.04

u/l

0.22

502

3836

Ulcerative colitis (strict definition, all Crohn cases excluded)

317

2214

1.45

8.93

1.8

2.0

38.82

39.39

u/l

0.21

274

2010

Cholecystitis

264

1779

1.51

8.91

2.0

1.8

39.30

38.73

u/l

0.15

225

1537

Benign neoplasm: Rectum, anus and anal canal

371

2664

1.41

8.91

1.9

39.16

38.69

u/l

0.18

321

2289

Other specific arthropathies, wide

258

2.43

8.90

1.7

2.3

35.50

40.16

u/l

0.95

237

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

581

4462

1.31

8.89

1.8

2.1

40.83

39.52

u/l

0.72

516

4099

Dislocation, sprain and strain of joints and ligaments of knee

1401

10984

1.19

8.89

2.1

40.24

39.56

u/l

0.64

1266

9917

Barrett oesophagus

110

595

1.91

8.87

1.8

1.9

38.11

39.15

u/l

0.21

510

Chronic periodontitis, including avohilmo

2051

13170

1.16

8.87

1.9

2.0

39.84

39.41

u/l

0.39

1793

11742

Benign neoplasm of meninges

201

1281

1.60

8.84

1.7

2.0

36.54

39.71

u/l

1.68

171

1110

L04AC Interleukin inhibitors

126

713

1.82

8.79

1.4

2.1

40.97

39.56

u/l

0.31

117

649

Any dementia, excluding more controls

324

3179

0.70

8.79

1.4

1.6

36.53

38.14

u/l

0.65

254

2646

Stroke, including SAH

1273

7874

1.20

8.77

1.6

1.9

36.99

39.13

u/l

3.05

1050

6852

Pneumoconiosis due to dust containing silica

6.18

8.75

2.6

1.8

48.62

42.49

u/l

0.37

DVT of lower extremities

372

2684

1.40

8.69

1.9

37.60

38.86

u/l

0.54

322

2337

Other contact dermatitis

181

1131

1.63

8.65

1.9

2.0

41.27

39.44

u/l

0.55

159

1027

Algoneurodystrophy

446

2.05

8.65

1.7

2.1

38.07

38.97

u/l

0.18

406

Tinnitus

493

3722

1.34

8.62

2.1

1.9

38.27

39.28

u/l

0.57

435

3285

Benign neoplasm: Cerebral meninges

184

1156

1.62

8.62

1.8

2.0

36.70

39.37

u/l

1.19

157

1008

Chronic lymphocytic leukaemia

313

2.26

8.61

1.8

2.0

42.23

38.35

u/l

0.64

271

Dementia, including avohilmo

473

4332

0.75

8.57

1.4

1.7

37.36

38.19

u/l

0.32

384

3633

Non-allergic asthma

190

1204

1.61

8.56

1.8

1.9

42.93

39.10

u/l

1.67

160

1074

Alzheimer’s disease (Late onset)

136

1956

0.59

8.55

1.4

1.6

38.16

38.07

u/l

0.02

1608

Benign neoplasm: Rectum

330

2342

1.43

8.52

2.0

1.8

39.31

38.70

u/l

0.23

284

2006

Other noninflammatory disorders of vulva and perineum

188

1190

1.61

8.50

2.2

2.0

38.56

39.63

u/l

0.30

165

1083

Tonsillectomy and adenotomy

1319

7722

1.20

8.49

2.0

2.1

39.51

39.81

u/l

0.23

1218

7127

Primary open-angle glaucoma

558

4182

1.31

8.46

2.0

1.7

39.68

38.57

u/l

0.62

483

3516

Acne

209

1356

1.56

8.44

1.9

2.0

41.79

39.34

u/l

1.02

196

1274

Acute pancreatitis (for exclusion)

402

2953

1.38

8.44

1.7

1.9

38.84

39.02

u/l

0.06

355

2583

Other disorders of binocular movement

297

2.28

8.41

1.3

2.1

35.45

40.24

u/l

1.32

268

923

0.37

8.40

1.2

1.8

42.87

37.71

u/l

0.53

788

Atopic dermatitis, strict definition

628

4813

1.29

8.40

1.9

2.0

39.96

39.45

u/l

0.29

577

4447

Osteonecrosis

133

775

1.76

8.39

2.0

1.8

39.90

39.22

u/l

0.14

117

681

Late syphilis

169

2.77

8.38

3.0

2.3

36.12

39.27

u/l

0.42

151

Preparation and fitting of bite rail to mouth

306

2151

1.45

8.38

2.0

39.63

39.11

u/l

0.18

275

1957

Other abnormal findings of blood chemistry

104

564

1.90

8.36

2.0

43.98

38.55

u/l

1.60

502

Other or unspecified ileus, impaction or obstruction

335

2389

1.42

8.36

1.6

1.8

38.73

38.58

u/l

0.04

291

2049

Blepharochalasis

553

4261

1.31

8.34

1.8

38.78

39.17

u/l

0.17

476

3663

Speech therapy

550

4236

1.31

8.33

1.8

1.9

39.62

39.21

u/l

0.18

484

3727

Other erythematous conditions

474

1.99

8.30

1.6

2.0

38.18

38.59

u/l

0.07

421

Chondrocostal junction syndrome [Tietze]

481

1.98

8.28

2.0

2.1

38.85

38.99

u/l

0.02

433

Arthropathic psoriasis

248

1680

1.50

8.26

1.6

1.9

40.77

39.40

u/l

0.48

232

1502

Cholangitis (primary sclerosing, PSC)

126

726

1.78

8.23

1.7

1.8

39.22

38.92

u/l

0.06

112

640

Simple and mucopurulent chronic bronchitis

439

2.01

8.21

1.9

2.0

39.41

38.48

u/l

0.13

372

Paraplegia, diplegia of upper limbs

268

2.34

8.20

1.5

2.1

32.87

39.28

u/l

1.53

239

Parodontitis and operation codes

1929

13042

1.16

8.20

1.9

2.0

39.62

39.48

u/l

0.10

1688

11624

Panniculitis affecting regions of neck and back

475

1.97

8.19

1.6

2.0

39.75

38.16

u/l

0.37

425

Recurrent dislocation and subluxation of joint

154

938

1.67

8.17

1.6

2.0

40.68

39.02

u/l

0.57

141

869

Other and unspecified follicular disorders

533

1.92

8.16

2.5

2.0

39.76

39.68

u/l

0.01

481

Melanocytic naevi

607

4749

1.29

8.15

1.9

2.0

38.28

39.42

u/l

0.83

539

4261

Endometriosis of rectovaginal septum and vagina

167

1040

1.64

8.13

1.9

2.0

40.00

40.05

u/l

0.01

154

935

Umbilical hernia

557

4317

1.30

8.06

2.1

1.9

38.94

38.82

u/l

0.05

495

3846

Peripheral arterial reconstruction

285

1990

1.45

8.05

1.6

39.02

38.17

u/l

0.26

233

1675

Infective dermatitis

234

1575

1.51

8.04

2.0

1.9

38.17

39.07

u/l

0.27

216

1393

Diseases of tongue

135

799

1.73

8.03

1.8

2.0

39.48

39.92

u/l

0.10

122

706

Drug-induced neutropenia

159

984

1.66

8.00

1.7

1.9

40.92

38.50

u/l

0.61

146

869

Acute gastritis

155

953

1.66

7.95

1.7

1.8

39.04

38.99

u/l

0.01

140

825

Substance use, excluding alcohol

419

3128

1.36

7.95

1.6

2.0

42.45

39.36

u/l

1.88

364

2846

Dementia in Alzheimer disease

102

1546

0.56

7.93

1.3

1.6

35.84

38.12

u/l

0.41

1271

Olecranon bursitis

130

765

1.74

7.90

2.1

2.0

37.47

38.09

u/l

0.13

115

665

Carbimazole or st.post thyroidectomy, condition for graves disease

439

3304

1.35

7.90

2.1

2.0

38.50

39.63

u/l

0.57

386

2971

Other ulcerative colitis

139

834

1.71

7.89

1.9

2.0

39.93

39.98

u/l

0.01

124

758

Varicose veins

1339

8581

1.19

7.89

2.1

1.9

39.19

39.40

u/l

0.15

1160

7560

Follicular lymphoma

496

1.93

7.89

1.8

1.9

41.28

38.63

u/l

0.54

431

Major coronary heart disease event

1469

8365

1.18

7.87

1.8

1.9

37.14

39.33

u/l

3.24

1215

7295

Fracture of lumbar spine and pelvis

384

2828

1.37

7.87

1.9

1.8

42.98

38.52

u/l

3.30

321

2447

Endometriosis ASRM stages 1,2

393

2912

1.37

7.86

1.9

2.1

38.38

39.80

u/l

0.74

348

2692

Mental and behavioural disorders due to tobacco

188

1216

1.58

7.84

1.5

1.9

41.97

39.17

u/l

0.99

154

1086

Synovial cyst of popliteal space [Baker]

148

903

1.67

7.84

2.1

1.8

38.92

38.42

u/l

0.10

131

797

Endometriosis ASRM stages 3,4

492

3768

1.32

7.82

2.0

2.1

39.83

39.64

u/l

0.07

439

3419

Smoking dependency

188

1219

1.57

7.76

1.5

1.9

41.97

39.07

u/l

1.05

154

1089

Aortic aneurysm

401

2931

1.36

7.75

1.7

37.50

38.18

u/l

0.26

346

2498

Medial epicondylitis

499

1.92

7.75

1.5

2.0

38.93

38.57

u/l

0.07

449

Other disorders of pigmentation

542

1.88

7.74

1.9

40.43

38.99

u/l

0.28

473

Other or unspecified immunodeficiency

4.94

7.70

3.4

1.2

42.11

42.00

u/l

0.01

Correction of physiology of bite - demanding therapy visit

160

1001

1.63

7.70

1.8

2.0

40.29

39.44

u/l

0.23

145

919

Dental caries 2 and operation codes

1747

12058

1.16

7.60

2.1

2.0

39.99

39.49

u/l

0.48

1571

10914

Unspecified nephritic syndrome

264

2.29

7.60

1.6

2.1

35.91

39.42

u/l

0.58

231

Respiratory conditions due to other external agents

239

2.37

7.59

1.3

2.2

44.91

38.86

u/l

0.54

210

327

2235

1.40

7.57

1.7

1.6

39.82

38.13

u/l

0.63

271

1850

Diseases of peritoneum

207

1377

1.53

7.57

1.7

1.8

39.55

38.94

u/l

0.15

187

1213

COPD, hospital admissions 3, with asthma pneumonia sepsis

465

3008

1.33

7.57

1.6

1.7

36.22

38.03

u/l

1.12

390

2542

Benign neoplasm of mouth and pharynx

219

1474

1.51

7.56

2.0

1.9

41.65

39.29

u/l

0.98

192

1283

Combinations of oral blood glucose lowering drugs

562

4403

1.29

7.52

1.9

1.8

35.63

39.26

u/l

3.75

486

3861

Other and unspecified mononeuropathies, also in other diseases

358

2.08

7.50

1.8

2.1

40.59

39.22

u/l

0.20

315

Unspecified urinary incontinence

174

1117

1.59

7.49

2.0

1.9

40.83

39.54

u/l

0.40

157

976

Psoriatic arthropathies, ICD10

235

1609

1.49

7.48

1.6

1.9

39.85

39.14

u/l

0.22

221

1447

Other postsurgical states

128

762

1.72

7.47

1.7

1.8

36.64

39.17

u/l

0.78

115

678

Benign neoplasm of eye and adnexa

193

1269

1.55

7.46

2.5

1.9

40.24

38.93

u/l

0.37

172

1100

Artificial joint re-operation

143

878

1.67

7.46

2.1

1.8

40.00

38.67

u/l

0.30

127

764

Dental caries 2

1777

12164

1.15

7.44

2.1

2.0

40.09

39.47

u/l

0.65

1600

11002

Other retinal artery occlusion

247

2.32

7.44

1.7

2.0

41.41

38.27

u/l

0.47

220

Benign neoplasm: Adrenal gland

159

1005

1.62

7.37

2.0

1.8

38.20

38.77

u/l

0.13

139

885

Suppurative and unspecified otitis media

755

5424

1.24

7.37

2.0

39.90

39.37

u/l

0.31

692

4969

Infection of intervertebral disc (pyogenic)

139

2.82

7.36

1.4

2.1

44.71

37.47

u/l

0.98

126

Unspecified privation

223

1516

1.50

7.35

2.0

1.9

39.79

39.11

u/l

0.19

191

1349

Chronic pancreatitis

244

1689

1.47

7.32

1.6

1.8

43.93

38.62

u/l

2.88

222

1476

Open wound of head

1042

8607

1.20

7.27

1.9

40.64

38.90

u/l

1.71

905

7603

Calcific tendinitis of shoulder

130

784

1.70

7.26

2.3

1.9

39.97

39.16

u/l

0.17

116

706

Convalescence

118

695

1.74

7.21

1.8

1.9

36.62

39.49

u/l

0.77

101

622

Anomalies of dental arch relationship, including avohilmo

386

2592

1.35

7.18

2.1

1.9

40.63

39.28

u/l

0.70

351

2379

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

264

2.24

7.17

1.2

2.0

33.78

38.60

u/l

0.93

228

Multiple myeloma

264

2.24

7.17

1.2

2.0

33.78

38.60

u/l

0.93

228

Superficial injury of wrist and hand

393

2954

1.34

7.16

2.1

2.0

40.49

39.32

u/l

0.52

354

2686

Other disorders of optic disc

153

2.70

7.15

2.3

2.2

35.85

40.25

u/l

0.73

139

Hypermetropia

138

848

1.66

7.14

2.1

1.9

40.76

39.63

u/l

0.28

124

762

Acne vulgaris

167

1076

1.58

7.08

1.9

2.0

42.05

39.25

u/l

1.08

159

1012

Benign neoplasm: Other and unspecified parts of mouth

429

1.95

7.08

2.1

40.37

38.80

u/l

0.30

374

Sequelae of cerebrovascular disease

620

4338

1.26

7.05

1.6

1.8

36.42

38.62

u/l

1.68

513

3713

Crohn's disease NAS

148

930

1.63

7.04

1.6

2.0

37.93

39.37

u/l

0.45

134

848

Radial styloid tenosynovitis [de Quervain]

124

745

1.70

7.04

2.0

38.38

38.96

u/l

0.13

117

685

Nonspecific lymphadenitis

143

892

1.64

7.02

2.2

38.69

38.66

u/l

0.01

128

814

Otitis externa, unspecified

224

1540

1.48

6.99

1.9

41.96

38.97

u/l

1.33

197

1393

Intestinal stricture

574

4550

1.27

6.99

1.8

1.9

39.56

38.96

u/l

0.28

504

3936

Sub-endpoint used in defining T1D endpoints

583

4551

1.27

6.98

2.0

1.9

43.49

38.96

u/l

4.75

519

4058

Persons encountering health services for specific procedures, not carried out

158

1010

1.59

6.97

1.7

1.9

40.45

39.28

u/l

0.30

139

916

Inflammatory diseases of prostate (prostatitis)

253

1781

1.44

6.95

1.8

1.9

41.67

38.39

u/l

1.48

225

1538

Postzoster neuralgia

149

2.68

6.95

2.0

44.41

39.67

u/l

0.62

131

Leiomyoma of uterus

1067

5044

1.20

6.91

2.1

40.37

40.05

u/l

0.20

948

4600

Oral lichen ruber planus

316

2.11

6.89

2.3

43.46

40.37

u/l

0.59

278

Other superficial mycoses

283

2.17

6.85

2.6

2.2

36.13

38.03

u/l

0.38

255

Dipeptidyl peptidase 4 (DPP-4) inhibitors

221

1523

1.47

6.82

1.8

1.7

40.90

39.07

u/l

0.56

191

1318

Acute peritonitis

129

790

1.67

6.81

1.7

1.9

39.34

38.63

u/l

0.13

116

686

Benign neoplasm of meninges

201

1361

1.50

6.81

1.7

1.9

36.54

39.40

u/l

1.46

171

1211

Benign neoplasm: Sigmoid colon

343

2549

1.36

6.80

2.0

1.8

38.47

38.74

u/l

0.09

297

2185

Prurigo nodularis

297

2.13

6.79

1.7

2.2

37.07

40.45

u/l

0.80

265

Benign neoplasm: Liver/bile ducts

297

2.13

6.79

1.9

2.2

42.16

39.85

u/l

0.45

270

Hyperkinetic disorders, excluding more controls

183

1180

1.53

6.78

1.7

2.1

38.44

40.03

u/l

0.51

162

1119

Benign neoplasm: Cerebral meninges

184

1225

1.53

6.78

1.8

36.70

39.38

u/l

1.21

157

1091

Plantar fascial fibromatosis

203

1378

1.50

6.78

2.1

2.0

42.53

39.17

u/l

1.59

183

1244

Disorders of oesophagus in diseases classified elsewhere

238

2.28

6.78

1.8

1.9

38.34

37.26

u/l

0.14

200

Discitis, unspecified

169

2.54

6.76

1.5

2.1

32.57

36.68

u/l

0.61

151

Other benign neoplasms of skin

733

5994

1.23

6.75

2.1

1.9

39.18

38.99

u/l

0.09

643

5244

Diabetic retinopathy, strict definition

360

2366

1.36

6.75

2.0

2.1

41.86

37.80

u/l

2.54

306

2023

Thoracic aortic aneurysm

259

1842

1.43

6.74

1.8

38.44

38.53

u/l

0.02

223

1583

Superficial injury of ankle and foot

244

1717

1.44

6.73

2.0

39.33

39.14

u/l

0.05

221

1578

Lichen sclerosus et atrophicus

198

1340

1.50

6.73

2.4

2.0

40.77

39.47

u/l

0.38

175

1178

Vitamin B12 deficiency anaemia

195

1314

1.51

6.72

1.5

1.8

35.60

38.66

u/l

1.51

159

1132

Ulcerative enterocolitis

437

1.91

6.71

1.8

2.1

38.76

39.29

u/l

0.08

397

Glaucoma secondary to drugs

4.29

6.69

3.3

1.9

40.68

41.77

u/l

0.09

Other localized connective tissue disorders

246

2.25

6.69

1.8

2.0

37.09

40.38

u/l

0.43

214

Tubulo-interstitial nephritis, not specified as acute or chronic

133

824

1.64

6.68

2.0

1.9

35.79

39.32

u/l

1.28

116

732

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

592

4738

1.26

6.67

2.0

39.79

39.59

u/l

0.08

542

4285

Follicular lymphoma, hilmo

525

1.82

6.66

1.8

2.0

41.28

39.49

u/l

0.33

460

Other and unspecified diseases of blood and blood-forming organs

313

2.09

6.65

2.1

37.09

38.21

u/l

0.17

278

Oligomenorrhoea

423

1.92

6.65

1.9

45.04

37.85

u/l

2.29

394

Other disorders of iris and ciliary body

299

2.11

6.65

2.2

2.1

43.76

38.63

u/l

0.90

262

Schizophrenia

181

2675

0.67

6.65

1.7

2.0

37.58

39.68

u/l

0.68

158

2433

Lymphoid leukaemia

103

598

1.76

6.64

1.5

1.7

43.93

38.42

u/l

1.61

501

Other diseases of spinal cord

375

1.98

6.64

2.1

37.66

39.06

u/l

0.29

338

L01XE Protein kinase inhibitors

122

743

1.68

6.64

1.5

1.9

43.35

38.64

u/l

1.79

105

652

Benign neoplasm: Liver

260

2.20

6.62

2.0

2.2

42.14

40.51

u/l

0.27

235

Pneumonia due to Streptococcus pneumoniae

489

1.84

6.60

2.2

1.8

38.70

39.67

u/l

0.16

431

Superficial injury of abdomen, lower back and pelvis

294

2143

1.39

6.60

1.7

1.9

39.25

38.81

u/l

0.14

269

1915

Other psoriatic arthropathies

224

1560

1.46

6.59

1.6

1.9

40.16

39.20

u/l

0.31

210

1403

Leiomyoma of uterus

1383

6774

1.17

6.57

2.0

2.1

40.12

40.18

u/l

0.04

1222

6129

Tobacco use

119

722

1.69

6.57

1.6

2.0

43.24

39.16

u/l

1.27

111

643

Other embolism and thrombosis

252

1792

1.43

6.56

1.8

1.9

40.40

38.81

u/l

0.53

221

1570

Benign neoplasm of urinary organs

527

1.81

6.55

1.7

1.9

37.73

39.33

u/l

0.33

455

Haemolytic anaemias

405

1.93

6.54

2.7

1.9

36.20

38.82

u/l

0.45

359

Amputation

169

1112

1.54

6.53

2.0

1.8

39.93

37.95

u/l

0.58

139

945

Follow-up care involving plastic surgery

499

1.83

6.52

2.5

2.0

42.33

39.49

u/l

0.71

450

Benign neoplasm: Rectum, anus and anal canal

371

2808

1.34

6.51

1.9

1.8

39.16

38.61

u/l

0.22

321

2411

Pure hyperglyceridaemia

255

2.20

6.51

1.8

2.0

33.33

40.05

u/l

1.47

229

Erosion of teeth, including avohilmo

411

3046

1.32

6.50

1.9

2.1

39.05

39.46

u/l

0.17

380

2794

Primary angle-closure glaucoma

492

1.83

6.48

1.5

1.8

37.85

39.18

u/l

0.29

432

Other hearing loss

472

3624

1.29

6.48

1.9

1.8

38.88

39.05

u/l

0.06

409

3077

Acquired haemolytic anaemia

269

2.16

6.47

2.7

2.1

36.43

39.21

u/l

0.36

238

Autoimmune hyperthyroidism

118

716

1.68

6.46

2.4

2.1

40.94

40.14

u/l

0.14

108

645

Vascular disorders of the intestines

117

708

1.68

6.46

1.7

1.8

38.52

38.31

u/l

0.04

595

Benign neoplasm of brain and other parts of central nervous system

131

818

1.64

6.43

1.9

38.09

38.73

u/l

0.14

115

714

Acute laryngitis and tracheitis

231

1597

1.44

6.41

2.1

2.0

40.88

39.88

u/l

0.29

218

1470

Contact with and exposure to communicable diseases

651

5271

1.24

6.36

1.9

2.0

36.90

39.64

u/l

3.39

604

4888

Congenital malformations, deformations and chromosomal abnormalities

1300

10759

1.16

6.35

1.9

2.0

38.62

39.49

u/l

0.88

1161

9764

Substance abuse, excluding more controls

1176

8817

1.17

6.34

1.7

2.0

40.59

38.91

u/l

1.72

1030

7879

Open wound of lower leg

274

1989

1.39

6.33

2.1

1.9

37.41

38.85

u/l

0.59

240

1773

Opening and dilatation of root channel of tooth

142

908

1.60

6.33

1.8

2.0

38.00

39.76

u/l

0.52

127

826

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

172

1147

1.53

6.32

2.2

1.9

36.87

39.20

u/l

0.85

148

1014

Adenomyosis (Endometriosis of uterus)

266

1923

1.40

6.31

1.8

2.0

38.69

39.85

u/l

0.46

241

1707

Isolated proteinuria with specified morphological lesion

139

2.67

6.31

1.8

2.3

35.60

39.11

u/l

0.48

126

Benign neoplasm of mouth and pharynx

219

1532

1.45

6.29

2.0

1.9

41.65

38.88

u/l

1.25

192

1351

Myeloproliferative diseases

164

1084

1.54

6.28

1.7

1.8

39.94

38.54

u/l

0.36

136

946

Superficial injury of hip and thigh

257

1847

1.41

6.27

1.6

1.8

38.77

38.76

u/l

0.00

231

1606

Dental caries 2, only avohilmo

1729

12012

1.14

6.24

2.1

2.0

40.09

39.51

u/l

0.60

1568

10863

Seborrhoeic keratosis

404

3114

1.31

6.23

2.2

1.8

39.78

38.94

u/l

0.40

356

2683

Hypertrophic disorders of skin

128

802

1.63

6.22

2.3

2.0

40.26

39.41

u/l

0.17

120

730

Fracture of foot, except ankle

488

3855

1.28

6.19

2.0

40.78

39.44

u/l

0.73

431

3476

Other and unspecified disorders of binocular movement

3.60

6.19

1.4

1.5

33.19

39.33

u/l

0.76

Oral lichen ruber planus, hypothyreosis or thyroxin

209

2.31

6.18

1.9

2.2

45.06

39.94

u/l

0.90

188

Superficial injury of thorax

286

2100

1.38

6.17

2.2

1.9

42.31

39.08

u/l

1.53

252

1856

Lateral epicondylitis

279

2041

1.38

6.17

2.0

2.1

40.48

39.98

u/l

0.16

252

1848

therapeutic use

365

1.95

6.12

2.6

2.0

40.79

39.50

u/l

0.21

320

Disorders of adult personality and behaviour

600

4860

1.24

6.11

1.9

2.0

41.66

39.55

u/l

1.61

528

4467

Unspecified fall

951

7983

1.19

6.10

1.9

40.86

39.14

u/l

1.68

832

7065

Thyrotoxicosis with diffuse goitre

286

2105

1.38

6.09

2.1

2.0

40.59

39.50

u/l

0.38

261

1901

Mixed hyperlipidaemia

480

1.82

6.09

1.8

1.9

34.69

39.53

u/l

1.25

419

Other autoimmune haemolytic anaemias

136

2.64

6.04

2.0

2.3

42.55

40.03

u/l

0.23

122

Coxarthrosis, primary

1141

8509

1.17

5.97

1.9

1.8

39.01

38.88

u/l

0.07

996

7339

Other obstetric conditions, not elsewhere classified

670

3554

1.23

5.96

2.0

38.46

39.16

u/l

0.48

637

3347

Monoamine oxidase A inhibitors

243

1749

1.41

5.95

2.0

1.9

38.74

39.53

u/l

0.25

211

1544

Congenital malformations of the urinary system

119

741

1.64

5.94

1.7

2.0

37.22

39.54

u/l

0.58

105

668

Congenital iodine-deficiency syndrome/hypothyroidism

347

1.96

5.94

1.8

2.0

42.45

40.06

u/l

0.53

307

Viral meningitis

514

1.78

5.94

2.1

2.0

41.36

39.94

u/l

0.28

474

Meningitis

115

711

1.66

5.94

1.9

2.0

37.92

39.73

u/l

0.51

102

637

Wet age-related macular degeneration

253

1798

1.40

5.93

1.9

1.6

38.93

38.19

u/l

0.21

214

1488

Benign neoplasm: Pituitary gland, craniopharyngeal duct

110

673

1.67

5.91

1.8

2.0

38.39

38.85

u/l

0.08

102

592

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

104

627

1.70

5.91

1.6

2.1

41.46

38.41

u/l

0.78

573

Benign neoplasm: Caecum

182

1246

1.48

5.89

1.7

1.8

39.76

38.64

u/l

0.33

164

1048

Familial hypercholesterolemia, with ischemic heart disease

168

1132

1.51

5.88

1.6

1.7

36.41

38.66

u/l

0.67

135

943

Acute suppurative otitis media

525

3927

1.26

5.86

2.0

40.12

39.40

u/l

0.36

485

3640

Other/unspecified disorders of vestibular function

457

1.82

5.85

1.7

1.9

39.01

39.08

u/l

0.01

401

Subacute thyroiditis

450

1.83

5.84

1.8

2.0

36.56

39.71

u/l

0.82

404

Female genital prolapse

623

2916

1.24

5.83

1.9

2.1

40.25

40.33

u/l

0.03

562

2610

Drug-induced headache, not elsewhere classified

3.36

5.82

1.4

2.6

35.59

41.58

u/l

0.80

260

2.11

5.82

2.2

1.9

35.10

37.13

u/l

0.34

222

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

650

3444

1.23

5.82

2.0

38.45

39.16

u/l

0.48

619

3250

Myeloproliferative diseases (CML excluded)

148

976

1.54

5.77

1.7

1.8

40.44

38.46

u/l

0.50

122

846

Benign neoplasm of eye and adnexa

193

1343

1.46

5.75

2.5

1.8

40.24

38.80

u/l

0.42

172

1182

Aortic valve malfunction, age under 60 years

199

1394

1.45

5.74

2.0

40.45

39.27

u/l

0.28

165

1247

Hyperaldosteronism

345

1.95

5.73

2.2

2.1

43.02

39.72

u/l

0.72

306

Oral lichen ruber planus, including avohilmo

125

796

1.61

5.73

2.1

2.0

40.68

39.47

u/l

0.27

108

707

Supplementary factors related to causes of morbidity and mortality classified elsewhere

597

4869

1.24

5.73

2.1

1.9

41.29

39.05

u/l

1.66

532

4342

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

414

2708

1.29

5.71

1.8

37.18

38.24

u/l

0.50

357

2288

Benign neoplasm: Liver

276

2.07

5.71

2.0

2.2

42.14

40.31

u/l

0.31

252

Type of accident

557

4512

1.24

5.71

2.1

1.9

41.07

39.01

u/l

1.37

495

4021

Other disorders of glucose regulation and pancreatic internal secretion

164

1107

1.51

5.71

1.9

41.39

38.88

u/l

0.85

141

988

Sacrococcygeal disorders, not elsewhere classified

388

1.88

5.70

2.0

2.1

40.44

39.23

u/l

0.18

349

Haemangioma and lymphangioma, any site

173

1181

1.49

5.70

2.1

2.0

40.44

38.98

u/l

0.41

157

1056

Benign neoplasm: Rectum

330

2509

1.33

5.69

2.0

1.8

39.31

38.52

u/l

0.31

284

2155

Benign neoplasm: Liver/bile ducts

318

1.99

5.69

1.9

2.1

42.16

39.55

u/l

0.53

288

Personality disorders

569

4622

1.24

5.68

1.9

2.0

40.96

39.43

u/l

0.94

505

4240

Polypectomy (DHB20)

144

948

1.55

5.68

1.8

1.9

35.21

38.87

u/l

1.71

130

832

Benign neoplasm: Other and unspecified parts of mouth

463

1.80

5.64

2.1

40.37

39.41

u/l

0.17

412

Enteropathic arthropathies

284

2.04

5.63

1.6

2.3

36.75

39.93

u/l

0.67

263

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

179

1231

1.47

5.62

1.6

1.7

39.61

37.97

u/l

0.46

151

1008

Early lumbar disc prolapse operation

242

1760

1.39

5.62

2.2

41.53

39.77

u/l

0.76

230

1627

Intestinal malabsorption

100

606

1.69

5.61

1.7

2.0

44.27

39.68

u/l

1.11

543

Testicular dysfunction

509

1.76

5.59

1.8

2.1

43.27

39.55

u/l

0.85

458

L01XX Other antineoplastic agents

108

668

1.65

5.58

1.8

40.14

38.56

u/l

0.28

577

Ingrowing nail

120

762

1.61

5.57

2.3

2.0

37.23

39.19

u/l

0.48

111

688

Open wound of wrist and hand

901

7582

1.18

5.54

1.9

2.0

40.25

39.26

u/l

0.79

817

6812

Bronchitis, not specified as acute or chronic

164

1114

1.49

5.53

2.2

1.9

37.92

39.56

u/l

0.54

151

976

Other and unspecified haemorrhagic conditions

186

2.30

5.52

2.9

2.1

44.49

40.00

u/l

0.60

167

Open wound of ankle and foot

200

1412

1.44

5.52

2.7

1.9

39.94

38.42

u/l

0.43

180

1264

Fracture of skull and facial bones

422

3327

1.28

5.51

2.1

2.0

41.86

39.27

u/l

1.67

365

2968

Primary open-angle glaucoma, strict

438

3461

1.27

5.50

2.0

1.7

39.53

38.66

u/l

0.38

389

2922

Extreme obesity with alveolar hypoventilation

534

1.73

5.49

1.6

1.9

34.97

39.23

u/l

1.10

467

Ovarian dysfunction

148

987

1.52

5.48

1.7

2.1

43.37

38.97

u/l

1.63

140

933

COPD, hospital admissions 1, only main diagnosis

604

4214

1.23

5.45

1.7

1.8

36.66

38.41

u/l

1.30

511

3586

Benign neoplasm of brain and other parts of central nervous system

131

853

1.57

5.45

1.9

38.09

39.00

u/l

0.21

115

754

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

589

4825

1.23

5.45

2.0

39.67

39.23

u/l

0.20

532

4308

Other disorders of Eustachian tube

380

1.87

5.44

2.0

38.31

39.32

u/l

0.21

345

Personal history of malignant neoplasm

438

1.80

5.43

1.8

1.9

38.48

39.25

u/l

0.12

386

Benign neoplasm of urinary organs

558

1.71

5.42

1.7

1.9

37.73

38.47

u/l

0.14

491

Left ventricular outflow tract obstruction (LVOTO), broad definition

209

1494

1.42

5.40

2.0

40.24

39.38

u/l

0.20

173

1339

Inflammation of lacrimal passages (acute and unspecified)

201

2.22

5.38

2.5

2.4

37.19

40.54

u/l

0.43

177

Other noninflammatory disorders of vagina

152

1024

1.51

5.37

2.0

39.68

39.92

u/l

0.04

133

929

Biomechanical lesions, not elsewhere classified

104

645

1.65

5.35

1.6

2.0

38.15

39.29

u/l

0.23

570

Hallux rigidus

249

1833

1.37

5.35

2.2

1.9

40.39

39.25

u/l

0.44

216

1591

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

133

872

1.55

5.34

1.9

34.71

39.26

u/l

2.02

119

753

Haemangioma, any site

161

1100

1.49

5.32

2.1

2.0

40.42

39.04

u/l

0.36

145

985

Effects of foreign body entering through natural orifice

478

3841

1.26

5.31

2.0

1.9

40.42

39.05

u/l

0.76

423

3444

Personal history of other diseases and conditions

204

1448

1.42

5.31

2.2

1.8

38.91

39.16

u/l

0.06

181

1348

Pulmonary oedema

144

2.43

5.31

1.6

2.0

32.59

38.75

u/l

0.81

125

Benign neoplasm: Kidney

383

1.85

5.30

1.9

2.0

39.19

39.12

u/l

0.01

330

Herpesviral keratitis and keratoconjunctivitis

539

1.71

5.30

1.8

2.0

40.19

39.26

u/l

0.14

478

Other Crohn's disease

151

1020

1.51

5.29

1.6

2.0

35.91

39.82

u/l

1.92

136

940

Iron deficiency

229

2.12

5.28

1.4

2.1

33.24

40.59

u/l

2.22

214

Other maternal disorders predominantly related to pregnancy

1270

6965

1.15

5.26

2.1

39.82

39.87

u/l

0.04

1164

6365

Lichen ruber planus, wide definition including periferal and oral lichen planus

412

3261

1.28

5.25

2.1

1.9

40.22

39.24

u/l

0.41

353

2865

Cyst of kidney

129

845

1.56

5.24

2.8

1.9

43.00

38.73

u/l

1.08

112

733

Retinal detachment with retinal break

234

1713

1.38

5.23

1.6

1.8

41.41

38.32

u/l

1.37

206

1487

Palmar fascial fibromatosis [Dupuytren]

263

1959

1.36

5.23

1.7

39.44

37.90

u/l

0.60

223

1667

Other predominantly sexually transmitted diseases, not elsewhere classified

355

2759

1.30

5.23

2.4

2.0

41.49

39.25

u/l

1.27

330

2571

Carrier of infectious disease

293

1.97

5.19

1.5

2.2

41.82

39.28

u/l

0.39

266

Viral encephalitis, not elsewhere classified/unspecified

238

2.09

5.17

1.6

2.2

29.67

39.07

u/l

3.46

214

Complications of other internal prosthetic devices, implants and grafts

438

1.78

5.14

1.8

1.9

40.48

39.09

u/l

0.24

386

Psychotic depression

118

761

1.58

5.12

2.0

38.11

39.05

u/l

0.18

106

686

Benign neoplasm: Parathyroid gland

123

2.57

5.11

2.6

2.3

37.32

42.32

u/l

0.68

107

Viral warts

196

1400

1.42

5.10

2.9

1.9

40.32

39.16

u/l

0.31

179

1273

Sudden idiopathic hearing loss

192

1367

1.42

5.10

2.0

1.9

40.50

38.99

u/l

0.48

162

1198

Lymphoid leukaemia

103

645

1.63

5.09

1.5

1.8

43.93

38.07

u/l

1.80

560

Other problems related to primary support group, including family circumstances

220

1561

1.39

5.08

2.2

2.0

38.98

39.07

u/l

0.02

199

1457

Benign neoplasm of bone and articular cartilage

166

1152

1.46

5.08

1.9

39.49

38.75

u/l

0.19

149

1037

Arterial embolism and thrombosis

100

621

1.64

5.08

1.6

1.7

35.69

38.21

u/l

0.58

533

Bacterial, viral and other infectious agents

186

1319

1.43

5.06

2.0

2.1

41.89

39.30

u/l

0.98

165

1187

Viral and other specified intestinal infections

382

2935

1.28

5.06

1.9

39.47

39.37

u/l

0.03

349

2699

Corneal scars and opacities

317

1.92

5.05

1.9

2.1

36.89

40.52

u/l

0.72

282

Glucosamine medication

936

6408

1.17

5.05

1.8

1.9

38.83

39.29

u/l

0.27

806

5498

Benign neoplasm: Choroid

112

718

1.59

5.03

2.7

1.9

38.80

39.43

u/l

0.11

626

Multifocal fibrosclerosis

3.11

5.02

1.9

2.0

33.46

39.37

u/l

0.76

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1225

8751

1.15

5.00

2.2

2.0

40.00

39.33

u/l

0.59

1119

7885

Amputation of foot

269

1.99

4.98

2.6

1.8

40.09

37.62

u/l

0.39

236

Corneal degeneration

175

2.27

4.98

1.7

2.3

45.59

39.01

u/l

0.82

153

Vertical strabismus

443

1.76

4.98

1.9

2.2

34.02

39.27

u/l

1.62

393

Folate deficiency anaemia

2.85

4.98

1.3

2.2

37.89

38.72

u/l

0.05

Insulin, fast-acting (human)

291

2219

1.32

4.96

2.2

2.0

45.27

39.21

u/l

4.21

257

2016

Benign neoplasm: Pituitary gland, craniopharyngeal duct

110

706

1.59

4.93

1.8

2.0

38.39

39.36

u/l

0.17

102

630

Inflammatory disease of uterus

283

2154

1.33

4.91

2.1

2.0

37.43

39.21

u/l

0.96

247

1985

Testicular hypofunction

454

1.74

4.87

1.9

2.1

43.12

39.59

u/l

0.75

407

Specific personality disorders

480

3901

1.24

4.85

2.0

41.84

39.35

u/l

1.69

423

3587

Benign neoplasm: Skin of other and unspecified parts of face

189

1354

1.41

4.85

2.0

1.9

36.71

38.87

u/l

0.81

164

1172

Follow-up examination after treatment for malignant neoplasms

162

1128

1.45

4.85

2.1

1.7

40.26

38.29

u/l

0.57

144

967

Other obstructive and reflux uropathy

514

1.69

4.84

1.6

1.9

37.64

39.97

u/l

0.53

463

Disorders of breast

1013

8143

1.16

4.83

2.1

2.0

40.55

39.95

u/l

0.45

927

7330

Exposure to other and unspecified inanimate mechanical forces

143

975

1.49

4.83

2.8

2.0

38.61

39.52

u/l

0.24

131

879

Postprocedural musculoskeletal disorders, not elsewhere classified

134

902

1.51

4.83

1.6

1.9

41.19

38.95

u/l

0.65

122

783

In situ neoplasms

639

5093

1.20

4.83

2.0

1.9

38.61

39.01

u/l

0.19

557

4460

Obsessive-compulsive disorder

121

796

1.54

4.82

1.9

2.0

41.58

38.67

u/l

1.03

115

747

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

150

1033

1.48

4.81

2.1

2.0

35.89

39.33

u/l

1.40

131

915

Benign neoplasm: Rectosigmoid junction

470

1.72

4.81

1.6

1.9

38.33

39.20

u/l

0.13

402

Acute nephritic syndrome

280

1.96

4.81

1.8

2.1

38.29

38.48

u/l

0.02

256

Disorders of continuity of bone

186

1333

1.42

4.78

2.3

1.9

42.27

39.39

u/l

1.08

167

1205

Benign neoplasm: Duodenum

295

1.92

4.76

1.6

2.0

36.63

39.21

u/l

0.40

255

Unspecified contracted kidney

3.11

4.76

2.4

2.1

40.41

40.20

u/l

0.01

Use of donepezil

143

1986

0.69

4.74

1.7

1.6

36.58

38.43

u/l

0.50

110

1639

Impacted cerumen

170

1201

1.44

4.74

1.6

1.8

39.33

38.72

u/l

0.14

132

1038

Hordeolum and other deep inflammation of eyelid

109

705

1.57

4.73

2.1

2.0

40.20

39.25

u/l

0.16

632

Hypertrophic scar

111

721

1.57

4.73

2.0

2.1

39.00

39.58

u/l

0.10

105

657

Cramp and spasm

100

635

1.61

4.72

1.6

2.0

37.89

38.56

u/l

0.13

568

Vulvovaginal ulceration/inflammation in other diseases

117

769

1.55

4.72

2.2

2.1

39.71

38.73

u/l

0.23

112

706

Syphilis

340

1.85

4.69

2.5

2.0

40.62

38.47

u/l

0.25

307

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

151

1049

1.46

4.64

2.2

1.9

40.11

39.16

u/l

0.22

138

933

Unstable angina pectoris

683

4771

1.19

4.63

1.8

36.25

38.95

u/l

2.76

576

4080

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

623

1.61

4.63

2.3

2.2

45.43

39.88

u/l

1.47

575

Superficial injury of head

411

3302

1.25

4.62

1.8

1.9

39.60

39.09

u/l

0.21

363

2929

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

302

2263

1.30

4.61

1.7

1.9

37.36

39.29

u/l

0.94

261

2033

Peripheral artery operations in Hilmo

201

1469

1.38

4.56

2.0

1.7

40.86

38.33

u/l

0.89

166

1237

Unspecified visual impairment (binocular)

162

2.24

4.54

1.8

2.3

44.53

38.92

u/l

0.56

144

Melanocytic naevi of trunk

220

1635

1.36

4.54

1.7

2.0

38.08

38.93

u/l

0.26

193

1464

Benign neoplasm of major salivary glands

176

1262

1.41

4.53

1.9

1.8

39.38

38.58

u/l

0.19

150

1092

Benign neoplasm: Small intestine

471

1.70

4.52

1.7

1.9

37.54

38.78

u/l

0.19

405

Embedded teeth, including avohilmo

177

1271

1.41

4.51

2.3

2.0

40.04

38.84

u/l

0.39

166

1187

Nontoxic single thyroid nodule

140

965

1.47

4.50

1.7

2.0

38.95

39.39

u/l

0.10

124

868

Polyp of the female genital tract

656

3201

1.20

4.50

2.1

40.35

40.20

u/l

0.06

575

2887

Corns and callosities

129

875

1.50

4.49

1.9

1.8

39.92

38.96

u/l

0.20

115

764

Disorders of eyelid in diseases classified elsewhere

412

1.74

4.46

1.5

2.1

41.24

40.03

u/l

0.18

367

Other disorders of the genitourinary system

236

1780

1.34

4.43

2.0

1.9

39.14

39.64

u/l

0.14

203

1559

Benign neoplasm: Caecum

182

1319

1.40

4.42

1.7

1.8

39.76

38.51

u/l

0.38

164

1131

Vascular diseases of the intestine

375

1.77

4.42

1.4

1.8

38.86

38.19

u/l

0.08

325

Hemiplegia

100

645

1.58

4.41

1.5

2.0

41.48

39.26

u/l

0.49

575

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

131

896

1.49

4.40

2.0

36.56

39.17

u/l

0.86

117

798

Vasomotor rhinitis (mode)

148

1036

1.45

4.40

2.7

1.9

38.73

38.94

u/l

0.05

136

923

Postprocedural disorders of digestive system, not elsewhere classified

385

1.76

4.35

1.8

2.0

41.44

39.65

u/l

0.26

340

Peritonsillar abscess

403

3258

1.25

4.33

1.8

2.0

39.64

39.72

u/l

0.03

363

2963

Tongue abnormality

119

802

1.51

4.31

1.9

39.06

39.24

u/l

0.04

108

706

Meralgia paraesthetica

432

1.71

4.30

2.3

2.1

39.52

38.78

u/l

0.14

377

Carcinoma in situ of skin of trunk

284

1.88

4.27

1.4

2.0

42.52

38.71

u/l

0.50

232

Unspecified jaundice

532

1.62

4.26

1.8

1.9

41.72

38.50

u/l

0.56

461

Haemangioma and lymphangioma, any site

173

1252

1.40

4.26

2.1

1.9

40.44

38.83

u/l

0.46

157

1121

Sequelae of other external causes

104

684

1.55

4.23

2.2

2.0

39.43

38.69

u/l

0.13

607

Postmenopausal atrophic vaginitis

502

2489

1.22

4.22

2.1

41.62

40.62

u/l

0.55

457

2201

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

344

2280

1.27

4.21

1.7

1.8

37.13

38.05

u/l

0.36

290

1917

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

456

1.67

4.21

1.7

1.9

37.57

38.83

u/l

0.21

385

Encephalopathy

116

2.44

4.21

1.6

2.1

39.60

38.81

u/l

0.06

103

Contusion of other and unspecified parts of foot

101

661

1.56

4.21

2.4

2.1

37.93

39.61

u/l

0.42

610

Deep endometriosis

189

1391

1.38

4.20

2.0

39.83

39.38

u/l

0.11

176

1264

Deficiency of other B group vitamins

236

1.96

4.20

1.4

2.1

35.00

39.95

u/l

1.44

207

Total colectomy

567

1.60

4.19

1.8

2.1

39.42

38.65

u/l

0.15

505

Total colectomy operation

567

1.60

4.19

1.8

2.1

39.42

38.65

u/l

0.15

505

Lichen planus

241

1839

1.33

4.19

2.3

1.9

40.20

39.62

u/l

0.17

209

1618

Disturbances of smell and taste

544

1.61

4.17

2.0

39.42

39.54

u/l

0.02

482

Cystic kidney disease

413

1.71

4.17

2.0

2.1

36.48

40.00

u/l

0.68

370

Pneumonia derived septicemia

390

1.73

4.16

2.2

1.9

38.15

38.28

u/l

0.02

348

Combined immunodeficiencies

104

2.50

4.15

2.8

1.2

39.52

36.24

u/l

0.30

Traumatic subdural haemorrhage

180

1294

1.38

4.11

1.4

1.7

39.33

38.47

u/l

0.22

145

1111

Abnormality of white blood cells, not elsewhere classified

105

2.52

4.11

1.3

2.3

38.60

40.97

u/l

0.22

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

170

1234

1.39

4.10

1.5

1.8

36.86

38.00

u/l

0.29

144

1034

Fasciculation

143

2.26

4.10

1.3

2.2

40.29

38.79

u/l

0.19

131

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

244

1760

1.32

4.10

1.8

38.17

38.01

u/l

0.04

210

1473

Lesion of plantar nerve

121

828

1.49

4.08

1.8

2.0

42.14

39.71

u/l

0.55

106

739

Benign neoplasm: Duodenum

311

1.82

4.08

1.6

2.1

36.63

38.86

u/l

0.33

274

Intestinal adhesions without obstruction

142

1001

1.44

4.07

1.8

1.9

41.71

38.43

u/l

1.17

120

863

Glaucoma, exfoliation

165

1193

1.40

4.07

1.8

1.7

40.19

38.70

u/l

0.44

135

1006

Injuries to the hip and thigh

842

6689

1.16

4.04

1.7

1.9

38.92

39.00

u/l

0.04

737

5815

Injuries to unspecified part of trunk, limb or body region

179

1315

1.38

4.03

1.6

1.9

36.96

38.91

u/l

0.61

160

1169

Benign neoplasm: Parathyroid gland

138

2.28

4.02

2.6

2.4

37.32

40.60

u/l

0.40

122

Benign neoplasm: Choroid

112

758

1.50

4.01

2.7

1.9

38.80

39.20

u/l

0.07

670

Fracture of lower leg, including ankle

1112

9806

1.13

4.01

1.9

2.0

39.76

39.45

u/l

0.19

985

8703

Fracture at wrist and hand level

667

5696

1.18

4.00

1.9

2.0

40.29

39.51

u/l

0.44

600

5095

Benign neoplasm of middle ear and respiratory system

139

980

1.44

3.99

2.2

1.9

37.77

38.71

u/l

0.22

124

846

Emotionally unstable personality disorder

244

1879

1.31

3.98

1.8

2.0

41.56

38.85

u/l

1.05

215

1752

Haemangioma, any site

161

1166

1.40

3.98

2.1

1.9

40.42

38.87

u/l

0.42

145

1044

Oesophagitis

103

686

1.53

3.98

1.7

1.8

40.44

38.46

u/l

0.42

588

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

3.31

3.94

3.3

2.1

38.47

42.18

u/l

0.32

Dysplasia of cervi uteri

475

3044

1.21

3.93

2.1

38.73

39.78

u/l

0.61

440

2795

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

343

2506

1.25

3.92

1.7

1.9

37.65

39.44

u/l

1.06

312

2373

Sleep disorders, other/unspecified

429

1.67

3.88

1.7

2.2

40.01

39.11

u/l

0.14

390

Orthopaedic devices associated with adverse incidents

215

1.98

3.88

2.9

2.2

38.51

38.75

u/l

0.03

185

Eating disorder

158

1143

1.40

3.88

1.6

2.0

39.68

39.01

u/l

0.16

141

1075

Other otitis externa (chronic)

125

870

1.46

3.88

1.4

1.9

38.37

38.83

u/l

0.10

103

776

Amputation of toe

118

812

1.47

3.88

2.0

1.8

40.32

38.25

u/l

0.49

688

Additional codes for the location of defect, injury or illness

109

739

1.50

3.88

2.2

2.0

40.11

38.72

u/l

0.32

101

656

Lichen planus, including avohilmo

340

2737

1.25

3.88

2.2

1.9

40.63

39.28

u/l

0.55

294

2403

Atopic conjunctivitis

546

1.58

3.87

2.0

2.2

41.36

39.84

u/l

0.35

498

Myocardial infarction, strict

869

5525

1.15

3.87

1.8

1.9

36.27

39.08

u/l

3.28

713

4795

Malignant neoplasm of endocrine gland

140

996

1.43

3.86

1.9

36.51

39.00

u/l

0.85

122

891

Other and unspecified injuries of lower leg

143

1021

1.42

3.85

1.7

1.9

41.41

39.06

u/l

0.58

121

936

Ventral hernia

439

3631

1.22

3.84

1.9

39.20

39.10

u/l

0.03

383

3195

Squamous cell neoplasms and carcinomas of the skin

179

1325

1.36

3.84

1.6

1.7

39.61

37.80

u/l

0.52

151

1098

Disorders of magnesium metabolism

2.65

3.84

1.1

2.0

39.13

39.42

u/l

0.02

Disturbance of activity and attention

178

1301

1.36

3.81

1.7

2.0

38.55

39.94

u/l

0.42

158

1235

Allergic contact dermatitis due to drugs in contact with skin

281

1.83

3.81

1.7

2.3

40.93

39.73

u/l

0.13

250

Vestibular neuronitis

166

1218

1.38

3.80

1.9

37.45

39.33

u/l

0.55

144

1076

Haemorrhage in early pregnancy

572

4732

1.19

3.80

2.1

39.42

39.61

u/l

0.09

523

4359

Central retinal artery occlusion

216

1.95

3.80

1.7

2.1

36.45

39.48

u/l

0.43

192

Status epilepticus

393

1.69

3.79

1.6

1.9

40.46

39.43

u/l

0.11

348

Other/unspecified crystal arthropathies

2.95

3.79

1.9

39.70

40.34

u/l

0.04

Fall on and from stairs and steps

471

3928

1.21

3.78

2.0

1.9

38.39

39.05

u/l

0.32

406

3465

Overexertion and strenuous or repetitive movements

198

1494

1.34

3.78

2.2

2.0

39.77

39.15

u/l

0.15

184

1347

Benign neoplasm: Descending colon

117

810

1.47

3.75

1.9

1.8

37.86

38.50

u/l

0.13

103

688

Spinal instabilities

372

1.71

3.75

1.7

2.2

43.75

38.49

u/l

1.54

336

Benign neoplasm: Pancreas

305

1.79

3.74

1.7

2.0

40.04

39.57

u/l

0.06

260

Injury of unspecified body region

138

985

1.42

3.73

1.6

1.9

35.33

39.11

u/l

1.49

124

880

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

581

4941

1.18

3.73

1.8

2.0

40.83

39.46

u/l

0.78

516

4537

Inflammatory disease of cervix uteri

127

894

1.44

3.73

1.7

1.9

44.04

39.48

u/l

1.00

111

805

Fall on same level involving ice and snow

1138

10142

1.13

3.72

2.0

40.17

39.48

u/l

0.53

1019

9004

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

101

680

1.51

3.72

2.1

1.7

37.64

38.39

u/l

0.14

571

Acute nasopharyngitis (common cold)

238

1834

1.30

3.72

2.1

2.2

40.10

40.16

u/l

0.02

210

1639

Ménière disease

175

1300

1.36

3.71

1.7

1.8

38.70

39.11

u/l

0.11

159

1148

Melanocytic naevi of lower limb, including hip

553

1.57

3.69

1.8

1.9

39.95

38.83

u/l

0.23

495

Benign neoplasm: Kidney

428

1.65

3.68

1.9

2.0

39.19

38.51

u/l

0.10

379

Abrasion of teeth

543

3370

1.19

3.68

2.1

39.95

39.65

u/l

0.13

487

3068

Other diseases of pancreas

135

963

1.42

3.68

1.9

1.8

39.68

38.37

u/l

0.30

120

838

Mantle cell lymphoma

111

2.37

3.67

1.4

2.0

36.60

37.76

u/l

0.09

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

111

762

1.47

3.66

1.5

1.9

37.00

38.94

u/l

0.45

656

Hypoglycaemia, other or unspecified

125

880

1.44

3.66

2.0

42.07

39.00

u/l

0.93

111

789

Other and unspecified psoriasis

126

889

1.44

3.66

1.7

1.9

39.44

39.01

u/l

0.08

112

779

Benign lipomatous neoplasm

543

4601

1.19

3.66

1.8

2.0

38.54

39.12

u/l

0.30

477

4052

Other salmonella infections

499

1.59

3.66

1.4

2.0

40.95

39.81

u/l

0.18

436

Benign neoplasm of bone and articular cartilage

166

1227

1.37

3.65

1.9

39.49

38.90

u/l

0.15

149

1103

Ulcer of oesophagus

119

831

1.45

3.64

1.8

38.46

38.84

u/l

0.06

106

702

Carcinoma in situ of skin of trunk

300

1.77

3.62

1.4

1.9

42.52

37.66

u/l

0.70

257

Short Achilles tendon (acquired)

330

1.74

3.62

1.7

2.0

37.66

39.29

u/l

0.35

298

Occupational exposure to risk-factors

454

1.62

3.61

1.7

2.0

37.36

39.25

u/l

0.29

406

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

384

1.68

3.61

1.8

2.2

37.29

39.39

u/l

0.40

353

Golimumab

470

1.61

3.59

1.7

2.2

37.59

39.18

u/l

0.33

433

Acne conglobata

2.85

3.59

1.4

2.0

39.00

38.62

u/l

0.04

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

134

959

1.42

3.59

2.0

40.43

38.48

u/l

0.58

123

896

Other condition

257

2023

1.28

3.58

2.0

1.9

40.62

39.32

u/l

0.42

227

1818

Myeloid leukaemia

279

1.80

3.58

1.8

2.1

35.60

38.92

u/l

0.56

235

Benign neoplasm: Rectosigmoid junction

510

1.58

3.58

1.6

2.0

38.33

39.08

u/l

0.11

452

Acidosis

214

1.92

3.57

1.4

1.9

46.06

40.82

u/l

0.80

188

Melanocytic naevi of trunk

220

1699

1.31

3.57

1.7

1.9

38.08

38.93

u/l

0.26

193

1528

Use of rivastigmine

1355

0.67

3.56

1.4

1.6

35.45

38.04

u/l

0.63

1118

Essential (haemorrhagic) thrombocythaemia

440

1.62

3.54

1.7

1.9

38.45

39.07

u/l

0.08

375

Infectious mononucleosis

161

1190

1.37

3.54

1.7

2.0

38.63

38.74

u/l

0.03

148

1110

Primary coxarthrosis, bilateral

486

4093

1.20

3.53

1.7

1.8

38.31

38.69

u/l

0.15

428

3485

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

898

5435

1.14

3.49

1.9

38.84

39.02

u/l

0.10

764

4705

Cerebral aneurysm, nonruptured

161

1194

1.37

3.48

1.9

37.65

39.45

u/l

0.45

139

1067

Dental pulpitis 3

205

1125

1.32

3.47

1.5

1.6

36.95

38.62

u/l

0.76

192

1073

Drug-induced hypoglycaemia without coma

188

1.97

3.46

1.8

1.9

38.79

39.29

u/l

0.05

168

Melanocytic naevi of upper limb, including shoulder

268

1.80

3.44

1.4

2.1

38.81

39.38

u/l

0.06

242

Benign neoplasm of major salivary glands

176

1326

1.34

3.43

1.9

1.8

39.38

38.87

u/l

0.12

150

1158

Hereditary corneal dystrophies

374

1.67

3.43

2.1

37.12

39.26

u/l

0.46

324

Xerosis cutis

161

2.05

3.42

2.0

2.2

41.69

39.00

u/l

0.24

142

Hyphaema and other vascular disorders of iris and ciliary body

210

1.91

3.42

2.2

2.1

45.48

39.66

u/l

0.73

184

Superficial injury of shoulder and upper arm

206

1588

1.31

3.40

2.0

1.9

42.33

39.01

u/l

1.45

187

1417

Other infective otitis externa

115

811

1.44

3.38

1.6

1.9

38.32

39.04

u/l

0.15

721

Personal history of medical treatment

102

2.35

3.38

3.0

2.2

41.46

39.46

u/l

0.12

Malignant neoplasm of prostate

501

3734

0.84

3.38

1.6

1.7

37.57

37.40

u/l

0.06

415

3176

Other and unspecified mood [affective] disorders

130

936

1.41

3.37

2.1

39.99

38.56

u/l

0.40

124

870

Non-small cell lung cancer

244

1925

1.28

3.35

1.8

1.7

38.17

38.16

u/l

0.00

210

1629

Injury of eye and orbit

271

2167

1.26

3.34

2.2

2.0

41.40

39.44

u/l

0.79

246

1948

Infarction of spleen

2.59

3.33

1.9

41.64

39.15

u/l

0.15

Crohn's disease of small intestine

138

1007

1.39

3.33

1.5

2.1

37.13

39.37

u/l

0.77

119

914

Ulcerative ileocolitis

600

1.51

3.32

1.8

2.1

37.55

39.62

u/l

0.46

549

Other, unspecified and serous retinal detachments

362

1.67

3.32

1.5

2.1

42.73

38.77

u/l

0.63

318

Pneumococcal septicemia

393

1.64

3.31

2.2

2.1

37.61

38.77

u/l

0.17

351

Malignant melanoma, excluding all cancers (controls excluding all cancers)

280

2249

1.26

3.31

1.9

1.8

40.20

38.44

u/l

0.71

247

1917

Oral lichen ruber planus wide, hypothyreosis or thyroxin

102

707

1.47

3.31

1.9

2.0

39.47

39.57

u/l

0.02

631

In situ neoplasms

639

5533

1.16

3.31

2.0

1.9

38.61

39.18

u/l

0.28

557

4832

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1052

6407

1.13

3.31

1.9

39.58

39.01

u/l

0.38

904

5595

Endometriosis of intestine

184

1.95

3.31

2.3

2.0

40.14

39.07

u/l

0.15

174

Benign neoplasm: Skin of other and unspecified parts of face

189

1447

1.32

3.30

2.0

1.8

36.71

38.95

u/l

0.86

164

1267

Colectomy operation

292

2359

1.25

3.29

2.0

1.8

39.18

38.63

u/l

0.17

255

2044

Carcinoma in situ of skin of other and unspecified parts of face

107

748

1.45

3.29

2.1

1.7

40.74

38.11

u/l

0.47

603

Benign neoplasm: Skin of eyelid, including canthus

259

2065

1.27

3.28

2.1

1.9

41.57

39.25

u/l

0.94

230

1785

Hyperkinetic disorders

183

1377

1.32

3.28

1.7

2.0

38.44

39.78

u/l

0.41

162

1305

All dysplastic lesions of the vulva

594

1.51

3.27

2.1

2.0

41.44

39.75

u/l

0.28

535

Anankastic personality disorder

554

1.53

3.26

2.2

2.1

41.89

39.53

u/l

0.51

511

Eating disorders

189

1448

1.32

3.25

1.7

2.0

40.14

38.52

u/l

0.50

170

1349

Sequelae of injuries, of poisoning and of other consequences of external causes

457

3862

1.19

3.24

1.9

2.0

38.98

39.55

u/l

0.24

404

3467

Injury of muscle and tendon at shoulder and upper arm level

675

5880

1.15

3.24

2.0

1.9

40.31

38.59

u/l

1.45

599

5138

Congenital malformations and deformations of the musculoskeletal system

152

1125

1.36

3.23

2.1

2.0

42.54

39.41

u/l

1.23

138

1050

Impotence

100

694

1.46

3.23

1.9

1.8

38.78

38.07

u/l

0.12

590

Mixed conductive and sensorineural hearing loss

210

1636

1.30

3.22

1.9

1.8

38.66

39.00

u/l

0.09

182

1421

Benign neoplasm: other/unspecified salivary gland

304

1.71

3.21

1.8

2.1

36.55

38.89

u/l

0.39

264

Benign neoplasm: Pancreas

320

1.70

3.20

1.7

2.0

40.04

39.11

u/l

0.13

278

Malignant neoplasm of thymus

3.33

3.19

3.8

2.0

39.42

41.98

u/l

0.17

Anogenital herpesviral [herpes simplex] infection

122

879

1.41

3.19

2.3

2.2

41.74

38.76

u/l

0.86

108

816

Actinomycosis

3.28

3.17

1.2

2.1

38.25

42.66

u/l

0.28

Hyperfunction of pituitary gland

655

1.47

3.17

1.8

2.1

40.54

39.20

u/l

0.30

603

Erythema intertrigo

275

1.75

3.17

2.0

2.1

34.38

40.07

u/l

0.89

248

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

919

5591

1.13

3.17

1.9

39.35

38.99

u/l

0.20

778

4849

Malignant neoplasm of skin

1123

7593

1.12

3.17

1.8

39.69

38.75

u/l

0.79

950

6535

malignant neoplasm of male genital organs

527

3909

0.85

3.15

1.6

1.7

37.69

37.50

u/l

0.07

437

3339

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

135

992

1.38

3.14

1.5

2.1

37.53

39.85

u/l

0.74

120

909

Bitten or struck by other mammals

207

1616

1.29

3.14

1.9

2.0

40.05

39.10

u/l

0.28

185

1482

Later onset COPD

415

2731

1.20

3.14

1.4

1.6

36.02

37.52

u/l

0.70

350

2257

Other neurotic disorders

632

1.48

3.13

2.3

2.0

43.72

39.41

u/l

1.00

552

Basal cell carcinoma, including avohilmo

1009

7101

1.12

3.13

1.8

38.56

38.75

u/l

0.11

853

6084

Female infertility, associated with anovulation

143

1060

1.36

3.13

2.0

1.9

41.47

38.83

u/l

0.93

132

1018

Basal cell carcinoma

980

6968

1.12

3.12

1.8

38.60

38.71

u/l

0.06

828

5967

Vertigo of central origin

167

1.97

3.11

1.6

2.1

33.55

41.69

u/l

1.46

147

Bruxism

262

1.77

3.11

2.3

2.1

38.27

40.29

u/l

0.32

238

Organic, including symptomatic, mental disorders

653

5408

0.87

3.11

1.5

1.8

36.98

38.59

u/l

1.14

534

4611

Other disorders of breast

240

1911

1.27

3.11

2.4

2.0

41.86

39.87

u/l

1.01

225

1720

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

455

1.56

3.11

2.0

34.58

40.75

u/l

2.32

420

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

876

5356

1.13

3.08

1.9

38.90

39.01

u/l

0.05

746

4631

Substance abuse

1176

10151

1.11

3.08

1.7

2.0

40.59

38.99

u/l

1.59

1030

9066

Malignant neoplasm of thyroid gland

127

928

1.39

3.07

2.0

1.9

35.75

39.09

u/l

1.24

113

833

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

183

1410

1.31

3.07

1.4

1.8

36.24

37.81

u/l

0.46

153

1182

Benign neoplasm: Descending colon

117

844

1.41

3.06

1.9

1.8

37.86

38.55

u/l

0.14

103

730

Benign neoplasm: Small intestine

522

1.52

3.06

1.7

2.0

37.54

39.25

u/l

0.29

461

Respiratory tuberculosis, not confirmed

449

1.56

3.04

2.0

37.67

38.36

u/l

0.11

388

Tooth eruption problems

237

1870

1.26

3.02

2.1

1.9

38.17

39.18

u/l

0.38

220

1745

Other disorders of gingiva or/and edentulous alveolar ridge

604

1.48

3.02

1.7

2.0

42.15

39.65

u/l

0.63

531

Crohn disease (strict definition, require KELA, min 2 HDR)

125

914

1.39

3.02

1.5

2.0

37.01

39.73

u/l

0.91

111

835

Other/unspecified soft tissue disorders related to use, overuse and pressure

364

1.63

3.01

1.9

2.0

40.47

38.47

u/l

0.28

324

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

155

1172

1.34

3.01

2.9

2.1

37.95

39.85

u/l

0.59

141

1100

Benign neoplasm: salivary glands, exclude unknown (D119)

158

1198

1.33

3.01

1.9

1.8

39.01

38.82

u/l

0.04

135

1057

Mental and behavioural disorders due to psychoactive substance use

1212

10362

1.11

2.99

1.7

2.0

40.68

38.99

u/l

1.76

1064

9259

Sequelae of infectious and parasitic diseases

141

1052

1.36

2.99

1.5

2.0

43.10

39.27

u/l

1.41

126

945

Other congenital malformations

154

1163

1.34

2.99

2.0

38.57

39.26

u/l

0.16

143

1068

Follicular cysts of skin and subcutaneous tissue

338

2804

1.21

2.98

1.7

1.9

40.53

39.30

u/l

0.53

305

2497

Fracture of neck

101

714

1.43

2.98

1.6

1.9

38.35

38.51

u/l

0.02

626

Dental pulpitis 3, only avohilmo

186

1047

1.31

2.97

1.5

1.6

36.10

38.53

u/l

1.33

174

997

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

485

1.53

2.96

2.1

2.0

36.52

39.09

u/l

0.60

421

Other noninflammatory disorders of uterus, except cervix

406

2328

1.20

2.96

1.8

2.1

38.46

40.30

u/l

1.00

355

2046

Fracture of shoulder and upper arm

644

5627

1.15

2.96

1.7

1.9

40.16

39.22

u/l

0.49

559

4936

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

159

1210

1.33

2.95

1.9

2.0

40.10

38.84

u/l

0.36

146

1118

Scar conditions and fibrosis of skin

526

1.51

2.95

2.8

2.0

42.77

39.21

u/l

0.79

470

Other and unspecified mononeuropathies of lower limb

343

1.64

2.94

2.3

2.1

34.67

40.09

u/l

1.29

299

Poisoning by medicine

413

3493

1.19

2.94

1.7

2.0

39.80

39.54

u/l

0.08

362

3198

Benign neoplasm: Long bones of lower limb

438

1.56

2.93

1.8

2.0

39.43

39.28

u/l

0.02

392

Other specified disorders of kidney and ureter

423

1.57

2.91

1.4

2.0

36.83

38.48

u/l

0.25

371

Crohn disease (strict definition, require KELA)

126

929

1.37

2.91

1.5

2.0

36.96

39.74

u/l

0.95

112

849

Injury of nerves at wrist and hand level

528

1.50

2.90

2.1

42.20

39.47

u/l

0.44

477

Social phobias

145

1091

1.34

2.90

1.8

2.1

39.84

39.73

u/l

0.02

138

1018

Poisoning by drugs, medicaments and biological substances

457

3904

1.18

2.89

1.7

2.0

40.08

39.35

u/l

0.28

401

3569

Melanocytic naevi, other sites/unspecified

137

1024

1.35

2.88

2.1

1.9

39.29

38.98

u/l

0.06

128

917

Assault by bodily force

148

1120

1.34

2.87

1.9

2.1

41.30

39.85

u/l

0.37

137

1035

Open wound of forearm

164

1259

1.32

2.86

1.6

2.0

40.76

38.95

u/l

0.51

151

1123

Adult respiratory distress syndrome

137

2.03

2.86

1.4

2.2

44.71

37.76

u/l

0.44

120

Other symptoms and signs involving general sensations and perceptions

416

1.56

2.86

1.5

2.0

40.11

39.01

u/l

0.18

378

Varicose veins of other sites

127

941

1.37

2.85

2.1

2.0

40.93

38.86

u/l

0.52

106

839

Benign neoplasm of middle ear and respiratory system

139

1044

1.35

2.84

2.2

1.9

37.77

38.85

u/l

0.26

124

908

Myeloid leukaemia

300

1.67

2.83

1.8

2.0

35.60

39.17

u/l

0.62

263

Foreign body on external eye

277

2268

1.23

2.82

2.1

2.0

40.21

39.48

u/l

0.23

243

2030

Ulcerative proctitis

121

892

1.37

2.81

2.0

36.35

39.52

u/l

1.45

110

817

Papillary adenocarcinoma of thyroid gland

699

1.42

2.78

2.0

36.16

39.42

u/l

0.93

623

Sequelae of injuries of upper limb

184

1442

1.29

2.77

2.0

1.9

39.85

39.08

u/l

0.19

164

1292

Other interventions on the root canals of the tooth

257

1.72

2.75

1.3

2.3

36.56

39.00

u/l

0.42

237

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

143

1085

1.33

2.74

1.8

1.9

38.91

38.84

u/l

0.01

125

957

Schizophrenia or delusion

479

5547

0.86

2.74

1.7

2.0

38.78

39.67

u/l

0.39

412

5024

Melanocytic naevi of upper limb, including shoulder

288

1.67

2.72

1.4

2.2

38.81

40.41

u/l

0.19

257

Malignant neoplasm of breast

815

6587

0.89

2.72

1.9

2.1

41.61

40.12

u/l

1.37

714

5864

Benign neoplasm: Parotid gland

132

993

1.34

2.69

1.9

39.80

38.05

u/l

0.39

112

850

Otitis media, unspecified

184

1330

1.28

2.68

1.8

1.9

38.12

39.47

u/l

0.44

170

1225

Chronic mastoiditis

336

1.61

2.68

2.0

36.66

38.69

u/l

0.32

294

Assault

249

2028

1.24

2.68

1.9

2.1

42.85

39.58

u/l

1.54

226

1861

Lesion of radial nerve

464

1.51

2.67

1.8

2.1

41.99

39.38

u/l

0.50

408

Other and unspecified aplastic anaemias

120

2.06

2.67

1.5

2.2

36.74

39.15

u/l

0.23

110

Injury of muscle and tendon at lower leg level

276

2274

1.22

2.66

2.1

1.9

37.91

39.00

u/l

0.39

248

2024

Duodenal ulcer

168

1308

1.29

2.65

1.9

1.8

38.48

38.56

u/l

0.02

148

1101

Melanocytic naevi of lower limb, including hip

597

1.45

2.65

1.8

2.0

39.95

39.64

u/l

0.05

536

Cysts of oral region, not elsewhere classified

580

1.45

2.65

1.6

2.0

39.18

39.14

u/l

0.01

511

Family history of malignant neoplasm

192

1522

1.27

2.64

1.9

40.42

39.57

u/l

0.25

178

1390

Focal brain injury

696

1.41

2.64

1.7

1.9

39.36

39.20

u/l

0.02

607

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

942

7425

1.11

2.64

2.2

2.1

39.31

39.91

u/l

0.43

856

6777

Schizophrenia, schizotypal and delusional disorders

482

5562

0.86

2.64

1.7

2.0

38.68

39.65

u/l

0.44

416

5038

Ulcerative rectosigmoiditis

158

1223

1.31

2.64

1.8

2.0

37.88

39.00

u/l

0.31

138

1115

Synovial hypertrophy, not elsewhere classified

114

2.08

2.62

1.8

2.4

39.13

37.91

u/l

0.14

105

Ankylosing spondylitis, strict definition

674

1.42

2.62

1.9

2.1

38.60

39.97

u/l

0.38

621

Other mental disorders due to brain damage and dysfunction and to physical disease

177

1391

1.28

2.61

1.6

1.8

38.64

38.95

u/l

0.07

149

1185

Abnormal findings in secretions and smears from cervix uteri vagina vulva

993

7049

1.11

2.61

2.3

2.0

40.10

39.66

u/l

0.31

915

6449

Prepatellar bursitis

582

1.45

2.61

2.3

2.1

39.51

37.87

u/l

0.27

520

Other malignant neoplasms of skin (=non-melanoma skin cancer)

945

6724

1.11

2.59

1.7

1.8

39.36

38.50

u/l

0.63

792

5755

Decubitus ulcer and pressure area

582

1.44

2.59

2.3

1.8

37.48

38.07

u/l

0.08

502

False labour

624

3443

1.14

2.59

2.0

2.1

37.75

39.51

u/l

1.71

582

3236

Benign neoplasm: Long bones of lower limb

452

1.51

2.58

1.8

2.1

39.43

38.96

u/l

0.07

407

Mixed and other personality disorders

162

1263

1.30

2.57

1.9

2.1

41.27

39.64

u/l

0.54

148

1171

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

229

1858

1.24

2.57

1.9

1.8

41.01

38.43

u/l

1.05

203

1584

Idiopathic urticaria

262

1.68

2.56

2.4

2.1

43.65

39.75

u/l

0.54

239

Alcohol use disorder, Swedish definition

1093

9230

1.10

2.55

1.7

2.0

40.88

38.97

u/l

1.97

974

8199

Malignant neoplasm of breast, HER2-negative

791

6492

0.89

2.54

1.9

2.1

41.63

40.13

u/l

1.35

693

5772

Other and unspecified mononeuropathies of upper limb

397

1.54

2.53

2.3

2.1

41.58

39.60

u/l

0.36

355

Acute bronchiolitis

509

1.44

2.53

1.6

1.7

37.00

40.38

u/l

1.04

477

Medical abortion

1351

6729

1.09

2.52

2.0

39.93

39.57

u/l

0.25

1213

6052

Pilonidal cyst

168

1320

1.28

2.51

2.1

40.63

39.44

u/l

0.30

152

1212

Non-small cell lung cancer, adenocarcinoma, helper endpoint

101

739

1.38

2.49

2.1

1.8

37.64

38.37

u/l

0.14

630

Non-small cell lung cancer, adenocarcinoma

101

739

1.38

2.49

2.1

1.8

37.64

38.37

u/l

0.14

630

L02BB Anti-androgens

959

0.68

2.48

1.7

1.6

37.54

36.57

u/l

0.12

791

Unspecified misadventure during surgical and medical care

715

1.39

2.48

1.7

1.9

41.59

39.03

u/l

0.65

636

Coxarthrosis, primary, with hip surgery

805

6848

1.12

2.48

1.9

1.8

38.89

38.81

u/l

0.04

703

5859

Melanoma in situ

448

1.50

2.47

1.5

1.9

36.22

38.28

u/l

0.31

379

Other bacterial agents as the cause of diseases classified to other chapters

110

2.07

2.46

1.3

1.9

39.95

38.84

u/l

0.09

Hidradenitis suppurativa

498

1.47

2.46

1.5

2.1

36.99

39.76

u/l

0.59

461

Focal epilepsy, strict definition

332

2805

1.19

2.46

1.8

1.9

39.10

39.01

u/l

0.02

298

2484

Focal epilepsy

360

3062

1.18

2.45

1.8

1.9

39.46

39.08

u/l

0.12

324

2719

Superficial injury of forearm

170

1342

1.28

2.45

1.6

2.0

39.04

38.53

u/l

0.13

149

1218

Anisometropia and aniseikonia

384

1.54

2.45

1.5

2.1

36.23

39.89

u/l

0.72

347

1149

9641

1.10

2.45

1.7

2.0

40.86

38.94

u/l

2.02

1020

8567

Macular hole

674

1.40

2.45

1.8

1.7

41.87

39.07

u/l

0.57

582

Other arterial embolism and thrombosis

289

1.62

2.43

1.4

1.9

32.06

37.63

u/l

1.15

252

Benign neoplasm: other/unspecified salivary gland

329

1.58

2.43

1.8

2.1

36.55

39.42

u/l

0.50

289

Malignant neoplasm of digestive organs

481

5424

0.87

2.41

1.6

1.8

38.55

38.47

u/l

0.03

422

4626

Gingival hyperplasia

394

1.52

2.40

1.8

2.0

43.67

39.42

u/l

0.88

346

Female infertility

607

3306

1.14

2.38

1.9

2.1

40.14

39.72

u/l

0.22

565

3027

Presbycusis

177

1401

1.26

2.38

1.9

1.6

38.06

38.67

u/l

0.14

149

1154

Malignant melanoma

239

1968

1.22

2.36

2.0

1.8

40.49

38.71

u/l

0.62

212

1701

Abscess of anal and rectal regions

156

1225

1.29

2.36

1.8

1.9

39.27

38.91

u/l

0.08

140

1093

Alzheimer’s disease, wide definition, excluding more controls

133

1173

0.77

2.35

1.4

1.6

39.20

38.74

u/l

0.09

979

Other disorders of penis

162

1279

1.28

2.35

2.0

1.9

38.95

39.02

u/l

0.01

138

1108

Intrahepatic Cholestasis of Pregnancy (ICP)

134

1033

1.31

2.35

2.0

2.1

40.43

39.03

u/l

0.38

123

967

Complications of genitourinary prosthetic devices, implants and grafts

300

1.60

2.35

2.0

2.2

42.10

39.16

u/l

0.39

262

Focal epilepsy, mode (most common among epilepsy diagnosis)

316

2671

1.19

2.35

1.8

1.9

39.06

39.10

u/l

0.01

286

2363

Chronic suppurative otitis media, including avohilmo

138

1068

1.30

2.34

2.1

1.9

38.97

39.44

u/l

0.11

124

959

Deep bite

185

1296

1.26

2.33

2.1

1.9

40.30

39.15

u/l

0.33

168

1188

Complications following abortion and ectopic and molar pregnancy

479

1.47

2.33

1.8

2.0

40.49

39.25

u/l

0.23

428

Other specified/unspecified spondylopathies

277

1.62

2.32

1.2

2.2

37.52

38.95

u/l

0.20

240

Emotional disorders starting during childhood or adolecense, excluding more controls

428

1.48

2.31

1.3

1.9

35.52

39.62

u/l

1.18

405

Alzheimer’s disease (Late onset), excluding more controls

122

1064

0.76

2.30

1.5

1.6

38.96

38.62

u/l

0.06

881

Leisure time condition

307

2595

1.19

2.30

2.2

1.9

41.23

38.91

u/l

1.23

275

2313

Benign neoplasm: Cranial nerves

350

1.54

2.29

2.5

2.0

36.63

39.71

u/l

0.48

309

Disorders of globe

294

1.59

2.29

2.0

2.1

37.37

39.82

u/l

0.43

256

Arthropathy in ulcerative colitis

179

1.78

2.29

1.8

2.3

36.69

39.49

u/l

0.34

162

Other and unspecified disorders of pigmentation

2.17

2.29

1.3

2.2

45.44

40.39

u/l

0.57

Ovarian dysfunction, other/unspecified

2.29

2.27

1.8

2.2

39.19

40.57

u/l

0.09

Polycythaemia vera

391

1.51

2.27

2.2

1.9

40.15

39.30

u/l

0.10

330

Salpingitis and oophoritis

345

2949

1.18

2.27

1.6

2.1

39.31

40.11

u/l

0.33

310

2655

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

159

1259

1.28

2.27

1.9

2.1

40.10

39.08

u/l

0.28

146

1160

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

733

5334

0.89

2.26

2.0

2.1

42.13

40.09

u/l

2.03

646

4791

Chronic suppurative otitis media

117

891

1.33

2.25

2.2

2.0

40.28

38.93

u/l

0.32

103

797

Other aneurysm

625

1.39

2.25

1.9

1.8

37.01

38.62

u/l

0.28

537

Hypertrophy of breast in women and men

378

3258

1.17

2.24

2.1

2.0

41.36

39.84

u/l

0.86

353

2962

Fentanyl

142

1109

1.29

2.24

1.4

1.9

40.23

38.48

u/l

0.41

119

954

Orchitis and epididymitis

151

1190

1.28

2.23

1.6

1.9

38.25

38.61

u/l

0.07

129

1027

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

734

5334

0.90

2.22

2.0

2.1

42.12

40.09

u/l

2.02

647

4791

Benign leiomyoma with endometriosis

279

2348

1.20

2.22

1.7

2.0

39.54

39.75

u/l

0.05

234

2082

Other fall from one level to another

387

3342

1.16

2.21

1.7

1.9

39.79

38.95

u/l

0.33

351

2977

Post-traumatic wound infection, not elsewhere classified

329

1.55

2.21

2.3

2.0

45.09

38.31

u/l

0.83

296

Polycystic ovarian syndrome

695

1.37

2.21

1.6

2.0

43.30

38.82

u/l

1.33

660

Other vitreous opacities

485

1.44

2.20

2.4

2.0

33.84

39.53

u/l

1.88

422

Bicipital tendinitis

628

1.39

2.20

2.7

2.0

38.17

37.88

u/l

0.05

559

Perforation of tympanic membrane

174

1400

1.25

2.18

1.8

1.9

39.19

39.25

u/l

0.01

147

1247

Other specified/unspecified disorders of bone/cartilage

379

1.50

2.18

2.2

2.0

38.78

39.14

u/l

0.05

339

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

105

792

1.34

2.17

1.6

1.8

37.20

38.48

u/l

0.25

673

Hyperprolactinaemia

478

1.44

2.17

1.8

2.2

41.10

39.82

u/l

0.23

446

Benign neoplasm: Skin of eyelid, including canthus

259

2170

1.20

2.17

2.1

1.9

41.57

39.10

u/l

1.03

230

1890

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

520

1.42

2.17

2.1

2.0

36.52

39.23

u/l

0.65

461

Fourth [trochlear] nerve palsy

291

1.58

2.16

2.0

1.9

40.00

39.66

u/l

0.03

257

Osteonecrosis due to drugs

160

1.81

2.16

2.1

2.3

35.87

38.30

u/l

0.23

143

Residual foreign body in soft tissue

647

1.38

2.16

2.9

2.1

42.20

37.43

u/l

1.19

578

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

182

1.74

2.15

1.4

2.0

36.21

39.20

u/l

0.36

167

Entropion and trichiasis of eyelid

121

932

1.31

2.15

1.7

1.8

37.21

38.97

u/l

0.37

781

1212

10009

1.09

2.15

1.7

2.0

40.68

38.94

u/l

1.83

1078

8906

Social disorders starting during childhood or adolecense, excluding more controls

2.27

2.14

1.9

2.0

36.93

38.82

u/l

0.23

Carcinoma in situ of skin of other and unspecified parts of face

107

811

1.33

2.14

2.1

1.7

40.74

38.51

u/l

0.38

671

Conductive hearing loss, unspecified

146

1154

1.28

2.14

1.8

1.9

39.48

39.08

u/l

0.09

130

1031

Mumps

373

1.50

2.12

2.4

2.1

38.74

38.65

u/l

0.01

335

Delirium, not induced by alcohol and other psychoactive substances

161

1286

1.26

2.12

1.3

1.8

38.42

38.54

u/l

0.02

131

1095

Dronedarone medication

308

1.55

2.12

1.8

1.6

36.00

40.80

u/l

1.11

272

Crohn disease (strict definition, all UC cases excluded)

719

1.35

2.10

1.4

2.1

37.09

40.19

u/l

0.95

656

Amputation of ankle bones

238

1.63

2.08

2.7

1.9

44.32

38.07

u/l

0.97

208

Convergent concomitant strabismus

106

807

1.33

2.07

2.0

2.1

40.70

40.44

u/l

0.04

741

Urethral stricture

669

1.36

2.07

1.6

1.8

37.39

37.64

u/l

0.04

565

Other sexually transmitted chlamydial diseases

120

930

1.30

2.06

1.9

2.2

42.68

39.16

u/l

1.33

111

871

Malignant neoplasm of rectum

1175

0.74

2.05

1.5

1.8

36.86

38.26

u/l

0.24

1001

Female infertility, cervigal, vaginal, other or unspecified origin

541

3210

1.13

2.05

2.0

2.1

39.75

39.86

u/l

0.05

506

2943

Secondary parkinsonism, excluding more controls

231

1.63

2.04

1.4

2.0

35.79

39.34

u/l

0.63

193

Polycystic ovarian syndrome, broad definition

189

1546

1.23

2.04

1.9

41.14

38.71

u/l

1.05

175

1467

Abscess of tendon sheath

2.23

2.03

1.9

2.6

36.67

38.01

u/l

0.08

Dental caries 2 and operation codes, only avohilmo

1556

8999

1.08

2.03

2.1

2.0

39.87

39.61

u/l

0.19

1407

8155

Other secondary gonarthrosis

672

1.36

2.02

2.2

1.9

36.48

38.80

u/l

0.50

595

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

209

1.66

2.01

1.1

2.1

34.96

39.52

u/l

0.89

191

Examination and encounter for administrative purposes

435

1.44

2.01

2.7

2.0

40.06

37.42

u/l

0.42

372

Benign neoplasm: Skin of trunk

528

1.40

2.01

2.4

2.0

39.90

39.04

u/l

0.14

467

Event of undetermined intent

113

873

1.31

2.00

1.8

2.1

40.92

38.93

u/l

0.40

101

798

Speech and linguistic disorders, excluding more controls

115

837

1.30

2.00

1.9

37.07

39.73

u/l

0.93

779

Other diseases of biliary tract

133

1049

1.28

2.00

1.8

43.78

38.93

u/l

2.12

122

909

CR(E)ST syndrome

210

1.66

2.00

1.4

2.4

41.74

41.17

u/l

0.06

188

Unspecified threat to breathing

120

1.89

1.97

3.5

2.3

34.68

40.99

u/l

1.08

111

Parodontitis, under 40 years

158

1274

1.25

1.97

2.0

40.05

40.02

u/l

0.01

151

1215

234

1.61

1.96

1.6

2.2

38.43

38.53

u/l

0.01

217

Benign neoplasm: Cranial nerves

364

1.48

1.95

2.5

2.0

36.63

39.75

u/l

0.49

322

Crohn's disease of large intestine

755

1.33

1.94

1.6

2.0

37.12

39.82

u/l

0.65

686

Parodontitis, under 40 years, or operation codes

158

1276

1.25

1.94

2.0

40.05

40.01

u/l

0.01

151

1216

Sequelae of other and unspecified infectious and parasitic diseases

108

834

1.31

1.94

1.4

2.1

42.95

39.66

u/l

0.90

100

762

Malignant melanoma of skin

180

1476

1.23

1.93

2.0

1.8

41.33

38.39

u/l

1.05

160

1271

Melanoma in situ

473

1.42

1.93

1.5

2.0

36.22

38.66

u/l

0.38

415

Arterial embolism and thrombosis of lower extremity artery

356

1.48

1.92

1.8

1.9

39.14

38.40

u/l

0.09

310

Severe combined immunodeficiency [SCID] with reticular dysgenesis

2.79

1.91

1.0

1.2

37.88

32.37

u/l

—

Congenital malformations of the circulatory system

239

1951

1.19

1.91

1.6

1.9

37.97

39.33

u/l

0.46

209

1761

Suicide or other Intentional self-harm

460

4071

1.14

1.91

1.7

2.0

41.39

39.57

u/l

0.93

404

3709

Filling of root of tooth

424

1.44

1.91

1.7

2.1

42.08

39.68

u/l

0.44

386

Acute inflammation of orbit

2.16

1.91

2.1

2.5

39.13

39.02

u/l

0.01

Other disorders originating in the perinatal period

2.20

1.90

4.2

2.1

38.29

40.75

u/l

0.16

Melanocytic naevi of other and unspecified parts of face

100

767

1.32

1.89

1.8

2.0

38.57

39.28

u/l

0.19

692

Disorder of the sleep-wake schedule

206

1.63

1.86

3.4

2.2

45.04

39.15

u/l

0.98

189

Melanocytic naevi, other sites/unspecified

137

1096

1.26

1.86

2.1

1.9

39.29

39.19

u/l

0.02

128

986

Alzheimer disease, excluding more controls

160

1313

0.81

1.86

1.5

1.6

38.22

38.35

u/l

0.02

119

1100

Early complications of trauma

553

1.37

1.86

2.7

2.1

42.30

39.61

u/l

0.39

498

!Aliquae complicationes praecoces traumatis

553

1.37

1.86

2.7

2.1

42.30

39.61

u/l

0.39

498

Problems related to social environment

318

1.50

1.86

1.7

2.1

38.39

38.01

u/l

0.04

287

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1234

0.76

1.85

1.7

1.8

37.90

38.43

u/l

0.08

1054

Alzheimer’s disease (Atypical or mixed)

763

0.70

1.85

1.4

1.7

32.44

38.23

u/l

0.90

621

Pityriasis rubra pilaris

2.94

1.84

3.5

1.6

42.13

38.86

u/l

—

Malignant neoplasm, without specification of site

286

1.52

1.84

1.3

1.8

34.07

37.38

u/l

0.50

242

Other puerperal infections

133

1062

1.26

1.83

1.8

2.1

37.57

38.46

u/l

0.24

124

1002

Impetigo

554

1.37

1.83

1.5

2.0

38.96

39.15

u/l

0.03

515

Somnolence, stupor and coma

520

1.38

1.83

2.1

1.9

40.58

39.08

u/l

0.28

460

Alcohol-induced chronic pancreatitis

116

912

1.29

1.83

1.6

1.9

44.40

38.85

u/l

1.74

108

803

LSIL lesion of the vulva

411

1.43

1.83

2.3

2.2

45.27

39.31

u/l

1.16

373

Benign neoplasm of male genital organs

207

1.62

1.83

1.8

1.7

35.90

39.22

u/l

0.37

180

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

143

1153

1.25

1.82

1.8

1.9

38.91

39.06

u/l

0.03

125

1034

Carcinoma in situ of skin

110

859

1.29

1.82

1.9

1.8

37.68

38.50

u/l

0.11

713

Injuries to the elbow and forearm

1392

11749

1.07

1.82

1.8

2.0

40.35

39.57

u/l

0.76

1230

10514

Listeriosis

2.44

1.82

1.7

2.0

29.00

46.39

u/l

1.89

Benign neoplasm: Bronchus and lung

146

1.75

1.81

2.1

2.2

32.35

40.86

u/l

1.12

130

Use of biperiden

736

0.70

1.80

1.9

2.0

41.83

39.23

u/l

0.26

657

Aneurysms, operations, SAH

276

2370

1.17

1.79

1.7

1.9

37.43

39.48

u/l

0.88

234

2083

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

154

1.72

1.79

1.5

2.2

42.22

39.66

u/l

0.19

130

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

898

0.73

1.79

1.5

1.8

38.33

37.98

u/l

0.04

758

Spinal enthesopathy

231

1.57

1.78

1.4

1.8

39.26

36.01

u/l

0.34

197

Presbyopia

114

898

1.28

1.78

2.7

2.1

40.44

39.53

u/l

0.17

105

808

Brain meningioma, excluding all cancers (controls excluding all cancers)

661

1.33

1.78

1.6

1.9

33.64

39.65

u/l

3.04

582

Crossbite

102

733

1.30

1.77

2.2

1.9

43.94

39.84

u/l

1.17

678

Benign lipomatous neoplasm

543

4882

1.12

1.75

1.8

2.0

38.54

39.14

u/l

0.31

477

4303

L02BA Anti-estrogens

218

2574

0.84

1.75

2.0

2.1

42.49

40.01

u/l

1.01

199

2298

Divergent concomitant strabismus

139

1123

1.25

1.75

2.0

37.66

39.79

u/l

0.61

128

1019

Varicella [chickenpox]

663

1.33

1.75

2.6

2.2

38.89

39.98

u/l

0.21

596

Benign neoplasm: Parotid gland

132

1061

1.26

1.74

1.9

1.8

39.80

38.76

u/l

0.21

112

933

Spermatocele

121

963

1.27

1.73

1.7

1.8

36.65

38.13

u/l

0.33

106

817

Other acquired deformities of musculoskeletal system and connective tissue

647

1.33

1.73

1.7

2.0

38.86

38.92

u/l

0.01

576

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

399

2712

0.88

1.72

1.6

1.8

37.82

37.65

u/l

0.05

338

2311

Benign mammary dysplasia

246

2102

1.18

1.72

1.9

2.0

38.89

40.21

u/l

0.47

222

1849

Pre-eclampsia or eclampsia

411

3642

1.13

1.72

2.1

39.50

39.81

u/l

0.12

372

3345

Persons encountering health services in circumstances related to reproduction

1225

7731

1.08

1.71

2.0

2.1

40.23

40.02

u/l

0.14

1126

7050

Septal defects

736

1.30

1.71

1.5

2.0

37.87

39.85

u/l

0.53

669

Medicines for HER+ breast cancer

543

5867

0.90

1.71

1.9

2.0

41.69

40.16

u/l

1.02

485

5177

Ill-defined and unknown causes of mortality

717

0.71

1.70

1.4

1.8

33.78

37.93

u/l

0.70

616

Adenocarcinoma and papilloma adenocarcinoma of rectum

1182

0.77

1.68

1.8

37.81

38.21

u/l

0.06

1007

Other and/or unspecified nontoxic goitre

135

1093

1.25

1.68

1.7

1.9

41.93

39.33

u/l

0.84

121

970

Single delivery by forceps and vacuum extractor

225

1613

0.84

1.68

2.1

2.0

40.58

39.77

u/l

0.28

213

1524

Hereditary angioödema type 1

3.96

1.67

1.0

1.4

38.00

42.71

u/l

—

Pregnancy hypertension

829

6871

1.09

1.67

2.2

2.0

39.53

39.72

u/l

0.10

753

6301

Benign neoplasm: Short bones of lower limb

120

1.80

1.66

1.4

2.4

34.48

40.03

u/l

0.66

108

Malignant neoplasm of breast, HER-positive

510

5584

0.90

1.66

1.9

2.0

41.89

40.22

u/l

1.15

454

4914

Erectile dysfunction

122

979

1.26

1.65

2.1

1.6

36.46

37.09

u/l

0.11

823

Other other unspecified disorders of the circulatory system

445

1.39

1.65

1.7

2.0

34.24

39.76

u/l

1.47

397

Other and unspecified paralytic syndromes

166

1.66

1.65

3.0

2.2

36.32

39.90

u/l

0.36

151

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

161

1327

1.22

1.64

1.6

33.89

37.22

u/l

1.21

136

1098

Emotional disorders and disorders of social functioning with onset specific to childhood

540

1.34

1.64

1.4

1.7

36.94

39.87

u/l

0.88

512

Eustachian salpingitis and obstruction

149

1223

1.23

1.64

2.3

2.2

37.63

39.73

u/l

0.60

138

1134

Malignant neoplasm of mesothelium and soft tissue

514

1.36

1.64

1.6

1.9

34.35

39.18

u/l

1.14

449

Hand

2.08

1.64

1.7

2.5

37.64

40.55

u/l

0.21

Acute myeloid leukaemia and myelodysplastic syndromes

174

1.64

1.63

1.4

2.0

31.41

39.37

u/l

1.25

150

Benign lipomatous neoplasm of other sites/unspecified

134

1088

1.24

1.63

2.1

1.9

37.68

39.09

u/l

0.40

121

935

Benign leiomyoma with endometriosis

279

2420

1.16

1.63

1.7

2.0

39.54

39.89

u/l

0.09

234

2155

Benign neoplasm: Vagina

167

1.66

1.62

1.4

2.3

41.88

39.80

u/l

0.16

146

Perineal laceration during delivery

214

2240

0.85

1.61

2.3

1.9

38.53

38.83

u/l

0.09

199

2110

Dyshidrosis [pompholyx]

207

1.58

1.60

1.8

2.3

48.26

41.46

u/l

0.90

187

Hypertrophy of breast

322

2825

1.15

1.60

2.0

2.1

41.65

40.02

u/l

0.85

300

2574

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

629

1.32

1.60

1.5

2.0

33.74

38.89

u/l

1.85

552

Parodontitis, under 40 years and operation codes

145

1190

1.23

1.59

2.0

40.11

40.04

u/l

0.02

138

1134

Graves disease, strict definition

175

1464

1.20

1.59

2.0

40.41

39.42

u/l

0.25

161

1345

Anorexia (incl.atypical)

101

796

1.28

1.59

1.7

1.9

39.87

38.42

u/l

0.28

735

Parodontitis, operation under 40 years and operation codes

145

1191

1.23

1.58

2.0

40.11

40.05

u/l

0.01

138

1135

Other and unspecified localized connective tissue disorders

2.39

1.58

2.8

2.2

35.20

44.56

u/l

—

Oral leukoplakia and related diseases, including avohilmo

147

1211

1.22

1.57

1.9

41.47

38.85

u/l

0.81

130

1078

HSIL lesion of the cervix uteri, vagina or vulva

355

3139

1.14

1.57

2.2

2.1

39.06

39.61

u/l

0.23

326

2937

Fracture of spine, level unspecified

2.77

1.56

1.3

1.8

52.29

39.28

u/l

—

Congenital deformities of feet

323

1.45

1.56

1.5

2.1

41.37

38.99

u/l

0.33

294

Invasive ventilation

116

933

1.25

1.56

1.7

1.9

36.71

38.35

u/l

0.41

817

Erythrasma

2.75

1.55

2.6

2.3

43.29

39.40

u/l

—

Other appendicitis

149

1231

1.22

1.55

2.1

2.0

39.44

38.70

u/l

0.15

128

1123

Hypotension due to drugs

138

1.70

1.54

2.6

1.9

37.20

37.52

u/l

0.02

123

Mental disorders, not otherwise specified

151

1250

1.22

1.54

1.9

2.1

41.39

39.05

u/l

0.88

140

1151

Congenital malformations of cardiac septa

105

808

1.27

1.54

1.5

2.0

38.55

39.51

u/l

0.22

734

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

417

1.39

1.54

2.3

2.1

44.12

39.20

u/l

0.93

374

Unspecified event, undetermined intent

333

1.43

1.53

1.5

2.2

45.00

39.33

u/l

1.06

302

Melanoma in situ of upper limb, including shoulder

2.01

1.52

2.3

2.6

39.43

41.75

u/l

0.18

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

226

1942

1.17

1.51

1.9

38.59

39.42

u/l

0.28

200

1706

Foreign body in respiratory tract

679

1.29

1.51

2.1

2.0

40.12

38.68

u/l

0.28

612

Benign neoplasm: Short bones of lower limb

124

1.74

1.50

1.4

2.5

34.48

40.28

u/l

0.71

115

Embedded and impacted teeth

451

3443

1.12

1.50

2.1

1.9

38.67

39.06

u/l

0.17

422

3218

Other diseases of peritoneum

583

1.32

1.50

1.7

2.0

40.70

39.28

u/l

0.23

513

Other and unspecified neuropathies

2.31

1.50

1.4

1.8

50.80

35.86

u/l

—

Other congenital malformations of skin

514

1.34

1.49

1.6

2.1

36.22

38.63

u/l

0.48

464

Rapidly progressive nephritic syndrome

2.64

1.49

2.4

1.6

30.89

47.02

u/l

—

Other deformities of toe(s)

428

1.37

1.49

1.6

2.1

42.23

39.13

u/l

0.60

386

Inguinal hernia

1168

7366

1.07

1.49

1.9

2.0

38.62

39.07

u/l

0.30

1011

6533

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

633

5394

0.91

1.48

1.7

1.9

39.70

38.83

u/l

0.45

556

4675

Effects of other external causes

386

1.39

1.48

3.1

2.1

42.07

39.75

u/l

0.33

358

UC patients in KELA-register (code 208), prior to 1994

620

1.30

1.48

2.0

38.51

39.85

u/l

0.23

549

Other conjunctival vascular disorders and cysts

302

1.45

1.48

3.1

2.2

42.76

40.08

u/l

0.43

264

Distal bite

366

1.40

1.47

1.7

2.0

38.82

39.50

u/l

0.11

341

Social disorders starting during childhood or adolescence

1.92

1.47

1.9

2.0

36.93

39.44

u/l

0.32

Pustular psoriasis

647

1.30

1.47

1.9

2.0

38.47

39.49

u/l

0.18

579

HSIL lesion of the vulva

204

1.55

1.46

1.7

2.1

34.13

39.94

u/l

0.72

183

Secondary polycythaemia

286

1.46

1.9

2.0

42.29

38.47

u/l

0.49

250

Benign neoplasm: Skin of ear and external auricular canal

421

1.37

1.45

1.7

1.9

36.29

39.88

u/l

0.73

361

Pathological resorption of teeth

379

1.39

1.45

2.1

36.37

39.52

u/l

0.65

341

Burns and corrosions

236

2044

1.16

1.44

2.0

42.95

39.10

u/l

1.70

220

1843

Benign neoplasm: Bronchus and lung

157

1.63

1.43

2.1

2.2

32.35

39.82

u/l

0.95

139

Malnutrition

213

1.53

1.43

1.3

2.1

39.85

39.26

u/l

0.05

183

Pre-eclampsia

377

3369

1.12

1.43

2.1

39.31

39.87

u/l

0.21

341

3098

Preterm labour and delivery

492

4459

1.11

1.43

2.2

2.1

41.33

39.87

u/l

0.87

441

4074

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

254

1.47

1.42

1.6

1.7

47.24

38.07

u/l

1.12

206

Other acute skin changes due to ultraviolet radiation

449

1.35

1.42

1.8

2.1

45.31

38.81

u/l

1.13

396

Melanocytic naevi of other and unspecified parts of face

100

801

1.26

1.42

1.8

2.0

38.57

39.26

u/l

0.18

725

Acquired keratosis [keratoderma] palmaris et plantaris

2.16

1.42

1.4

2.2

41.00

39.84

u/l

0.06

Benign neoplasm of other and unspecified female genital organs

571

1.31

1.42

1.8

2.0

40.24

39.63

u/l

0.08

503

Campylobacter enteritis

364

1.39

1.41

1.5

2.1

37.00

39.18

u/l

0.34

330

Other specified/unspecified hearing loss

121

990

1.23

1.41

1.8

37.34

39.10

u/l

0.46

114

866

Lesion of sciatic nerve

475

1.34

1.41

1.4

1.9

37.90

38.49

u/l

0.07

405

Family history of certain disabilities and chronic diseases leading to disablement

589

1.30

1.41

2.1

2.0

45.77

40.41

u/l

1.26

549

Dissection of aorta

330

1.41

1.40

1.8

1.9

33.05

38.59

u/l

1.22

290

Use of riluzole

2.29

1.40

1.1

2.2

39.00

41.07

u/l

—

Abdominal aortic aneurysm (AAA)

126

1027

1.22

1.40

1.3

1.6

36.33

37.59

u/l

0.28

108

840

Marasmic kwashiorkor

2.73

1.39

1.2

1.7

32.33

37.56

u/l

—

Multiple delivery

114

1389

0.81

1.37

1.8

2.1

40.20

40.47

u/l

0.06

103

1287

Unspecified dementia

926

0.79

1.36

1.3

1.7

34.24

38.05

u/l

0.65

762

Other melanin hyperpigmentation

257

1.46

1.36

1.2

2.0

35.22

39.73

u/l

0.55

226

Redundant prepuce, phimosis and paraphimosis

350

3110

1.12

1.36

2.2

2.1

38.90

39.49

u/l

0.19

302

2786

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

645

1.28

1.36

1.8

43.91

37.86

u/l

1.45

533

Cholesteatoma of middle ear

690

1.27

1.36

1.9

39.90

38.59

u/l

0.21

601

Other eating disorders

628

1.28

1.35

1.6

1.9

38.93

38.82

u/l

0.02

589

Bullous disorders

691

1.27

1.34

1.7

1.9

37.93

38.65

u/l

0.12

603

Antepartum haemorrhage, not elsewhere classified

156

1317

1.19

1.33

1.7

2.1

38.18

39.63

u/l

0.48

149

1248

Mental and behavioural disorders due to opioids

524

1.31

1.33

1.8

2.2

48.61

40.15

u/l

1.33

491

Intentional self-harm by sharp object

300

1.42

1.33

1.7

2.2

50.42

37.79

u/l

2.07

281

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

429

2901

0.90

1.33

1.7

1.8

38.16

37.81

u/l

0.12

365

2487

Other ill-defined and unspecified causes of mortality

625

0.73

1.32

1.4

1.8

33.80

38.60

u/l

0.74

533

Contusion of toe(s) without damage to nail

318

1.40

1.31

1.5

2.3

40.09

38.58

u/l

0.17

289

Other dermatomyositis

2.00

1.31

2.2

2.5

45.83

42.41

u/l

0.30

Schizoaffective disorder

1173

0.80

1.31

1.6

2.1

40.48

39.36

u/l

0.16

1073

Sequelae of injuries of neck and trunk

404

1.35

1.31

2.6

2.2

33.54

40.05

u/l

1.50

364

Recurrent dislocation of patella

658

1.27

1.30

1.9

2.2

38.22

39.29

u/l

0.23

624

Disorders of male genital organs in diseases classified elsewhere

1.84

1.30

1.8

2.2

39.85

39.63

u/l

0.01

Malignant neoplasm of respiratory system and intrathoracic organs

302

2466

1.13

1.30

1.7

37.06

38.03

u/l

0.37

262

2078

Struck by thrown, projected or falling objec

668

1.27

1.30

2.1

2.0

42.67

39.17

u/l

0.94

606

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

2.05

1.29

2.9

2.3

38.93

36.22

u/l

0.16

Pterygium

336

1.39

1.29

1.6

2.0

34.05

39.17

u/l

1.19

296

Benign neoplasm of other and unspecified female genital organs

580

1.29

1.8

1.9

40.24

39.86

u/l

0.05

512

Dislocation of lens

130

1.64

1.28

1.8

1.9

40.75

36.67

u/l

0.34

113

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

300

2666

1.13

1.28

1.7

2.0

40.54

39.31

u/l

0.42

262

2439

Other diseases of gallbladder

545

1.30

1.28

1.7

1.9

38.19

39.67

u/l

0.25

475

Delivery, wide proxy

563

3268

0.91

1.27

1.8

1.9

39.54

39.50

u/l

0.02

493

2901

L02BG Aromatase inhibitors

423

4661

0.90

1.26

1.8

2.0

41.98

40.11

u/l

1.12

374

4082

Pregnancy with abortive outcome

1372

6781

1.06

1.26

1.9

2.0

40.09

39.57

u/l

0.42

1250

6098

Mandibular retrognathia

109

893

1.23

1.25

1.8

2.0

42.53

40.02

u/l

0.75

102

828

Parapsoriasis

237

1.46

1.25

2.7

2.1

36.55

38.73

u/l

0.28

218

Use of selegiline

538

0.72

1.25

1.3

1.8

39.08

38.20

u/l

0.09

468

Congenital malformations of oesophagus

2.11

1.25

1.0

1.7

30.50

37.02

u/l

—

Chondromalacia

417

1.34

1.24

2.6

2.2

41.06

39.77

u/l

0.17

377

Artificial opening status

619

1.27

1.23

1.4

1.8

36.94

39.15

u/l

0.43

534

Vascular syndromes of brain in cerebrovascular disorders

522

1.30

1.23

1.4

2.0

34.36

38.59

u/l

1.21

452

Persistent delusional disorders

1097

0.81

1.23

1.8

1.9

36.64

39.55

u/l

0.85

984

Benign neoplasm: Vagina

181

1.52

1.21

1.4

2.3

41.88

40.07

u/l

0.14

162

Other and unspecified corneal deformities and disorders

427

1.33

1.21

2.0

2.1

39.49

39.43

u/l

0.01

377

Other lesions of median nerve

306

1.39

1.21

3.4

2.1

36.49

39.95

u/l

0.53

266

Benign neoplasm: Skin of trunk

577

1.28

1.21

2.4

1.9

39.90

38.64

u/l

0.22

512

Alcohol withdrawal state with delirium

973

0.80

1.20

1.5

1.9

42.73

38.98

u/l

0.71

851

Tic and related disorders

109

1.68

1.20

1.7

2.6

40.89

41.14

u/l

0.02

104

All dysplastic lesions of the cervix uteri, vagina or vulva

531

4849

1.09

1.20

2.2

2.1

39.53

39.67

u/l

0.06

494

4489

Melanoma in situ of upper limb, including shoulder

1.82

1.20

2.3

2.4

39.43

40.93

u/l

0.11

Other benign neoplasms of connective and other soft tissue

159

1360

1.18

1.19

2.0

41.58

38.83

u/l

1.04

148

1199

Carcinoma in situ of other and unspecified sites

341

1.36

1.19

1.3

1.7

37.27

38.59

u/l

0.20

277

Abnormal findings on antenatal screening of mother

131

1103

1.19

1.18

1.5

2.0

36.71

38.67

u/l

0.87

123

1049

Nontoxic diffuse goitre

385

1.34

1.18

1.7

2.0

41.67

39.30

u/l

0.41

341

Benign neoplasm of thyroid gland

429

1.32

1.18

2.2

2.1

35.84

39.79

u/l

0.91

382

Dislocation, sprain and strain of joint and ligaments of hip

430

1.32

1.16

1.4

1.8

35.48

38.96

u/l

0.91

382

Brain meningioma

652

1.25

1.16

1.6

1.9

33.31

39.61

u/l

2.95

572

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

100

1209

0.82

1.15

1.7

37.89

38.04

u/l

0.02

1011

Retained placenta and membranes, without haemorrhage

169

1952

0.86

1.14

2.4

2.0

39.86

40.30

u/l

0.12

154

1784

Contracture of joint

151

1.55

1.14

2.5

2.6

40.89

39.39

u/l

0.15

141

Sequelae of injuries of lower limb

162

1395

1.17

1.14

1.7

2.0

40.83

39.17

u/l

0.45

145

1262

Other osteochondropathies

125

1054

1.19

1.13

1.9

2.0

36.70

39.54

u/l

1.03

116

946

Mental and behavioural disorders due to sedatives or hypnotics

119

999

1.20

1.13

1.7

2.1

44.17

39.56

u/l

0.95

106

908

Foreign body or object entering through skin

109

908

1.21

1.13

2.1

2.0

39.55

39.27

u/l

0.05

818

Undefined dementia

919

0.81

1.13

1.3

1.6

34.24

37.21

u/l

0.46

758

Bulimia nervosa (incl. atypical)

441

1.30

1.12

1.5

2.0

38.33

38.01

u/l

0.04

411

Benign neoplasm: Skin of ear and external auricular canal

441

1.30

1.12

1.7

2.0

36.29

38.53

u/l

0.39

388

Delivery

703

3996

0.93

1.12

1.8

1.9

39.01

39.63

u/l

0.38

629

3568

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

267

2381

1.13

1.11

1.8

39.34

38.51

u/l

0.25

230

2009

Lymphangioma, anys site

1.77

1.11

1.9

2.4

38.93

42.90

u/l

0.34

Malignant neoplasm of breast, HER-negative

282

3142

0.89

1.11

2.0

41.13

39.63

u/l

0.65

240

2738

Alcohol dependence

405

4435

0.91

1.10

1.6

2.0

40.93

38.97

u/l

0.96

355

3933

Other disorders of breast and lactation associated with childbirth

219

1.44

1.09

2.0

2.1

35.70

41.11

u/l

0.97

205

Inflammatory disorders of breast

103

857

1.21

1.09

2.0

1.9

39.03

38.67

u/l

0.07

779

Disorders in reading

169

1.50

1.09

2.3

2.0

39.65

40.08

u/l

0.04

159

Amblyopia ex anopsia

461

1.29

1.08

1.7

2.1

41.42

39.05

u/l

0.38

417

Other specified/unspecified disorders of ear

2.20

1.08

1.3

2.1

40.29

46.04

u/l

—

Noise effects on inner ear

542

1.27

1.08

1.9

1.8

33.82

38.84

u/l

1.37

481

Pustulosis palmaris et plantaris

578

1.26

1.07

2.0

38.68

39.07

u/l

0.06

515

Behavioural disorders, excluding more controls

219

1.43

1.07

2.5

35.77

40.45

u/l

0.62

206

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

337

0.67

1.07

1.7

2.0

38.40

40.31

u/l

0.14

294

Exposure to excessive natural cold

122

0.48

1.07

1.3

2.0

53.67

37.82

u/l

—

106

Achalasia of cardia

203

1.45

1.07

1.9

43.43

38.85

u/l

0.79

179

Open wound of shoulder and upper arm

237

1.41

1.06

1.6

2.1

40.48

39.70

u/l

0.08

212

Benign neoplasm: Lip

237

1.41

1.06

1.8

2.1

40.85

39.15

u/l

0.21

206

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

1164

0.83

1.06

1.7

37.81

38.13

u/l

0.05

969

HSIL lesion of the vagina

179

1.48

1.05

1.7

2.3

39.95

39.53

u/l

0.04

162

Malignant neoplasm of urinary organs

139

1192

1.17

1.05

1.5

1.8

36.62

38.26

u/l

0.40

118

1009

Thyrotoxicosis with toxic multinodular goitre

770

1.22

1.04

1.6

1.9

35.99

39.31

u/l

0.94

676

Parodontitis or/and operation codes

1407

7968

1.05

1.04

2.0

2.1

40.09

39.72

u/l

0.25

1244

7236

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

134

1562

0.85

1.04

1.6

1.8

39.16

38.40

u/l

0.15

118

1313

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

155

1342

1.16

1.04

2.1

2.0

37.68

39.96

u/l

0.88

142

1221

Carcinoma in situ of skin

110

927

1.19

1.03

1.9

1.8

37.68

38.97

u/l

0.19

787

Right hemicolectomy

690

1.23

1.02

1.8

37.84

38.38

u/l

0.09

598

Use of ropinirole

472

0.73

1.02

1.8

1.9

33.27

39.24

u/l

1.56

409

Intermittent heterotropia

708

1.22

1.02

2.1

2.0

40.70

39.79

u/l

0.16

647

HSIL lesion of the cervix uteri

317

2873

1.11

1.02

2.3

2.1

39.36

39.51

u/l

0.05

296

2697

Chalazion

182

1597

1.15

1.01

2.2

1.9

38.59

39.09

u/l

0.13

158

1434

Injury of muscle and tendon at hip and thigh level

158

1374

1.16

1.00

1.9

39.18

39.24

u/l

0.01

144

1227

Single spontaneous delivery

701

3990

0.93

1.00

1.8

1.9

39.21

39.63

u/l

0.23

627

3563

Contusion of ankle

530

1.26

1.00

2.0

2.1

42.23

38.92

u/l

0.65

482

Parkinson's disease, excluding more controls

167

1421

1.15

0.99

1.5

1.7

37.55

38.13

u/l

0.15

142

1205

Endometriosis diagnosis and infertility diagnosis occurring together

186

1638

1.14

0.99

1.6

2.0

38.76

39.00

u/l

0.07

172

1527

Acute alcohol intoxication

368

4022

0.91

0.99

1.6

1.9

40.51

38.62

u/l

0.77

324

3566

Necrotizing fasciitis

1.91

0.99

1.4

2.6

35.10

39.16

u/l

—

Retinal haemorrhage

275

1.36

0.99

1.2

1.9

35.63

38.63

u/l

0.44

244

Cholera

558

1.25

0.98

2.6

2.0

43.97

39.42

u/l

1.26

489

Benign neoplasm of male genital organs

241

1.39

0.98

1.8

35.90

38.86

u/l

0.32

215

Chronic myeloproliferative disease

157

1.49

0.98

1.1

2.0

32.29

39.36

u/l

0.64

138

Burns and corrosions of external body surface, specified by site

177

1555

1.14

0.98

1.9

42.91

39.15

u/l

1.37

166

1403

Caught, crushed, jammed or pinched in or between objects

667

1.22

0.98

2.2

2.0

43.07

39.31

u/l

0.64

599

Malignant neoplasm of kidney, except renal pelvis

130

1117

1.17

0.97

1.6

1.8

37.29

38.66

u/l

0.30

112

946

Other and unspecified acute skin changes due to ultraviolet radiation

302

1.34

0.97

1.7

2.0

45.64

38.84

u/l

0.88

261

Injury of muscle and tendon at wrist and hand level

230

2057

1.12

0.96

2.1

2.0

41.03

39.46

u/l

0.50

206

1838

Complications of labour and delivery

1173

6871

0.95

0.94

2.0

39.56

39.81

u/l

0.17

1074

6224

Enteritis due to Yersinia enterocolitica

1.86

0.94

1.3

2.1

38.60

45.09

u/l

—

Other and unspecified disease of Bartholin gland

383

1.29

0.94

1.6

2.0

40.15

39.91

u/l

0.03

341

Other specified disorders of external ear

472

1.26

0.94

1.2

1.9

37.61

38.65

u/l

0.19

413

Abscess of Bartholin gland

357

1.30

0.93

2.0

2.1

38.68

40.31

u/l

0.30

331

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

226

2025

1.12

0.92

1.9

38.59

39.59

u/l

0.36

200

1799

Lymphangioma, anys site

1.66

0.92

1.9

2.3

38.93

42.58

u/l

0.31

Tic disorders

118

1.55

0.92

1.7

2.1

40.89

40.98

u/l

0.01

110

Attention to artificial openings

411

1.28

0.91

1.4

1.9

31.27

40.18

u/l

2.30

361

Other misadventures during surgical and medical care

262

1.35

0.91

2.2

2.0

38.20

39.08

u/l

0.10

233

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

142

1237

1.15

0.90

1.6

1.8

39.35

38.56

u/l

0.16

124

1049

Enterobiasis

1.95

0.90

2.4

1.8

37.79

36.89

u/l

—

Hypertrophy of bone

1.92

0.89

3.1

1.3

47.10

41.92

u/l

—

Foreign body entering into or through eye or natural orifice

132

1146

1.16

0.89

2.2

1.9

41.42

38.72

u/l

0.80

118

1024

Pneumonitis due to solids and liquids

105

895

1.18

0.89

2.0

1.9

39.83

38.07

u/l

0.32

775

Cachexia

1.90

0.88

1.5

1.9

39.13

40.61

u/l

—

Pedal cyclist injured in other and unspecified transport accidents

180

1597

1.13

0.88

1.7

1.9

38.78

39.04

u/l

0.06

160

1443

Ectropion of eyelid

360

1.29

0.88

1.5

1.7

34.73

37.68

u/l

0.46

300

Emotional disorders starting during childhood or adolescence

517

1.23

0.87

1.3

1.8

35.52

39.17

u/l

1.01

490

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

120

1.53

0.87

1.9

34.89

38.39

u/l

0.24

105

Foreign body in genitourinary tract

120

1.53

0.87

2.1

2.0

45.32

39.73

u/l

0.43

106

Parkinson's disease, strict definition, excluding more controls

153

1318

1.14

0.87

1.4

1.7

37.19

38.02

u/l

0.20

129

1114

Colorectal adenocarcinoma

233

2581

0.90

0.86

1.8

1.7

38.54

38.17

u/l

0.09

207

2192

Polymorphous light eruption

104

1.57

0.86

2.1

2.2

47.81

40.41

u/l

0.46

D07AA Corticosteroids, weak (group I)

248

2241

1.11

0.86

1.8

1.9

42.72

38.80

u/l

2.43

222

2046

Gilbert syndrome

1.60

0.86

1.6

1.9

39.73

41.52

u/l

0.14

Parkinson's disease, including avohilmo

174

1958

0.89

0.86

1.5

1.7

37.28

38.20

u/l

0.26

149

1663

Pregnancy examination and test

302

1719

1.10

0.85

2.0

38.86

39.61

u/l

0.31

282

1617

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

533

1.23

0.85

1.4

1.9

37.77

39.11

u/l

0.21

448

Open wound of abdomen, lower back and pelvis

407

1.26

0.85

1.7

2.1

36.31

38.97

u/l

0.45

370

Alzheimer’s disease (Atypical or mixed), excluding more controls

550

0.80

0.84

1.5

31.87

37.27

u/l

0.81

447

Parkinson's disease

167

1880

0.89

0.83

1.5

1.8

37.55

38.09

u/l

0.14

142

1594

Disorders of speech understanding and production

391

1.26

0.83

1.3

2.0

32.61

38.94

u/l

1.76

356

Alcohol abuse, main dg, excluding more controls

240

2173

1.11

0.83

1.5

2.0

39.82

39.37

u/l

0.11

212

1947

Lack of expected normal physiological development

112

1.49

0.83

1.0

1.4

37.89

40.19

u/l

0.22

106

Lumbosacral plexus disorders

1.75

0.82

5.0

2.7

31.54

42.14

u/l

—

Benign lipomatous neoplasm of other sites/unspecified

134

1174

1.15

0.81

2.1

1.8

37.68

38.61

u/l

0.24

121

1023

severe traumatic brain injury, does not include concussion

319

2931

1.09

0.81

1.6

1.8

39.95

38.48

u/l

0.57

267

2525

L02BX Other hormone antagonists and related agents

576

0.79

0.81

1.6

38.54

36.52

u/l

0.29

481

Other and unspecified nonorganic psychotic disorders

290

3165

0.91

0.81

1.6

2.0

39.45

39.38

u/l

0.02

249

2905

Systemic sclerosis,strict definition

131

1.48

0.80

1.5

2.6

42.68

41.50

u/l

0.10

115

Benign neoplasm: Skin, unspecified

501

1.23

0.80

2.3

2.0

40.81

38.64

u/l

0.32

437

Slow fetal growth and fetal malnutrition

0.00

0.79

0.0

1.2

—

36.92

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.4

—

36.05

—

Conduct disorder

251

1.33

0.79

2.4

2.1

35.29

39.30

u/l

0.54

233

Benign neoplasm of thyroid gland

457

1.24

0.78

2.2

35.84

39.29

u/l

0.76

405

Other viral hepatitis

110

954

1.16

0.78

1.8

2.1

46.95

40.00

u/l

1.60

101

880

Non-small cell lung cancer, squamous, helper endpoint

451

0.77

0.78

1.2

1.7

34.64

37.80

u/l

0.44

378

Non-small cell lung cancer, squamous

451

0.77

0.78

1.2

1.7

34.64

37.80

u/l

0.44

378

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

513

4439

0.94

0.78

1.9

2.1

41.89

40.24

u/l

1.12

456

3957

Congenital malformations of heart and great arteries

199

1735

1.11

0.78

1.6

1.9

36.84

39.40

u/l

1.08

168

1570

Myocardial infarction, with ST-elevation

243

2211

1.10

0.78

1.8

1.7

37.24

38.15

u/l

0.25

201

1878

Carcinoma in situ of other and unspecified genital organs

218

1.35

0.76

3.6

2.2

40.39

40.67

u/l

0.02

194

Unspecified abortion

780

1.17

0.76

2.2

2.1

43.89

40.23

u/l

1.14

718

Tic and related disorders

124

1.47

0.76

1.7

2.3

40.89

40.76

u/l

0.01

115

Oesophageal obstruction

405

1.24

0.75

1.5

1.9

41.11

38.91

u/l

0.30

342

Other specified and unspecified personality disorders

158

1409

1.13

0.75

2.0

42.66

38.91

u/l

1.27

143

1294

Normotensive glaucoma

115

1005

1.15

0.74

1.9

1.7

39.70

38.65

u/l

0.21

101

869

Carcinoma in situ of other and unspecified genital organs

219

1.34

0.74

3.6

2.3

40.39

40.73

u/l

0.02

193

Dental caries 3 and operation codes, only avohilmo

682

3238

1.06

0.74

1.8

1.9

38.04

39.34

u/l

1.04

620

2956

Specific development disorders of speech and language

627

1.19

0.74

1.6

2.0

33.72

39.76

u/l

2.45

581

Parkinson's disease, strict definition

153

1715

0.89

0.74

1.4

1.7

37.19

38.02

u/l

0.21

129

1453

Malignant neoplasm of penis

1.84

0.74

1.1

2.4

31.89

38.49

u/l

—

Contraceptive management

863

5780

1.05

0.74

2.0

2.2

40.11

39.95

u/l

0.08

793

5298

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

1.71

0.74

1.3

2.4

31.40

44.49

u/l

—

Accidental poisoning by and exposure to other gases and vapours

1.66

0.73

1.9

2.1

33.64

39.37

u/l

0.40

Diabetes mellitus in pregnancy

614

3759

1.06

0.73

2.2

2.1

39.61

39.48

u/l

0.06

569

3549

Bacterial meningitis

480

1.22

0.72

1.9

2.1

38.79

39.47

u/l

0.10

430

Left hemicolectomy

273

1.29

0.72

2.3

1.9

39.19

38.32

u/l

0.08

235

Female infertility, tubal origin

682

1.18

0.72

1.5

2.1

42.13

39.65

u/l

0.56

641

Cyst of Bartholin Gland

535

1.21

0.72

1.9

2.1

43.22

39.50

u/l

1.02

490

Inguinal or femoral hernia, bilateral

159

1423

1.12

0.72

1.8

34.86

37.82

u/l

1.17

138

1238

Emergency coronary revascularization (for ACS)

822

6197

0.95

0.72

1.6

1.8

35.82

38.66

u/l

2.93

679

5298

Inguinal hernia, bilateral

156

1395

1.12

0.71

1.8

1.7

34.97

37.79

u/l

1.06

135

1213

Evidence of alcohol involvement determined by blood alcohol level

205

0.67

0.71

1.1

2.2

44.57

39.49

u/l

0.42

190

Gestational [pregnancy-induced] hypertension

467

4376

1.07

0.70

2.3

2.0

39.72

39.70

u/l

0.01

429

4058

Congenital musculoskeletal deformities of head, face, spine and chest

144

0.62

0.70

1.8

1.9

35.11

39.55

u/l

—

133

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

105

917

1.15

0.70

1.7

2.0

42.15

39.67

u/l

0.40

846

Secondary parkinsonism+Parkinsonism in other disease

310

1.27

0.70

1.4

2.1

35.21

39.21

u/l

0.80

275

Complications predominantly related to the puerperium

468

4397

1.07

0.70

1.9

2.1

38.86

39.73

u/l

0.51

430

4060

Progressive vascular leukoencephalopathy

301

1.27

0.70

2.3

1.8

39.68

38.14

u/l

0.20

256

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.90

0.69

4.8

2.7

39.20

49.14

u/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

127

1.44

0.69

1.9

2.1

34.89

38.34

u/l

0.24

114

Scabies

602

1.19

0.69

1.5

2.1

40.41

39.45

u/l

0.17

543

Varus deformity, not elsewhere classified

144

1.41

0.69

1.9

2.3

38.75

39.26

u/l

0.06

135

Other complications of labour and delivery, not elsewhere classified

143

1542

0.89

0.69

1.7

1.9

39.12

38.37

u/l

0.20

133

1465

Acute appendicitis, with complications

340

3162

1.08

0.69

1.8

2.0

38.57

39.20

u/l

0.22

300

2815

Malignant neoplasm of bronchus and lung

244

2093

1.09

0.68

1.6

1.7

37.37

37.87

u/l

0.15

206

1764

Other intracranial haemorrhages

311

1.26

0.68

1.8

2.0

37.25

37.86

u/l

0.07

265

Acromegaly and pituitary gigantism

0.53

0.68

3.0

2.5

37.20

42.72

u/l

—

Other and unspecified injuries of head

789

1.16

0.68

1.4

1.9

40.99

39.16

u/l

0.33

698

Thromboangiitis obliterans

1.66

0.68

2.1

1.9

28.71

39.28

u/l

—

All dysplastic lesions of the vagina

357

1.24

0.67

2.1

42.35

40.01

u/l

0.35

316

Acute and transient psychotic disorders

168

1859

0.90

0.67

1.8

2.0

36.76

39.49

u/l

1.07

142

1697

Other benign neoplasms of connective and other soft tissue

159

1431

1.12

0.67

2.0

1.9

41.58

39.01

u/l

0.94

148

1277

Disorder of external ear, unspecified

421

1.22

0.67

1.7

2.0

37.52

39.11

u/l

0.27

378

Venous complications and haemorrhoids in pregnancy

250

1.29

0.67

1.4

2.3

39.37

40.66

u/l

0.14

232

Other and specified injuries of hip and thigh

259

1.29

0.66

1.7

2.1

37.00

39.48

u/l

0.36

229

Hypertrichosis

277

1.28

0.66

1.6

2.1

42.71

39.96

u/l

0.22

259

Other congenital malformations of urinary system

1.61

0.66

1.1

1.5

35.14

36.50

u/l

—

Mental retardation, excluding more controls

397

1.22

0.65

2.1

2.2

44.82

41.17

u/l

0.54

362

Fracture of forearm

1015

9132

1.04

0.64

1.8

2.0

39.92

39.66

u/l

0.16

889

8110

Atrial septal defect

457

1.20

0.63

1.7

2.0

37.33

39.95

u/l

0.49

415

Whooping cough

1.58

0.63

2.0

1.9

37.73

38.38

u/l

0.05

Pediculosis, acariasis and other infestations

804

1.15

0.63

1.4

2.0

39.42

39.31

u/l

0.02

728

Oral leukoplakia and related diseases

739

1.16

0.63

1.8

1.9

41.02

38.79

u/l

0.48

646

Erythema in diseases classified elsewhere

1.71

0.62

1.0

1.8

44.20

36.10

u/l

—

Renal agenesis and other reduction defects of kidney

1.63

0.62

2.3

1.8

43.25

40.50

u/l

—

LSIL lesion of the cervix uteri, vagina or vulva

235

2166

1.09

0.62

2.4

2.1

40.40

39.08

u/l

0.50

224

2011

Benign neoplasm: Lip

262

1.27

0.62

1.8

2.1

40.85

38.36

u/l

0.33

231

Malignant neoplasm of ureter

0.00

0.61

0.0

1.5

—

31.83

—

Sulfonylureas

545

4124

1.06

0.61

1.9

1.7

38.20

38.98

u/l

0.32

440

3514

Carcinoma in situ of oral cavity

0.00

0.61

0.0

1.8

—

38.13

—

Other benign neoplasms of uterus

651

0.84

0.61

1.4

1.8

35.84

40.06

u/l

0.94

553

Benign neoplasm: Tongue

326

1.24

0.60

2.4

2.0

40.83

40.18

u/l

0.07

282

Other disorders of carbohydrate metabolism

1.56

0.60

1.6

2.2

51.13

39.01

u/l

—

Behavioural disorders

245

1.27

0.60

2.5

2.1

35.77

38.91

u/l

0.38

228

Single delivery by caesarean section

317

1966

0.93

0.60

1.8

2.0

38.02

39.91

u/l

1.25

305

1847

Placenta praevia

661

0.84

0.60

2.3

2.1

35.55

39.76

u/l

1.19

616

Other infective (teno)synovitis

1.54

0.59

1.4

2.3

28.75

42.22

u/l

—

Obstructed labour due to maternal pelvic abnormality

240

2591

0.92

0.58

2.5

2.1

38.93

40.37

u/l

0.59

223

2348

Premenstrual syndrome

132

1.38

0.58

1.8

2.1

42.83

39.79

u/l

0.35

125

Colorectal cancer

295

3159

0.93

0.58

1.7

1.8

38.50

38.48

u/l

0.01

261

2691

Schizophrenia or delusion, excluding more controls

479

5013

0.95

0.57

1.7

2.1

38.78

39.45

u/l

0.27

412

4553

Poor fetal growth

167

1830

0.91

0.57

1.9

2.1

38.04

38.93

u/l

0.27

161

1730

Other benign neoplasm of uterus: Cervix uteri

0.57

1.0

2.6

29.40

41.58

u/l

—

Carcinoma in situ of uteri, other/unspecified

0.57

1.0

2.6

36.80

41.29

u/l

—

All dysplastic lesions of the cervix uteri

449

4240

1.06

0.57

2.2

2.1

38.60

39.57

u/l

0.57

422

3949

Memory loss

129

1162

1.11

0.56

1.6

1.8

40.02

38.84

u/l

0.27

104

987

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

252

2341

1.08

0.56

1.5

1.9

38.74

38.62

u/l

0.03

215

2005

Palatinal maxillary operation

1.47

0.56

1.0

1.1

31.75

32.40

u/l

—

Hydrocele

164

1496

1.10

0.56

1.6

1.8

37.28

38.21

u/l

0.24

142

1285

Laparoscopic right hemicolectomy

682

1.15

0.55

2.1

1.8

40.39

39.11

u/l

0.18

588

Cerebral atherosclerosis

107

1.41

0.55

1.2

1.8

31.73

39.51

u/l

1.30

Endovascular or surgical operations to intracerebral aneurysms

852

1.13

0.55

1.6

1.9

38.41

39.47

u/l

0.16

753

Carcinoma in situ of cervix uteri, endocervix

151

1.34

0.55

3.5

2.2

41.40

38.47

u/l

0.32

141

Alcohol-induced acute pancreatitis

488

1.18

0.54

1.4

2.0

41.91

39.36

u/l

0.37

435

Malignant neoplasm of eye, brain and central nervous system

553

1.16

0.54

1.7

2.0

32.54

39.25

u/l

2.11

494

Specific development disorders of scholastic skills

473

1.18

0.53

2.3

2.1

39.38

40.04

u/l

0.10

449

Congenital malformations of ovaries, fallopian tubes and broad ligaments

807

1.13

0.53

1.9

2.1

37.63

39.16

u/l

0.39

749

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

0.61

0.53

1.0

2.3

30.50

42.00

u/l

—

Contact with machinery

173

1589

1.09

0.53

2.2

1.9

38.90

38.74

u/l

0.03

155

1397

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

337

3432

0.94

0.51

2.0

41.02

40.00

u/l

0.45

290

3025

Torsion of testis

258

0.77

0.51

2.0

2.1

45.00

39.57

u/l

0.39

240

Other endocrine disorders

553

1.15

0.50

1.7

1.9

40.73

38.91

u/l

0.31

506

Acute alcohol intoxication, ICD10

293

3118

0.94

0.50

1.5

1.9

41.04

38.93

u/l

0.75

261

2798

Glaucoma secondary to eye trauma

1.45

0.50

3.6

2.1

39.92

38.21

u/l

0.13

Benign neoplasm: Skin, unspecified

529

1.16

0.50

2.3

1.9

40.81

38.95

u/l

0.27

466

Type 1 diabetes, definitions combined

160

1465

1.09

0.50

2.3

2.0

44.60

39.65

u/l

2.12

142

1377

Other obstructed labour

127

1154

1.10

0.50

2.0

2.1

37.79

40.00

u/l

0.68

118

1060

Calculus of lower urinary tract

623

1.14

0.49

1.7

1.8

38.80

37.67

u/l

0.19

525

Disorders of tooth development and eruption

579

1.15

0.49

1.8

2.1

39.96

40.14

u/l

0.03

530

Normal-pressure hydrocephalus

529

0.85

0.49

1.6

1.7

35.09

37.75

u/l

0.46

450

Antenatal screening

402

2388

0.95

0.49

2.1

39.86

39.87

u/l

0.01

381

2240

Medical treatment for female infertility

327

3454

0.94

0.48

1.8

2.2

40.12

39.51

u/l

0.27

314

3252

Car occupant injured in noncollision transport accident

503

1.16

0.48

1.8

2.1

35.02

39.74

u/l

1.22

458

Mandibular hypoplasia

1.43

0.48

1.8

2.6

42.08

41.28

u/l

0.08

Malignant neoplasm of stomach

570

0.86

0.47

1.4

1.8

39.46

38.77

u/l

0.08

484

Hirsutism in women

245

1.23

0.47

1.7

2.2

42.92

39.67

u/l

0.24

228

Paralytic ileus

420

1.17

0.47

1.7

2.0

42.49

39.11

u/l

0.40

370

Migraine, unspecified, drug-induced

1.40

0.47

3.1

2.1

35.08

40.02

u/l

0.33

Crowding of teeth, including avohilmo

119

892

1.10

0.46

1.9

1.8

38.64

39.37

u/l

0.18

111

835

Carcinoma in situ of uteri, other/unspecified

0.58

0.46

1.0

2.1

36.80

40.80

u/l

—

Unspecified lump in breast

260

2443

1.07

0.46

1.9

2.1

40.27

39.81

u/l

0.13

235

2176

Symptoms and signs involving appearance and behaviour

103

1.38

0.46

1.6

2.1

37.86

40.99

u/l

0.34

Secondary parkinsonism

311

1.20

0.45

1.4

2.0

35.79

39.30

u/l

0.64

276

Malignant neoplasm of bladder

742

1.12

0.45

1.8

1.7

33.93

37.13

u/l

0.61

619

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

1.39

0.44

1.2

2.4

39.44

39.31

u/l

0.01

Erosion and ectropion of cervix uteri

349

1.18

0.44

2.0

1.9

44.36

40.22

u/l

0.64

310

Maltreatment syndromes

754

1.12

0.43

2.3

2.2

45.14

40.15

u/l

1.09

708

Chronic myringitis

1.45

0.43

1.0

2.3

26.65

39.48

u/l

—

Pervasive developmental disorders excl. Autism + Asperger

0.65

0.42

1.5

1.8

39.33

38.02

u/l

—

Congenital malformations of spine and bony thorax

1.45

0.42

3.6

2.6

51.40

40.38

u/l

—

Carcinoma in situ of cervix uteri, exocervix

1.37

0.42

2.9

2.3

36.38

40.01

u/l

0.36

Speech and linguistic disorders

115

1008

1.10

0.42

1.9

37.07

39.87

u/l

1.02

942

Other and unspecified injuries of neck

1.37

0.42

2.0

2.2

37.92

40.18

u/l

0.25

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

303

3196

0.95

0.42

1.5

1.9

37.29

38.56

u/l

0.54

271

2752

Viral hepatitis

122

1119

1.09

0.42

2.0

46.57

39.73

u/l

1.72

111

1022

Supervision of high-risk pregnancy

394

2270

1.05

0.41

2.1

39.74

39.80

u/l

0.02

370

2127

Cardiovascular disorders originating in the perinatal period

0.00

0.41

0.0

1.4

—

39.00

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

159

1.27

0.41

2.1

2.3

41.13

39.83

u/l

0.08

135

Hereditary sideroblastic anaemia

1.49

0.41

1.0

2.3

46.80

42.47

u/l

—

Peripheral retinal degeneration

427

1.15

0.40

2.7

2.0

45.98

39.12

u/l

1.90

388

Childhood allergy (age < 16)

201

1550

1.07

0.40

1.6

1.7

39.13

38.80

u/l

0.09

184

1480

Contact with sharp glass

540

1.13

0.40

1.6

2.1

37.38

40.55

u/l

0.74

493

Other benign neoplasms of uterus

624

0.88

0.40

1.4

1.9

35.84

39.27

u/l

0.70

537

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

1.35

0.40

3.2

2.3

34.92

39.11

u/l

0.44

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

1.44

0.39

1.4

1.8

27.80

37.76

u/l

—

Other abortion

115

1.32

0.39

1.5

2.4

30.80

41.58

u/l

2.36

103

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

115

1.32

0.39

2.7

2.2

31.40

40.93

u/l

—

101

Use of levodopa decarboxylase inhibitor

147

1582

0.93

0.39

1.4

1.7

36.56

37.87

u/l

0.36

123

1334

Maternal care for known or suspected abnormality of pelvic organs

417

3004

0.96

0.38

2.0

2.1

39.24

39.60

u/l

0.16

389

2812

Certain conditions originating in the perinatal period

108

877

1.09

0.38

2.0

1.9

41.34

39.63

u/l

0.40

100

820

Carcinoma in situ of other and unspecified sites

401

1.15

0.38

1.3

1.7

37.27

38.09

u/l

0.12

343

malignant neoplasm of female genital organs

192

2045

0.94

0.38

2.0

1.9

38.43

39.91

u/l

0.46

167

1784

Epidural haemorrhage

1.36

0.38

1.8

40.81

36.71

u/l

0.19

Gonococcal infection

462

0.86

0.38

1.5

2.2

40.53

39.31

u/l

0.14

421

Cleft palate

136

0.73

0.38

1.9

2.0

37.20

41.21

u/l

—

125

Carcinoma in situ, bladder

317

1.17

0.38

1.4

1.7

36.55

38.49

u/l

0.25

258

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

143

1328

1.08

0.38

1.8

39.26

38.11

u/l

0.25

126

1095

Clear cell adenocarcinoma of kidney

581

1.12

0.38

1.4

1.9

37.77

38.62

u/l

0.12

501

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

1.32

0.37

2.9

2.5

41.33

40.87

u/l

—

Malignant neoplasm of ovary

588

0.88

0.37

1.7

1.9

40.46

40.00

u/l

0.06

517

Disorders of psychological development

159

1375

1.07

0.37

1.8

1.9

36.89

39.66

u/l

1.24

140

1286

Fistulae involving female genital tract

171

1.24

0.36

2.5

1.9

38.28

39.89

u/l

0.13

149

Corneal pigmentations and deposits

1.45

0.36

1.0

1.6

35.67

40.76

u/l

—

Multiple gestation

134

1441

0.93

0.36

1.9

2.2

37.46

40.28

u/l

1.13

127

1360

Congenital malformations of genital organs

142

1315

1.08

0.35

2.1

2.0

38.12

38.64

u/l

0.13

130

1220

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

1.41

0.35

2.0

2.4

32.67

42.19

u/l

—

Dental caries 1 and operation codes, only avohilmo

571

2770

1.04

0.35

1.9

38.52

39.09

u/l

0.31

516

2529

Supernumerary teeth EXCLUDE clefts and syndromes

1.38

0.35

1.2

2.0

37.33

36.76

u/l

—

Other abnormal products of conception

612

3945

1.03

0.34

2.1

2.0

37.92

39.71

u/l

1.81

588

3667

Postpartum haemorrhage due to anatomy

149

1393

1.07

0.34

1.9

2.0

39.34

38.65

u/l

0.18

138

1309

Abnormalities of forces of labour

161

1716

0.94

0.34

2.1

40.22

40.01

u/l

0.06

151

1608

Osteopathy in diseases classified elsewhere

1.34

0.34

1.8

2.6

39.08

40.94

u/l

0.10

Pyogenic granuloma

209

1.20

0.34

2.3

1.9

33.90

39.28

u/l

0.77

188

Maternal care for other known or suspected fetal problems

427

2633

1.04

0.34

1.9

2.0

38.45

39.45

u/l

0.53

409

2488

489

1.12

0.34

2.0

1.8

37.54

37.85

u/l

0.03

418

Type 1 diabetes, strict (exclude DM2)

156

1459

1.07

0.33

2.2

2.0

44.46

39.66

u/l

1.97

139

1373

Oher contracture of tendon (sheath)

1.32

0.33

1.0

2.6

51.17

37.19

u/l

—

Benign neoplasm: Floor of mouth

1.32

0.33

1.3

2.1

44.78

42.60

u/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

606

1.11

0.33

1.9

2.0

38.97

39.17

u/l

0.03

539

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

403

0.87

0.33

1.2

1.7

34.64

38.66

u/l

0.59

326

Gestational diabetes (for exclusion)

675

4634

1.03

0.33

2.3

2.0

38.94

39.39

u/l

0.25

626

4356

Intracerebral haemorrhage

136

1455

0.93

0.33

1.7

1.8

39.21

38.74

u/l

0.07

115

1239

Pregnancy, childbirth and the puerperium

502

2721

0.96

0.32

1.7

1.8

38.86

39.27

u/l

0.18

436

2406

Right ventricular outflow tract obstruction

1.36

0.32

2.0

1.9

39.60

38.50

u/l

—

Supervision of normal pregnancy

390

2320

0.96

0.32

2.0

2.1

38.58

39.76

u/l

0.72

371

2179

Other inflammation of vagina/vulva

483

1.12

0.32

2.0

2.1

41.50

39.54

u/l

0.35

449

Malignant neoplasm of head and neck

110

1020

1.08

0.32

1.6

1.8

37.86

38.47

u/l

0.10

871

Other maltreatment syndromes

493

1.12

0.32

1.8

2.1

43.77

39.16

u/l

0.75

453

Benign neoplasm: Tongue

351

1.15

0.32

2.4

2.1

40.83

40.51

u/l

0.03

307

Postpartum haemorrhage due to retained placenta

174

1844

0.94

0.32

1.9

2.1

37.95

39.50

u/l

0.54

160

1725

Other benign neoplasm of uterus: Other parts/unspecified

475

0.88

0.32

1.3

1.9

34.21

40.64

u/l

1.37

392

Congenital malformations of aortic and mitral valves

538

0.89

0.31

2.0

2.1

34.20

40.20

u/l

1.21

484

Acute alcohol intoxication ICD-9

443

0.88

0.31

1.5

2.0

41.89

38.80

u/l

0.28

393

Unspecified mental disorder

760

7399

1.03

0.31

1.7

2.1

38.51

39.44

u/l

0.62

673

6697

Crushed, pushed or stepped on by crowd or human stampede

109

1013

1.08

0.31

1.7

2.0

38.16

39.95

u/l

0.38

100

939

Other disorders of amniotic fluid and membranes

225

2121

1.05

0.31

1.9

2.1

39.28

39.69

u/l

0.14

213

2003

Crushing injury of wrist and hand

207

0.82

0.30

2.6

2.2

42.41

39.02

u/l

0.35

189

Other and unspecified myoneural disorders

1.29

0.30

1.3

2.3

26.71

40.51

u/l

—

Twin gestation

130

1387

0.94

0.30

1.9

2.2

37.17

40.30

u/l

1.31

123

1310

Diving or jumping into water causing injury other than drowning or submersion

1.28

0.30

2.0

1.8

46.57

42.61

u/l

—

Open wound of hip and thigh

429

1.12

0.30

1.6

2.1

37.28

39.46

u/l

0.29

396

Postpartum haemorrhage

413

3724

0.96

0.30

2.0

39.12

39.46

u/l

0.14

382

3478

Failed attempted abortion

157

1.22

0.30

1.8

2.3

40.00

40.25

u/l

0.02

146

Other and unspecified abdominal hernia

515

1.11

0.30

1.8

1.9

35.31

38.52

u/l

0.66

454

Other menopausal disorders

495

2760

1.03

0.30

1.9

2.1

38.60

40.48

u/l

1.53

451

2481

Long labour

399

3610

0.96

0.29

2.2

2.0

39.66

39.61

u/l

0.02

377

3367

Use of galantamine

619

0.90

0.29

1.3

1.6

34.08

37.59

u/l

0.61

503

Contact with heat and hot substances

708

1.09

0.29

1.5

2.0

42.20

39.40

u/l

0.48

638

Contact with hypodermic needle

1.33

0.28

1.2

2.2

29.50

40.68

u/l

—

Cleft lip, lip and palate or palate

216

0.83

0.28

1.9

2.1

34.11

39.31

u/l

1.06

196

Malignant neoplasm of liver and intrahepatic bile ducts

317

1.14

0.28

1.2

1.8

43.84

36.87

u/l

0.79

276

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.28

0.28

2.3

2.1

38.00

44.89

u/l

—

Embolic stroke

479

1.11

0.27

1.3

1.8

37.24

39.21

u/l

0.28

410

Injury of nerves and spinal cord at thorax level

1.24

0.27

1.3

2.5

40.13

40.59

u/l

—

Toxic effect of other gases, fumes and vapours

1.24

0.27

1.1

2.2

48.88

37.12

u/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

839

5054

0.98

0.27

2.0

2.1

40.30

39.91

u/l

0.24

785

4675

Malignant neoplasm of corpus uteri

1009

0.93

0.27

2.1

1.9

36.96

39.44

u/l

0.51

874

Ectopic pregnancy

305

2936

1.04

0.27

2.0

2.1

41.27

39.95

u/l

0.60

280

2675

Left ventricular outflow tract obstruction, narrow definition

646

0.91

0.27

1.8

2.1

33.94

40.02

u/l

1.52

581

Toxic effect of contact with venomous animals

531

0.90

0.27

1.4

1.9

39.11

39.40

u/l

0.04

475

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.20

0.26

2.3

2.1

38.00

41.48

u/l

—

Congenital malformations of eye, ear, face and neck

853

0.92

0.26

2.1

2.0

37.74

39.37

u/l

0.31

786

Discontinuity and dislocation of ear ossicles

0.70

0.26

1.6

2.6

43.20

40.09

u/l

—

Dependence on enabling machines and devices, not elsewhere classified

127

0.78

0.26

2.5

2.3

51.90

41.93

u/l

—

115

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

0.70

0.26

1.0

2.5

27.40

43.11

u/l

—

Bicuspidal aortic valve syndrome

478

0.90

0.26

2.1

2.0

33.28

39.69

u/l

1.22

429

Carcinoma in situ of cervix uteri, endocervix

169

1.19

0.26

3.6

2.2

41.40

38.45

u/l

0.32

154

145

1372

1.06

0.26

1.6

2.0

37.47

38.75

u/l

0.34

132

1302

Delayed puberty

0.66

0.26

1.0

2.0

36.00

37.51

u/l

—

Abnormal spermatozoa

157

1490

1.06

0.26

1.7

37.87

37.39

u/l

0.10

136

1255

Premature rupture of membranes

351

2670

0.96

0.26

2.3

2.0

39.27

39.58

u/l

0.13

328

2514

Carcinoma in situ of cervix uteri

130

1228

1.06

0.25

2.1

39.00

38.94

u/l

0.01

125

1140

Thiamine deficiency

1.19

0.25

1.0

2.3

37.90

39.66

u/l

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

340

1.12

0.24

1.6

1.9

33.91

39.61

u/l

0.97

278

Congenital deformities of hip

198

1.17

0.24

1.7

2.1

43.91

39.45

u/l

0.45

182

Unspecified renal colic

1.18

0.24

1.4

2.2

38.56

39.85

u/l

—

Juvenile Open Angle Glaucoma

1.30

0.24

2.3

2.2

47.80

40.29

u/l

—

Caries in Clefts patients

126

0.79

0.24

1.9

2.1

32.50

39.74

u/l

—

116

Infections of genitourinary tract in pregnancy

145

1376

1.06

0.24

2.5

2.0

41.34

39.47

u/l

0.47

136

1264

Other congenital malformations of limb(s)

1.29

0.24

1.5

2.0

41.30

39.73

u/l

—

Impacted teeth

279

2503

1.04

0.24

2.0

1.9

37.60

38.92

u/l

0.57

261

2354

Injury of urinary and pelvic organs

246

1.14

0.24

2.3

2.0

40.32

39.54

u/l

0.08

220

Maternal care for known or suspected malpresentation of fetus

294

2271

0.96

0.24

1.9

2.1

38.86

39.74

u/l

0.43

281

2148

Coronary revascularization (ANGIO or CABG)

749

5110

1.02

0.24

1.6

1.8

36.05

39.09

u/l

2.99

618

4424

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

475

1.10

0.24

1.3

1.8

43.82

38.04

u/l

0.94

410

Assault by unspecified means

275

0.87

0.23

1.3

2.1

43.18

39.37

u/l

0.49

253

Complications of the puerperium, not elsewhere classified

562

1.09

0.23

1.9

2.1

40.27

39.66

u/l

0.12

526

Pre-eclampsia or poor fetal growth

544

5291

1.03

0.23

2.0

2.1

39.28

39.62

u/l

0.16

501

4884

Fracture of femur

345

3050

1.03

0.23

1.7

39.96

38.82

u/l

0.41

287

2566

Onycholysis

1.26

0.23

1.2

2.4

46.36

42.27

u/l

0.25

LSIL lesion of the cervix uteri

176

1683

1.05

0.23

2.4

2.0

37.52

39.19

u/l

0.64

168

1566

Carcinoma in situ of rectum

0.75

0.23

1.4

2.5

40.29

38.20

u/l

—

Pedal cyclist injured in transport accident

362

3513

1.03

0.22

1.9

39.44

39.51

u/l

0.02

332

3156

Liposarcoma, excluding all cancers (controls excluding all cancers)

116

1.22

0.22

2.6

1.9

37.86

39.17

u/l

0.09

100

Otosclerosis

101

1071

0.94

0.22

1.8

1.9

40.57

39.08

u/l

0.29

949

Epileptic seizures related to drugs

1.23

0.22

1.0

1.7

35.40

41.97

u/l

—

Myocardial infarction, unclassifiable

282

2430

1.04

0.22

1.5

1.6

35.51

38.03

u/l

1.22

226

2035

Other congenital malformations of ear

135

0.81

0.22

1.5

1.9

40.45

39.93

u/l

0.02

125

Carcinoma in situ of cervix uteri, exocervix

107

1.23

0.22

2.9

2.3

36.38

38.72

u/l

0.22

100

Choroidal degeneration

0.00

0.22

0.0

1.7

—

45.65

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

248

1.13

0.22

2.2

41.43

39.41

u/l

0.15

224

Benign neoplasm: Endocrine gland, other/unspecified

1.20

0.22

2.0

2.5

59.40

39.88

u/l

—

Mental and behavioural disorders due to alcohol

934

8928

1.02

0.21

1.7

2.0

40.33

38.94

u/l

1.07

822

7954

Arthropod-borne viral fevers and viral haemorrhagic fevers

148

1412

1.05

0.21

1.9

40.36

38.88

u/l

0.32

139

1247

Polydactyly

0.00

0.21

0.0

1.3

—

35.85

—

Hyperalimentation, other specified

0.00

0.21

0.0

1.6

—

42.75

—

0.00

0.21

0.0

1.1

—

44.64

—

Other congenital malformations of intestine

102

0.78

0.21

1.4

2.3

51.25

41.61

u/l

—

Coronary angioplasty

555

4359

0.98

0.21

1.6

1.8

34.84

39.01

u/l

4.75

466

3763

Flatulence and related conditions

117

1.20

0.21

1.3

2.4

32.86

39.95

u/l

0.66

106

Tibial collateral bursitis [Pellegrini-Stieda]

123

0.81

0.20

1.9

2.5

44.00

39.22

u/l

—

115

Kela-code for severe mental illness

646

6593

0.98

0.20

1.7

2.0

38.16

39.52

u/l

0.92

569

5959

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

839

1.06

0.20

1.4

1.9

39.81

38.25

u/l

0.37

728

Dislocation, sprain and strain of joints and ligaments of elbow

892

0.94

0.20

2.6

2.0

42.79

39.37

u/l

0.76

809

Rheumatic fever incl heart disease

336

1.10

0.20

1.8

2.0

39.26

39.32

u/l

0.01

293

Dementia in other diseases classified elsewhere

489

0.92

0.19

1.2

1.9

34.16

38.66

u/l

0.78

419

Wilms' tumor, excluding all cancers (controls excluding all cancers)

1.14

0.19

1.2

2.0

36.78

38.98

u/l

—

Obstructed labour due to malposition and malpresentation of fetus

377

3642

0.97

0.18

2.0

2.1

38.19

39.87

u/l

1.02

352

3414

Pedal cyclist injured in collision with motor vehicle

425

0.91

0.18

2.1

2.2

43.77

39.37

u/l

0.67

387

Malignant neoplasm of floor of mouth

1.17

0.18

1.3

2.2

41.39

36.39

u/l

—

Superficial injury of ankle and foot, unspecified

1.17

0.18

2.4

2.1

36.71

37.48

u/l

—

Pedal cyclist injured in noncollision transport accidents

160

1663

0.96

0.18

2.0

1.9

39.21

38.99

u/l

0.05

147

1496

Factitial dermatitis

1.15

0.18

1.9

2.2

26.00

40.52

u/l

—

Ankyloglossia

128

1.17

0.17

1.5

1.9

36.33

38.67

u/l

0.23

119

Ankylosing hyperostosis [Forestier]

157

1.15

0.17

1.6

2.1

41.16

37.96

u/l

0.28

138

Carcinoma in situ of breast

1.13

0.17

1.1

2.3

31.43

41.82

u/l

—

Uterine polyps

139

1334

1.04

0.17

2.0

2.1

41.11

40.19

u/l

0.21

119

1194

Sequelae of injuries of head

747

1.06

0.17

1.7

2.1

37.14

39.16

u/l

0.38

675

Intentional self-harm by hanging, strangulation and suffocation

0.74

0.17

1.4

2.1

56.80

38.44

u/l

—

Other benign neoplasm of uterus: Cervix uteri

0.72

0.17

1.0

2.7

29.40

42.33

u/l

—

Other benign neoplasm of uterus: Other parts/unspecified

454

0.92

0.17

1.3

1.8

34.21

39.67

u/l

1.08

381

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

233

2400

0.97

0.17

1.8

38.54

38.18

u/l

0.09

207

2022

Acquired stenosis of external ear canal

120

1.17

0.16

1.4

2.1

40.21

38.16

u/l

0.17

107

Maternal care for cervical incompetence

546

0.93

0.16

1.7

1.9

45.11

40.07

u/l

1.06

491

Congenital malformations of pulmonary and tricuspid valves

1.15

0.16

1.4

2.4

37.75

40.55

u/l

—

Foreign body in alimentary tract

710

1.06

0.16

1.7

1.9

41.87

38.58

u/l

0.83

637

Outcome of delivery

290

1844

0.97

0.16

2.1

2.0

39.30

39.82

u/l

0.20

266

1734

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

0.77

0.16

2.0

2.5

40.50

42.54

u/l

—

Cleft lip and palate

0.76

0.16

1.7

2.5

33.33

39.76

u/l

—

Malignant neoplasm of nasal cavity and sinuses

0.75

0.16

1.0

2.3

26.67

40.20

u/l

—

Carcinoma in situ of breast, intraductal

116

1209

0.96

0.15

2.0

39.36

40.53

u/l

0.26

102

1075

Squamous cell neoplasms and carcinoma of cervix

1.16

0.15

2.9

2.5

41.33

39.85

u/l

—

Toxic effects of substances chiefly nonmedicinal as to source

170

1644

1.04

0.15

1.4

1.9

40.03

38.76

u/l

0.35

149

1480

Effects of heat and light

1.16

0.15

1.4

2.2

32.58

39.63

u/l

—

Benign neoplasm: Skin of upper limb, including shoulder

245

1.11

0.15

2.4

2.2

33.91

39.44

u/l

0.97

214

Benign neoplasm of other and unspecified sites

441

0.93

0.15

1.9

2.0

45.24

39.09

u/l

0.57

396

Benign neoplasm of ovary

261

2678

0.97

0.15

1.9

2.0

39.55

39.88

u/l

0.10

230

2370

Type 1 diabetes, strict definition, subgroup 1

114

1092

1.04

0.15

2.5

2.1

45.96

40.08

u/l

1.92

101

1040

Subarachnoid haemorrhage

138

1331

1.04

0.15

1.6

1.9

38.61

39.08

u/l

0.09

117

1169

Neurofibromatosis, type 1

0.78

0.14

1.3

2.1

34.09

41.34

u/l

—

Labour and delivery complicated by fetal stress [distress]

398

2710

0.98

0.14

2.1

2.0

39.14

39.01

u/l

0.05

375

2561

Coronary artery bypass grafting

393

2931

1.02

0.14

1.6

1.7

36.19

38.19

u/l

0.82

317

2502

Transient global amnesia

129

1244

1.04

0.14

2.3

1.8

40.86

38.71

u/l

0.57

118

1075

Small cell lung cancer

233

0.90

0.14

1.1

2.0

30.68

36.70

u/l

0.75

200

Small cell lung cancer, helper endpoint

233

0.90

0.14

1.1

2.0

30.68

36.70

u/l

0.75

200

Postpartum hemorraghe, all women as controls

413

4191

0.98

0.14

2.0

2.1

39.12

39.36

u/l

0.10

382

3924

Malignant neoplasm of colon

191

1855

1.03

0.14

1.7

1.8

39.10

38.41

u/l

0.17

169

1580

Malignant neoplasm of retroperitoneum and peritoneum

1.20

0.14

2.7

2.6

39.10

42.37

u/l

—

Other orthopaedic follow-up care

724

1.05

0.14

1.7

1.9

39.58

39.45

u/l

0.02

652

Open bite that required surgery (Lefort1 or BSSRO)

122

1.15

0.14

1.6

2.0

40.29

39.42

u/l

0.07

113

Other specified/unspecified nutritional deficiencies

100

0.79

0.14

2.1

2.3

42.38

43.94

u/l

—

Malignant neoplasm of larynx

170

0.88

0.14

1.7

1.9

43.40

37.69

u/l

0.49

147

Congenital malformations of breast

209

1.10

0.13

2.3

1.9

38.91

38.01

u/l

0.09

194

Benign neoplasm of breast

174

1788

0.97

0.12

1.7

2.0

41.87

40.18

u/l

0.51

152

1598

Failed induction of labour

783

0.96

0.12

2.2

2.1

40.81

38.49

u/l

0.74

742

Fall on and from ladder

1015

0.96

0.11

1.7

1.9

39.44

38.09

u/l

0.26

878

Mental retardation

464

1.06

0.11

2.1

44.82

40.26

u/l

0.73

427

Osteitis due to dental implant

1.17

0.11

1.5

2.3

39.92

41.58

u/l

—

Pedestrian injured in transport accident

953

0.96

0.11

2.5

1.9

36.65

39.57

u/l

0.83

856

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

434

0.94

0.11

1.6

2.0

39.00

39.11

u/l

0.01

383

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

642

1.05

0.10

1.9

2.0

38.97

39.87

u/l

0.16

576

Pyoderma

241

1.08

0.10

1.0

2.0

39.31

39.49

u/l

0.01

217

Other congenital malformations of female genitalia

1.15

0.10

2.3

2.0

36.45

37.93

u/l

0.09

Superficial injuries involving multiple body regions

331

0.93

0.10

1.5

2.0

39.30

38.75

u/l

0.05

294

Maternal care for known or suspected fetal abnormality and damage

246

2231

0.98

0.10

2.0

2.1

39.16

39.87

u/l

0.26

229

2103

Benign neoplasm: Vulva

261

1.08

0.10

2.5

2.1

37.38

39.30

u/l

0.19

232

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.14

0.10

1.0

2.3

32.16

40.77

u/l

—

Nezelof syndrome

1.14

0.10

4.6

1.3

40.40

36.99

u/l

—

Dislocation, sprain and strain of joints and ligaments of head

555

1.05

0.10

1.6

2.2

44.40

39.93

u/l

0.91

505

Drug-induced dystonia

1.12

0.10

5.8

2.0

36.14

39.25

u/l

—

Benign neoplasm: Mediastinum

1.09

0.10

3.4

2.5

31.40

44.61

u/l

—

Postpartum hemorraghe, parous women as controls

413

3664

0.99

0.09

2.0

2.1

39.12

39.23

u/l

0.04

382

3419

Chloasma

1.14

0.09

1.0

1.8

35.67

39.52

u/l

—

Perforation of oesophagus

1.14

0.09

1.0

2.1

29.62

35.79

u/l

—

Serous carcinoma of ovary

431

0.95

0.09

1.6

2.0

39.00

40.48

u/l

0.20

376

Vaginal lichen planus

1.07

0.09

3.3

1.9

39.83

39.85

u/l

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

1.05

0.08

1.0

1.9

49.33

41.96

u/l

—

Acute lymphocytic leukaemia, helper endpoint

1.05

0.08

1.0

1.9

49.33

41.96

u/l

—

Carcinoma in situ of cervix uteri

130

1269

1.03

0.08

2.1

39.00

39.09

u/l

0.02

125

1179

Left side

0.83

0.08

2.6

2.2

37.54

35.90

u/l

—

Other bursitis, not elsewhere classified

113

0.88

0.08

1.5

2.6

42.20

37.83

u/l

—

102

Other specified/unspecified diseases of inner ear

0.80

0.08

1.2

2.0

39.80

42.08

u/l

—

Male infertility

694

0.96

0.08

1.3

2.2

40.84

39.55

u/l

0.20

632

Anuria and oliguria

0.82

0.08

1.4

2.1

31.20

41.41

u/l

—

Renal cell carcinoma of kidney

361

1.05

0.08

1.6

1.9

33.91

38.10

u/l

0.63

313

Traumatic amputation of wrist and hand

562

0.96

0.08

2.1

1.8

41.32

38.27

u/l

0.40

502

Malignant neoplasm of anus and anal canal

1.05

0.08

1.3

2.4

39.29

39.95

u/l

—

Carcinoma in situ of breast

1.05

0.08

1.1

2.1

31.43

41.10

u/l

—

Amoebiasis

1.05

0.08

2.1

2.2

53.00

41.51

u/l

—

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

0.82

0.07

1.3

2.0

35.33

41.05

u/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.81

0.07

1.8

2.2

30.50

39.21

u/l

—

Other injuries of upper limb, level unspecified

137

1.10

0.07

1.3

2.3

37.72

40.20

u/l

—

126

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

844

0.97

0.07

2.1

2.0

40.04

39.58

u/l

0.08

738

Phakomatoses, not elsewhere classified

143

0.91

0.07

1.4

2.1

35.66

40.50

u/l

0.41

130

Exposure to excessive heat of man-made origin

1.05

0.07

2.1

2.0

53.38

38.77

u/l

—

Impacted maxillary canine

1.05

0.07

1.8

1.5

44.50

33.82

u/l

—

Mental retardation, wide definition

500

1.04

0.07

2.1

46.57

40.29

u/l

1.11

457

Other noninflammatory disorders of cervix uteri

629

1.03

0.07

2.1

2.0

39.27

40.51

u/l

0.20

556

Viral haemorrhagic fevers, not elsewhere classified/unspecified

118

1155

1.02

0.07

2.0

40.55

39.01

u/l

0.28

112

1029

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.86

0.07

1.3

2.1

42.50

37.20

u/l

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

0.84

0.06

1.8

2.3

29.13

42.56

u/l

—

Vascular dementia

706

0.97

0.06

1.4

1.6

33.99

37.50

u/l

0.73

579

Nontraumatic intracranial haemmorrhage

259

2623

0.99

0.06

1.7

1.8

38.15

38.99

u/l

0.23

218

2259

Alcohol abuse, main dg

240

2368

1.01

0.06

1.5

1.9

39.82

38.98

u/l

0.23

212

2122

Colorectal cancer, excluding all cancers (controls excluding all cancers)

373

3644

0.99

0.06

1.7

1.8

38.95

38.66

u/l

0.09

326

3109

Hepatocellular carcinoma

197

1.07

0.06

1.0

1.8

49.57

36.14

u/l

1.33

171

Other diseases of appendix

152

0.92

0.06

1.6

2.3

35.51

38.05

u/l

0.20

136

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

911

0.98

0.06

1.4

1.9

39.81

38.42

u/l

0.33

805

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

527

0.97

0.06

1.3

1.9

39.13

39.04

u/l

0.01

448

Malignant neoplasm of oral cavity

395

0.96

0.05

1.3

2.0

37.90

39.80

u/l

0.20

347

Other or unspecified paralytic strabismus

1.12

0.05

2.6

2.5

43.70

42.07

u/l

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

198

1.06

0.05

1.1

1.9

30.68

38.46

u/l

1.04

165

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

159

1.07

0.05

1.8

2.3

33.64

39.09

u/l

0.57

144

Use of disulfiram, acamprosate or naltrexone

139

1369

1.02

0.05

1.4

2.0

40.60

39.42

u/l

0.28

120

1230

Benign neoplasm: Skin of upper limb, including shoulder

258

1.05

0.05

2.4

2.2

33.91

40.13

u/l

1.14

230

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

486

1.03

0.04

1.4

2.0

38.07

38.51

u/l

0.05

422

Hydrocephalus

903

1.02

0.04

1.6

1.8

37.88

38.87

u/l

0.16

780

Other congenital malformations of face and neck

393

0.97

0.04

2.3

2.1

36.36

39.36

u/l

0.43

357

Other obstetric trauma

774

1.02

0.04

2.1

38.89

39.65

u/l

0.13

725

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

635

1.02

0.04

1.5

1.8

39.84

38.36

u/l

0.19

526

Injury of blood vessels at wrist and hand level

1.10

0.04

1.9

2.4

34.27

40.26

u/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

101

1027

0.98

0.04

1.6

2.1

48.20

40.07

u/l

2.13

959

Villonodular synovitis (pigmented)

101

1.09

0.04

1.4

2.8

37.18

39.20

u/l

0.12

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

119

1207

0.99

0.04

2.0

37.23

40.01

u/l

0.79

108

1040

Type 1 diabetes, strict definition

120

1180

1.01

0.04

2.7

2.1

45.32

39.87

u/l

1.80

106

1121

Injuries involving multiple body regions

498

1.02

0.03

1.7

2.1

37.42

38.95

u/l

0.20

451

Other disorders of male genital organs

498

1.02

0.03

1.9

2.0

41.91

38.69

u/l

0.45

446

Exclusion endpoint for supernumerary teeth

151

1.06

0.03

1.4

2.1

36.13

40.64

u/l

0.64

139

Other congenital malformations of tongue, mouth and pharynx

111

1.08

0.03

1.7

2.0

38.83

37.40

u/l

0.10

102

Carcinoma in situ of breast, intraductal

116

1174

0.99

0.03

2.0

2.1

39.36

40.21

u/l

0.17

102

1046

Injury of other and unspecified intrathoracic organs

828

1.02

0.02

2.4

1.9

46.04

38.55

u/l

2.38

733

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

132

1.06

0.02

1.2

2.1

39.71

41.06

u/l

0.09

113

Colon adenocarcinoma

143

1417

1.01

0.02

1.8

1.7

39.26

38.11

u/l

0.26

126

1199

Generalized epilepsy, mode (most common among epilepsy diagnosis)

431

1.02

0.02

1.7

2.1

44.36

38.82

u/l

0.90

397

Rheumatic valve diseases

222

1.04

0.02

1.9

1.8

37.72

37.83

u/l

0.01

196

Chronic viral hepatitis

800

1.01

0.02

1.9

2.1

50.86

40.33

u/l

2.13

740

Generalized epilepsy

581

1.02

0.02

1.6

2.1

45.66

39.83

u/l

1.20

533

Puerperal sepsis

208

2068

1.01

0.02

2.0

39.84

40.09

u/l

0.07

188

1866

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

260

2567

1.00

0.01

2.0

38.89

40.01

u/l

0.41

228

2246

Injury of muscle and tendon at ankle and foot level

338

0.98

0.01

1.8

2.1

39.96

38.42

u/l

0.19

307

Mixed specific developmental disorders

146

0.96

0.01

1.5

1.9

44.27

38.99

u/l

0.51

137

Routine general health check-up of defined subpopulation

217

0.97

0.01

1.2

2.2

39.52

39.49

u/l

0.00

200

Malignant neoplasm of testis

233

1.03

0.01

2.4

2.1

43.68

39.68

u/l

0.27

212

Spontaneous abortion

868

5895

1.00

0.01

2.1

2.0

39.99

39.68

u/l

0.20

802

5356

Alcohol use disorder, ICD-based

726

7250

1.00

0.01

1.6

2.0

40.23

39.02

u/l

0.74

641

6446

Mental and behavioural disorders due to alcohol, excluding acute intoxication

786

7844

1.00

0.00

1.7

2.0

40.47

39.00

u/l

1.04

693

6964

Benign neoplasm of ovary

261

2611

1.00

0.00

1.9

2.0

39.55

39.97

u/l

0.12

230

2302

Benign neoplasm of breast

174

1738

1.00

0.00

1.7

2.1

41.87

39.88

u/l

0.63

152

1548

Migraine without aura, drug-induced

165

1.03

0.00

4.2

2.4

38.45

40.31

u/l

0.16

149

Benign neoplasm: Vulva

285

0.98

0.00

2.5

2.1

37.38

39.71

u/l

0.24

249

Maternal care for known or suspected disproportion

684

0.99

0.00

2.7

2.2

36.65

40.48

u/l

1.02

644

Postpartum care and examination

240

1534

1.00

0.00

1.9

2.0

38.20

39.61

u/l

0.58

220

1450

Benign neoplasm of other and unspecified sites

412

0.99

0.00

1.9

2.1

45.24

39.17

u/l

0.56

362

Prolapse and hernia of ovary and fallopian tube

359

0.99

0.00

2.0

1.8

35.55

39.88

u/l

0.57

295

Carcinoma in situ, bladder

373

0.99

0.00

1.4

1.7

36.55

37.43

u/l

0.10

321

Delayed milestone in childhood

1.05

0.00

1.0

1.5

39.90

39.06

u/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

753

1.00

0.00

1.6

2.1

36.20

40.36

u/l

1.25

678

Liposarcoma

1.04

0.00

2.0

2.2

31.10

39.95

u/l

—

Type1 diabetes, definitions combined, early onset

919

1.00

0.00

2.7

2.1

44.24

39.91

u/l

1.05

865

Peptic ulcer

117

1.03

0.00

1.2

2.2

40.58

41.59

u/l

0.08

Findings of drugs and other substances, not normally found in blood

0.92

0.00

1.2

2.0

41.40

42.52

u/l

—

Defects in post-translational modification of lysosomal enzymes

0.00

0.0

1.7

—

40.86

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

0.0

3.0

—

46.43

—

Carcinoma in situ of rectum

0.88

0.00

1.4

2.2

40.29

41.69

u/l

—

Peutz-Jeghers syndrome

0.00

0.0

1.3

—

52.50

—

Other injuries of spine and trunk, level unspecified

0.95

0.00

2.6

2.4

46.67

38.63

u/l

—

Drug-induced tremor

0.91

0.00

1.0

2.7

46.29

41.58

u/l

—

Acute hepatitis B

0.88

0.00

1.7

2.5

64.50

40.15

u/l

—

Sequelae of intentional self-harm, assault and events of undetermined intent

0.99

0.00

1.3

1.9

46.25

39.51

u/l

—

Androgen resistance syndrome

0.00

0.0

1.6

—

45.40

—

Cleft lip and cleft lip and palate

0.92

0.00

1.9

2.2

29.56

39.67

u/l

—

Lupus erythematosus, drug-induced

0.00

0.0

1.2

—

43.17

—

Handgun discharge, undetermined intent

0.00

0.0

1.0

—

39.83

—

Hypercementosis

0.00

0.0

1.3

—

55.67

—

Drowning and submersion in swimming-pool or bath

0.00

0.0

3.2

—

41.33

—

Benign neoplasm: Mediastinum

0.92

0.00

3.4

2.4

31.40

42.69

u/l

—

Alopecia mucinosa

0.00

0.0

1.2

—

28.80

—

Traumatic amputation of forearm

0.00

0.0

2.6

—

45.10

—

Trachoma

0.00

0.0

3.6

—

30.20

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.87

0.00

1.5

2.1

39.17

39.57

u/l

—

Malignant neoplasm of pyriform sinus

0.00

0.0

2.3

—

30.88

—

Other injuries of lower limb, level unspecified

0.91

0.00

1.8

2.3

36.00

39.12

u/l

—

Burn and corrosion, body region unspecified

0.99

0.00

1.0

2.1

40.57

39.42

u/l

—

Leptospirosis

0.00

0.0

1.4

—

49.00

—

Toxic effect of aflatoxin and other mycotoxin food contaminants

0.00

0.0

3.0

—

29.00

—

Wilms' tumor

0.97

0.00

1.2

1.7

36.78

38.07

u/l

—

Dietary zinc deficiency

0.00

0.0

2.7

—

43.29

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

110

1.00

0.00

1.3

2.1

38.73

38.67

u/l

0.01

104

Acute lymphocytic leukaemia

1.02

0.00

1.0

1.8

49.33

42.02

u/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.02

0.00

2.0

2.4

34.00

42.62

u/l

—

Motor disorders, excluding more controls

0.96

0.00

1.0

2.0

41.00

38.95

u/l

—

Other perinatal haematological disorders

0.00

0.0

1.4

—

37.80

—

Haemolytic disease of fetus and newborn

0.00

0.0

1.0

—

26.40

—

Neonatal aspiration syndromes

0.00

0.0

1.0

—

29.71

—

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

0.92

0.00

1.4

2.6

40.00

47.36

u/l

—

Other/unspecified mastoiditis and related conditions

0.97

0.00

2.0

2.4

36.83

42.47

u/l

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.86

0.00

1.2

2.5

39.60

39.85

u/l

—

Total (external) ophthalmoplegia

0.00

0.0

3.0

—

53.83

—

Glaucoma in diseases classified elsewhere

0.00

0.0

1.8

—

49.33

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.98

0.00

2.0

34.00

42.53

u/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS